<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000934.pub3" GROUP_ID="PREG" ID="605999073011291323" MERGED_FROM="" MODIFIED="2015-07-07 15:32:30 +0100" MODIFIED_BY="Leanne Jones" REVIEW_NO="0128" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2015-07-07 15:32:30 +0100" MODIFIED_BY="Leanne Jones">
<TITLE MODIFIED="2009-02-04 10:53:05 +0000" MODIFIED_BY="Sonja Henderson">Alternative versus standard packages of antenatal care for low-risk pregnancy</TITLE>
<CONTACT MODIFIED="2015-07-07 15:32:30 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="7397" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lelia</FIRST_NAME><LAST_NAME>Duley</LAST_NAME><POSITION>Director/Professor of Clinical Trials Research</POSITION><EMAIL_1>lelia.duley@nottingham.ac.uk</EMAIL_1><MOBILE_PHONE>07979744934</MOBILE_PHONE><ADDRESS><DEPARTMENT>Nottingham Clinical Trials Unit</DEPARTMENT><ORGANISATION>Nottingham Health Science Partners</ORGANISATION><ADDRESS_1>C Floor, South Block</ADDRESS_1><ADDRESS_2>Queen's Medical Centre</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>44 115 8844919</PHONE_1><FAX_1>44 115 9194430</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-07-07 15:32:30 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="70FC7AD782E26AA201D1E765998F939C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Therese</FIRST_NAME><LAST_NAME>Dowswell</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>t.dowswell@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7959575</PHONE_1><FAX_1>+44 151 7959598</FAX_1></ADDRESS></PERSON><PERSON ID="5141" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Guillermo</FIRST_NAME><LAST_NAME>Carroli</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>gcarroli@crep.org.ar</EMAIL_1><ADDRESS><ORGANISATION>Centro Rosarino de Estudios Perinatales (CREP)</ORGANISATION><ADDRESS_1>Moreno 878 piso 6</ADDRESS_1><CITY>Rosario</CITY><ZIP>2000</ZIP><REGION>Santa Fe</REGION><COUNTRY CODE="AR">Argentina</COUNTRY><PHONE_1>+54 41 483887</PHONE_1><PHONE_2>+54 41 472625</PHONE_2><FAX_1>+54 41 483887</FAX_1></ADDRESS></PERSON><PERSON ID="7397" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lelia</FIRST_NAME><LAST_NAME>Duley</LAST_NAME><POSITION>Director/Professor of Clinical Trials Research</POSITION><EMAIL_1>lelia.duley@nottingham.ac.uk</EMAIL_1><MOBILE_PHONE>07979744934</MOBILE_PHONE><ADDRESS><DEPARTMENT>Nottingham Clinical Trials Unit</DEPARTMENT><ORGANISATION>Nottingham Health Science Partners</ORGANISATION><ADDRESS_1>C Floor, South Block</ADDRESS_1><ADDRESS_2>Queen's Medical Centre</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>44 115 8844919</PHONE_1><FAX_1>44 115 9194430</FAX_1></ADDRESS></PERSON><PERSON ID="9147" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Simon</FIRST_NAME><LAST_NAME>Gates</LAST_NAME><EMAIL_1>s.gates@warwick.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Warwick Clinical Trials Unit</DEPARTMENT><ORGANISATION>Division of Health Sciences, Warwick Medical School, The University of Warwick</ORGANISATION><ADDRESS_1>Gibbet Hill Road</ADDRESS_1><CITY>Coventry</CITY><ZIP>CV4 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 2476 575850</PHONE_1><FAX_1>+44 2476 574657</FAX_1></ADDRESS></PERSON><PERSON ID="15905" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>A Metin</FIRST_NAME><LAST_NAME>Gülmezoglu</LAST_NAME><POSITION>Scientist</POSITION><EMAIL_1>gulmezoglum@who.int</EMAIL_1><URL>http://www.who.int/reproductive-health/rhl/index.html</URL><ADDRESS><DEPARTMENT>UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research</DEPARTMENT><ORGANISATION>World Health Organization</ORGANISATION><ADDRESS_1>20 Avenue Appia</ADDRESS_1><CITY>Geneva</CITY><ZIP>1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 22 7913417</PHONE_1><FAX_1>+41 22 7914171</FAX_1></ADDRESS></PERSON><PERSON ID="15930" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Dina</FIRST_NAME><LAST_NAME>Khan-Neelofur</LAST_NAME><POSITION>Independent Consultant</POSITION><EMAIL_1>khan.dina@gmail.com</EMAIL_1><MOBILE_PHONE>+961 71 429089</MOBILE_PHONE><ADDRESS><ORGANISATION/><ADDRESS_1>Parkview Tower, 5th Floor</ADDRESS_1><CITY>Ras Beirut</CITY><COUNTRY CODE="LB">Lebanon</COUNTRY><PHONE_1>+961 1 378808</PHONE_1></ADDRESS></PERSON><PERSON ID="15990" ROLE="AUTHOR"><FIRST_NAME>Gilda</FIRST_NAME><LAST_NAME>Piaggio</LAST_NAME><POSITION>Honorary Professor</POSITION><EMAIL_1>gilda.piaggio@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Medical Statistics Department</DEPARTMENT><ORGANISATION>London School of Hygiene and Tropical Medicine</ORGANISATION><CITY>London</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-03-23 12:52:47 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="23" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="23" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="23" MONTH="3" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-05-27 09:20:14 +0100" MODIFIED_BY="Heather Maxwell">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-03-23 10:40:19 +0000" MODIFIED_BY="Sonja L Henderson">
<DATE DAY="23" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Review updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-05-27 09:20:14 +0100" MODIFIED_BY="Heather Maxwell">
<DATE DAY="23" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Search updated and five new reports identified. <LINK REF="STD-Famuyide-2014" TYPE="STUDY">Famuyide 2014</LINK> describes an ongoing study, which focuses on a reduced number of antenatal visits. <LINK REF="REF-Hutton-2004" TYPE="REFERENCE">Hutton 2004</LINK> and <LINK REF="REF-Vogel-2013" TYPE="REFERENCE">Vogel 2013</LINK> are reports of additional analyses relating to the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial, which is already included in the review. Two additional studies have been excluded: <LINK REF="STD-Clark-2013" TYPE="STUDY">Clark 2013</LINK> and <LINK REF="STD-Tomlinson-2014" TYPE="STUDY">Tomlinson 2014</LINK>. In total, the review now includes seven studies, 18 studies have been excluded and one is ongoing.</P>
<P>Methods updated and a 'Summary of findings' table has been incorporated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-01-14 10:36:05 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-01-14 10:36:05 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="9" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated. One new report added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (Hutton 2004).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-09-12 09:38:41 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="3" YEAR="2011"/>
<DESCRIPTION>
<P>Contact details amended.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2011-03-15 14:15:23 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="6" YEAR="2010"/>
<DESCRIPTION>
<P>The scope has been changed so that the review focuses on reduced schedules of antenatal visits and no longer includes studies looking at alternative care providers. New data from one trial have been included (<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>), and one further trial has been excluded (<LINK REF="STD-Kusulasai-1993" TYPE="STUDY">Kusulasai 1993</LINK>). We have updated the methods section, and have used new methods to analyse data from cluster-randomised trials. Conclusions have changed since the original review. Whilst there is little difference between groups for most outcomes, in studies carried out in low-resource settings, where many women attended for antenatal care on fewer than five occasions, there is some evidence that perinatal mortality may be increased with reduced visits.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-03-15 14:15:24 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="4" YEAR="2010"/>
<DESCRIPTION>
<P>Search updated. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-07 10:44:04 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-06-05 14:23:58 +0100" MODIFIED_BY="Leanne V Jones">
<INTERNAL_SOURCES MODIFIED="2010-08-17 10:54:30 +0100" MODIFIED_BY="Denise Atherton">
<SOURCE MODIFIED="2010-08-17 10:54:30 +0100" MODIFIED_BY="Denise Atherton">
<NAME>HRP-UNDP/UNFPA/WHO/WORLD BANK</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Leeds</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2010-03-23 11:27:33 +0000" MODIFIED_BY="[Empty name]">
<NAME>The University of Liverpool</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2015-06-05 14:23:58 +0100" MODIFIED_BY="Leanne V Jones">
<SOURCE MODIFIED="2015-06-05 14:23:58 +0100" MODIFIED_BY="Leanne V Jones">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>TD was supported in 2011 update by the NIHR NHS Cochrane Collaboration Programme grant scheme award for NHS-prioritised centrally-managed, pregnancy and childbirth systematic reviews: CPGS02</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-07-07 15:03:16 +0100" MODIFIED_BY="Leanne V Jones">
<SUMMARY MODIFIED="2015-04-01 11:10:42 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-05-19 09:39:15 +0100" MODIFIED_BY="[Empty name]">Alternative packages of antenatal care for low-risk pregnant women</TITLE>
<SUMMARY_BODY MODIFIED="2015-04-01 11:10:42 +0100" MODIFIED_BY="[Empty name]">
<P>A routine number of visits for pregnant women has developed as part of antenatal or prenatal care without evidence of how much care is necessary to optimise the health of mothers and babies, and what is helpful for the women. These visits can include tests, education and other health checks. The review set out to compare studies where women receiving standard care were compared with women attending on a reduced number of occasions. We included seven randomised controlled trials involving more than 60,000 women. We assessed studies for risk of bias and graded the quality of the evidence. The trials were carried out in both high-income (four trials) and low- and middle-income countries (three trials). In high-income countries the number of visits was reduced to around eight. In lower-income countries many women in the reduced visits group attended for care on fewer than five occasions, although the content of visits was altered so as to focus on specific goals. In this review there was no strong evidence of differences between groups receiving a reduced number of antenatal visits compared with standard care on the number of preterm births or low birthweight babies (moderate-quality evidence). However, there was some evidence from these trials that in low- and middle-income countries perinatal mortality may be increased with reduced visits (low-quality evidence) although there may have been fewer admissions to neonatal intensive care but the evidence for this latter outcome was not strong. There was no clear difference between groups for our other primary outcomes including maternal death and hypertensive disorders of pregnancy (including pre-eclampsia). There was evidence that women in all settings were less satisfied with the reduced schedule of visits; for some women the gap between visits was perceived as too long. Reduced visits may be associated with lower costs.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-05-27 09:08:57 +0100" MODIFIED_BY="Heather Maxwell">
<ABS_BACKGROUND MODIFIED="2010-07-26 10:13:02 +0100" MODIFIED_BY="[Empty name]">
<P>The number of visits for antenatal (prenatal) care developed without evidence of how many visits are necessary. The content of each visit also needs evaluation.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-07-21 12:19:58 +0100" MODIFIED_BY="Lelia Duley">
<P>To compare the effects of antenatal care programmes with reduced visits for low-risk women with standard care.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-03-23 12:53:13 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (23 March 2015), reference lists of articles and contacted researchers in the field.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-05-27 09:08:44 +0100" MODIFIED_BY="Heather Maxwell">
<P>Randomised trials comparing a reduced number of antenatal visits, with or without goal-oriented care, versus standard care.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-05-27 09:08:44 +0100" MODIFIED_BY="Heather Maxwell">
<P>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked for accuracy. We assessed studies for risk of bias and graded the quality of the evidence.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-05-27 09:08:57 +0100" MODIFIED_BY="Heather Maxwell">
<P>We included seven trials (more than 60,000 women): four in high-income countries with individual randomisation; three in low- and middle-income countries with cluster randomisation (clinics as the unit of randomisation). Most of the data included in the review came from the three large, well-designed cluster-randomised trials that took place in Argentina, Cuba, Saudi Arabia, Thailand and Zimbabwe. All results have been adjusted for the cluster design effect. All of the trials were at some risk of bias as blinding of women and staff was not feasible with this type of intervention. For primary outcomes, evidence was graded as being of moderate or low quality, with downgrading decisions due to risks of bias and imprecision of effects.</P>
<P>The number of visits for standard care varied, with fewer visits in low- and middle- income country trials. In studies in high-income countries, women in the reduced visits groups, on average, attended between 8.2 and 12 times. In low- and middle- income country trials, many women in the reduced visits group attended on fewer than five occasions, although in these trials the content as well as the number of visits was changed, so as to be more 'goal-oriented'.</P>
<P>Perinatal mortality was increased for those randomised to reduced visits rather than standard care, and this difference was borderline for statistical significance (risk ratio (RR) 1.14; 95% confidence interval (CI) 1.00 to 1.31; five trials, 56,431 babies; <I>moderate-quality evidence</I>). In the subgroup analysis, for high-income countries the number of deaths was small (32/5108), and there was no clear difference between the groups (RR 0.90; 95% CI 0.45 to 1.80, two trials); for low- and middle-income countries perinatal mortality was significantly higher in the reduced visits group (RR 1.15; 95% CI 1.01 to 1.32, three trials).</P>
<P>There was no clear difference between groups for our other primary outcomes: maternal death (RR 1.13, 95%CI 0.50 to 2.57, three cluster-randomised trials, 51,504 women, <I>low-quality evidence</I>); hypertensive disorders of pregnancy (various definitions including pre-eclampsia) (RR 0.95, 95% CI 0.80 to 1.12, six studies, 54,108 women, <I>low-quality evidence</I>); preterm birth (RR 1.02, 95% CI 0.94 to 1.11; seven studies, 53,661 women, <I>moderate-quality evidence</I>); and small-for-gestational age (RR 0.99, 95% CI 0.91 to 1.09, four studies 43,045 babies, <I>moderate-quality evidence</I>).</P>
<P>Reduced visits were associated with a reduction in admission to neonatal intensive care that was borderline for significance (RR 0.89; 95% CI 0.79 to 1.02, five studies, 43,048 babies, moderate quality evidence). There were no clear differences between the groups for the other secondary clinical outcomes.</P>
<P>Women in all settings were less satisfied with the reduced visits schedule and perceived the gap between visits as too long. Reduced visits may be associated with lower costs.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-01-19 14:07:51 +0000" MODIFIED_BY="[Empty name]">
<P>In settings with limited resources where the number of visits is already low, reduced visits programmes of antenatal care are associated with an increase in perinatal mortality compared to standard care, although admission to neonatal intensive care may be reduced. Women prefer the standard visits schedule. Where the standard number of visits is low, visits should not be reduced without close monitoring of fetal and neonatal outcome.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-07-07 15:03:16 +0100" MODIFIED_BY="Leanne V Jones">
<BACKGROUND MODIFIED="2015-05-27 09:09:30 +0100" MODIFIED_BY="Heather Maxwell">
<INTERVENTION MODIFIED="2015-05-27 09:09:30 +0100" MODIFIED_BY="Heather Maxwell">
<P>Antenatal (also known as prenatal) care programmes, as currently practised, originate from models developed in Europe in the early decades of the past century (<LINK REF="REF-Oakley-1982" TYPE="REFERENCE">Oakley 1982</LINK>). The concept arose from the (at that time) newly emerging belief in the possibility of avoidance of maternal death and also of fetal and infant death. In 1929, Dr Janet Campbell, a civil servant in the UK stated, "the first requirement of a maternity service is effective supervision of the health of the woman during pregnancy...." (<LINK REF="REF-Oakley-1982" TYPE="REFERENCE">Oakley 1982</LINK>). Around this time, the UK Ministry of Health specified that antenatal examination should begin at around 16 weeks, and be followed by visits at 24 and 28 weeks, then fortnightly to 36 weeks and weekly thereafter (<LINK REF="REF-Oakley-1982" TYPE="REFERENCE">Oakley 1982</LINK>). This guidance also laid out the content of the examination for each visit (such as measuring uterine height, checking the fetal heart and testing urine) and recommended those at 32 and 36 weeks be done by a medical officer. To our knowledge, these recommendations have formed the basis for antenatal care programmes throughout the world. As medical knowledge and technology have evolved, new components have been added to the routinely offered package of antenatal care. These have primarily been screening interventions to improve identification of high-risk women. There have also been shifting patterns, and power struggles between obstetricians, primary care physicians and midwives, in who delivers or manages antenatal care for low-risk women (<LINK REF="REF-Loudon-1992" TYPE="REFERENCE">Loudon 1992</LINK>). Since the inception of modern antenatal care, few of its common components have been formally evaluated, and there is little reliable evidence of the relative merits, hazards and costs of alternative packages of care. In the past, alternative schedules for the frequency of antenatal care visits, the interval between visits, and the content of each visit have not been rigorously compared. Antenatal care has perhaps been rather more ritualistic than rational.</P>
<P>Nevertheless, it is reasonable to assume that antenatal care does confer some health benefits, although how it does so may be complex and multifactorial. One example which supports antenatal and intrapartum care having a major impact on outcome comes from the US; where women in the state of Indiana who belong to a religious group who do not seek antenatal care, and who give birth at home without trained attendants, have perinatal mortality three times higher, and maternal mortality 100 times higher, than other women in the state (<LINK REF="REF-Kaunitz-1984" TYPE="REFERENCE">Kaunitz 1984</LINK>). However, few of the procedures commonly undertaken within antenatal care have been shown to have a major impact on maternal and perinatal morbidity or mortality, and some may have no effect. For others, there can be no impact unless other elements are also in place and functional. To further complicate the evaluation of antenatal care, there is a varying effect across populations and there may be different models and standards for care during childbirth which will also impact on outcome.</P>
<P>Observational studies tend to show that women who receive antenatal care have lower maternal and perinatal mortality and better pregnancy outcomes. These studies also tend to demonstrate an association between the number of antenatal visits, and/or gestational age at the initiation of care, and pregnancy outcomes, after controlling for confounding factors such as length of gestation. Because of this suggested dose-response effect, antenatal care programmes often seek to increase the quantity of care provided without taking into account that, by and large, low-risk women attend for antenatal care earlier in pregnancy than high-risk women. In recent years, apart from frequency of visits and the intervals between the visits, attention has also been directed to the essential elements of the antenatal care package, to ensure that quality is not overlooked in favour of quantity. It has also been suggested that, perhaps, more effective care could be provided with fewer but 'goal-oriented' visits, particularly focused on the components of antenatal care that have been proven to be effective and have an impact on substantive outcomes.</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2015-05-26 10:34:27 +0100" MODIFIED_BY="Heather Maxwell">
<P>Rigorous evaluation of the comparative clinical and cost effectiveness of alternative strategies for provision of antenatal care are required, along with information about the perception of such care by women, their preferences, and those of the care providers. The economic implications of alternative antenatal care programmes are of particular importance in low- and middle-income countries where resources are most scarce, but are also relevant in higher income/industrialised settings.</P>
<P>The key issue is not whether there is more or less antenatal care; rather it is that antenatal care should include only those activities supported by reasonable evidence of effectiveness and safety. The frequency of visits and the content of visits can then be planned accordingly. For overviews of systematic reviews on the effectiveness of different components of antenatal care, <I>see</I> <LINK REF="REF-Bergsjo-1997" TYPE="REFERENCE">Bergsjo 1997</LINK>; <LINK REF="REF-Carroli-2001a" TYPE="REFERENCE">Carroli 2001a</LINK>; <LINK REF="REF-De-Onis-1998" TYPE="REFERENCE">De Onis 1998</LINK>; <LINK REF="REF-G_x00fc_lmezoglu-1997" TYPE="REFERENCE">Gülmezoglu 1997</LINK>; <LINK REF="REF-Villar--1997" TYPE="REFERENCE">Villar 1997</LINK>; <LINK REF="REF-Villar-1998" TYPE="REFERENCE">Villar 1998</LINK>.</P>
<P>This review aims to assess whether similar clinical outcomes can be achieved with reduced rather than standard antenatal care packages.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-05-27 09:09:42 +0100" MODIFIED_BY="Heather Maxwell">
<P>The objectives of this review are to compare the effects of antenatal care programmes providing a reduced number of antenatal care visits for low-risk women with programmes providing the standard schedule of visits, and to assess the views of the care providers and the women receiving antenatal care.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-07-07 15:02:08 +0100" MODIFIED_BY="Leanne V Jones">
<SELECTION_CRITERIA MODIFIED="2015-05-27 09:10:07 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2015-05-27 09:09:57 +0100" MODIFIED_BY="Heather Maxwell">
<P>All acceptable randomised controlled trials comparing programmes of antenatal care with varied number of visits. We included quasi-randomised studies, such as those based on alternate allocation or allocation by days of the week. We included both cluster- and individually-randomised trials. Cross-over trials were not eligible for inclusion in this review.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-08-17 10:54:24 +0100" MODIFIED_BY="Denise Atherton">
<P>Pregnant women attending antenatal care clinics and considered (using criteria defined by the trialists) to be at low risk of developing complications during pregnancy and labour. We excluded studies that included primarily high-risk women. If any studies included both high- and low-risk women, where separate data were available, we planned to include only data for the low-risk women in the review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-02-12 13:55:01 +0000" MODIFIED_BY="[Empty name]">
<P>Provision of a schedule of reduced number of visits, with or without goal-oriented antenatal care, compared with a standard schedule of visits.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-05-27 09:10:07 +0100" MODIFIED_BY="Heather Maxwell">
<P>We considered outcome measures for this review mainly focusing on clinical outcomes including maternal, fetal and newborn outcomes. We also considered cost effectiveness and measures of perception of care by the women as well as care providers participating in the trials as important outcomes for the review. The list of outcomes includes the following.</P>
<SUBSECTION>
<HEADING LEVEL="4">Compliance with the allocated intervention</HEADING>
<UL>
<LI>Number of antenatal visits</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">For the women</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcomes</HEADING>
<UL>
<LI>Pre-eclampsia</LI>
<LI>Maternal death</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<UL>
<LI>Eclampsia</LI>
<LI>Gestational hypertension</LI>
<LI>Anaemia (haemoglobin less than 100 g/L</LI>
<LI>Urinary tract infection (requiring treatment with antibiotics)</LI>
<LI>Caesarean section</LI>
<LI>Induction of labour</LI>
<LI>Antepartum haemorrhage</LI>
<LI>Postpartum haemorrhage (less than 500 mL, less than 1000 mL)</LI>
<LI>Stroke</LI>
<LI>Postnatal depression</LI>
<LI>Antenatal depression</LI>
<LI>Women's views of antenatal care</LI>
<LI>Care providers' views of antenatal care</LI>
<LI>Long-term emotional and physical wellbeing</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">For the babies</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcomes</HEADING>
<UL>
<LI>Baby death (stillbirth, perinatal death, neonatal death, infant death)</LI>
<LI>Preterm birth (less than 37 weeks, less than 34 weeks)</LI>
<LI>Small-for-gestational age</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<UL>
<LI>Low birthweight (less than 2500 g, less than 1500 g, less than 1000 g)</LI>
<LI>Admission to neonatal intensive care</LI>
<LI>Breastfeeding</LI>
<LI>Measure of long-term growth and development</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs to the health services</HEADING>
<UL>
<LI>Number of antenatal visits</LI>
<LI>Admission to hospital, length of stay in hospital</LI>
<LI>Admission to intensive care or neonatal intensive care, and length of stay</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-03-23 12:54:16 +0000" MODIFIED_BY="[Empty name]">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2015-03-23 12:54:09 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (23 March 2015).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE, Embase and CINAHL, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-03-23 12:54:16 +0000" MODIFIED_BY="[Empty name]">
<P>We searched reference lists of retrieved papers and personal communications and contacted principal investigators of included trials to obtain data on the relevant outcomes which were not reported in the original publication.</P>
<P>We did not apply any language or date restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-07-07 15:02:08 +0100" MODIFIED_BY="Leanne V Jones">
<STUDY_SELECTION MODIFIED="2015-01-14 09:31:28 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any differences in opinion by discussion. If we could not reach agreement, we consulted a third author.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-01-14 09:47:46 +0000" MODIFIED_BY="[Empty name]">
<P>For this and previous updates, for eligible studies, two review authors independently extracted data from study reports using a standard form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-07-07 15:02:08 +0100" MODIFIED_BY="Leanne V Jones">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved disagreement by discussion or by involving a third assessor.</P>
<SUBSECTION>
<HEADING LEVEL="4"> (1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. .</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; randomisation, consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>Given the nature of the interventions evaluated, even in well-designed and well-conducted trials blinding of either care providers or women receiving care is not generally feasible. We have noted this in the 'Risk of bias' tables along with any attempts to achieve partial blinding.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>With this type of intervention blinding outcome assessors may not be feasible as those same staff providing care (usually unblinded) are also likely to measure and record outcomes in case notes. The fact that investigators taking information from case notes may be blind to treatment allocation may not overcome the possibility detection bias. For some outcomes (e.g. infant death), information may be obtained from records which are less susceptible to high risk of detection bias. We have noted attempts at partial blinding of outcome assessment in the 'Risk of bias' tables.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Selective reporting bias (checking for reporting bias)</HEADING>
<P>Without access to study protocols and all study publications it is difficult to know whether or not there has been outcome reporting bias. However, we have noted where we had any concerns about reporting bias (e.g. where key outcomes did not seem to be reported). We planned to assess publication bias using funnel plots if sufficient studies contributed data to the analyses. In future updates, if sufficient studies become available, we will carry out these planned analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Other sources of bias</HEADING>
<P>Where we had concerns about other possible sources of bias, for example, where there was baseline imbalance between groups, we have noted these concerns.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(8) Overall risk of bias</HEADING>
<P>We made explicit judgements about risk of bias for important outcomes both within and across studies. With reference to the bias domains described above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses, temporarily removing those studies at high risk of bias from the meta-analysis to see what impact this would have on the treatment effect. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of the quality of the evidence </HEADING>
<P>For this update, the quality of the evidence has been assessed using the GRADE approach (<LINK REF="REF-Schunemann-2009" TYPE="REFERENCE">Schunemann 2009</LINK>) in order to assess the quality of the body of evidence relating to the following outcomes for the main comparison: reduced number of antenatal care visits/goal-oriented versus standard antenatal care visits. In this comparison, we have set out findings for individually- and cluster-randomised trials separately; in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>, we have dismantled subgroups, and pooled results for individually- and cluster-randomised trials are reported together. This does not affect findings for most outcomes as most of the data were derived from three large cluster-randomised trials. We have included the following outcomes in our 'Summary of findings' table.</P>
<UL>
<LI>Maternal death</LI>
<LI>Hypertensive disorders of pregnancy (including pre-eclampsia)</LI>
<LI>Baby death (stillbirth, perinatal death, neonatal death, infant death)</LI>
<LI>Preterm birth (less than 37 weeks, less than 34 weeks)</LI>
<LI>Small-for-gestational age</LI>
<LI>Admission to neonatal intensive care</LI>
</UL>
<P>We used GRADEprofiler (<LINK REF="REF-GRADE-2014" TYPE="REFERENCE">GRADE 2014</LINK>) software to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-05-27 09:12:01 +0100" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>We used the mean difference if outcomes were measured in the same way between trials. In future updates, if appropriate, we will use the standardised mean difference to combine trials that measure the same outcome, but used different methods. If there was evidence in the trials of abnormally distributed data, we have reported this.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-05-27 09:12:14 +0100" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We have included three trials in the review where the unit of randomisation was the 'clinic' rather than the 'individual'. For those outcomes where both types of trials contributed data, we conducted pooled analyses using the generic inverse variance method with subtotals by unit of randomisation. For the cluster-randomised trials, we adjusted standard errors to take account of the design effect using the methods described in <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>. We used an estimate of the intracluster correlation co-efficient (ICC) derived from the trial or from another source. For most of the outcomes considered in the review, we used the ICCs from one of the included trials (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>) that have been published (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>). In the additional tables, we have described the source of the ICC for each outcome, and we carried out sensitivity analyses to investigate the effect of varying the ICC. We considered it reasonable to combine the results from both individually- and cluster-randomised trials if there was little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit was considered to be unlikely. (In the results text we have set out findings separately for cluster- and individually-randomised trials.)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cross-over trials</HEADING>
<P>Cross-over trials would not be a feasible design for this type of intervention and no such trials were identified by the search or included in the review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials with more than two arms</HEADING>
<P>None of the included trials included more than two arms. If such trials are identified and included in future versions of the review, we will use the methods set out in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) to analyse them.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-05-27 09:12:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>For included studies, we noted levels of attrition in the 'Risk of bias' tables. In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<SUBSECTION>
<HEADING LEVEL="4">Available case analysis</HEADING>
<P>Where possible we have analysed all cases according to randomisation group, irrespective of whether or not study participants received the intended intervention.</P>
</SUBSECTION>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-05-27 09:12:36 +0100" MODIFIED_BY="Heather Maxwell">
<P>We examined heterogeneity between the trials by visually examining the forest plots to judge whether there were any apparent differences in the direction or size of the treatment effect between studies. We also considered the I² and Tau² statistics and the P value of the Chi² test for heterogeneity. If we identified heterogeneity among the trials (if the value of I² was greater than 30%, and the value of Tau² was greater than zero or the P value of the Chi² test for heterogeneity was greater than 0.1), we planned to explore it by pre-specified subgroup analysis and by performing sensitivity analysis.<B>
<BR/>
</B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-01-15 14:45:05 +0000" MODIFIED_BY="[Empty name]">
<P>We attempted to assess reporting bias but without access to study protocols it is difficult to know whether or not there has been outcome reporting bias. However, we have noted in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables where we had any concerns about reporting bias (e.g. where key outcomes did not seem to be reported). We were unable to assess publication bias using funnel plots, as too few studies contributed data to the analyses.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-05-27 09:13:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar.</P>
<P>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. Where we used random-effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-05-27 09:13:29 +0100" MODIFIED_BY="Heather Maxwell">
<P>For this and the previous update, we modified the protocol to include the following subgroup analyses:</P>
<OL>
<LI>based on geographic location: recruitment in high-income countries, recruitment in low- and middle-income countries, recruitment in both types of settings;</LI>
<LI>based on the number of visits in the reduced visits package: five visits or less, more than five visits;</LI>
<LI>based on parity: primiparous only, multiparous only, mixed primiparous and multiparous, parity unclear;</LI>
<LI>based on whether reduced visits were particularly focused on key components of antenatal care that have been proven to be effective, or whether the number of visits was simply reduced.</LI>
</OL>
<P>We planned to use primary outcomes only in subgroup analyses and to assess subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We planned to report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. Insufficient data were available in this version of the review for this planned analysis.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-05-27 09:13:39 +0100" MODIFIED_BY="Heather Maxwell">
<P>For the previous update, we modified the protocol to include a sensitivity analysis based on varying the ICC for the cluster-randomised trials included in the review.</P>
<P>We planned to carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor-quality studies being excluded from the analyses in order to assess whether this makes any difference to the overall result. We will carry out this planned analysis in future updates if sufficient data become available.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-07-07 15:03:16 +0100" MODIFIED_BY="Leanne V Jones">
<STUDY_DESCRIPTION MODIFIED="2015-05-27 09:14:17 +0100" MODIFIED_BY="Heather Maxwell">
<SEARCH_RESULTS MODIFIED="2015-05-27 09:13:49 +0100" MODIFIED_BY="Heather Maxwell">
<P>An updated search retrieved five new reports. One of these reports describes an ongoing study focusing on a reduced number of antenatal visits (<LINK REF="STD-Famuyide-2014" TYPE="STUDY">Famuyide 2014</LINK>). Two reports (<LINK REF="REF-Hutton-2004" TYPE="REFERENCE">Hutton 2004</LINK>; <LINK REF="REF-Vogel-2013" TYPE="REFERENCE">Vogel 2013</LINK>) reported additional analyses relating to the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial. Two additional studies have been excluded (<LINK REF="STD-Clark-2013" TYPE="STUDY">Clark 2013</LINK>; <LINK REF="STD-Tomlinson-2014" TYPE="STUDY">Tomlinson 2014</LINK>).</P>
<P>In total the review now includes seven studies, 18 studies have been excluded and one is ongoing.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-05-27 09:14:10 +0100" MODIFIED_BY="Heather Maxwell">
<P>Seven trials (with more than 60,000 women) evaluated the number of visits; four of which were conducted in high-income countries (individual-randomisation trials) (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>; <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>; <LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>) and three in low- and middle-income countries (cluster-randomisation trials, with clinics as the unit of randomisation) (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>). All trials recruited both primiparous and multiparous women.</P>
<P>In the <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK> study, there was simple randomisation of clusters, while the clusters in the <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK> study were stratified according to whether or not radio communication was available, and then there was simple randomisation within strata. In the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial, which took place in Argentina, Cuba, Saudi Arabia and Thailand, randomisation was stratified both by country and by clinic size. We have not been able to take this stratification into account in our analyses in this review. We have used the results from trials set out in published papers and have adjusted for the cluster-design effect using the methods described in <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK> (so that all studies where clinics rather than individual women were randomised are analysed in the same way).</P>
<P>In all studies women were assessed at the antenatal booking visit for risk factors. In the studies where there was individual randomisation, women identified as having risk factors were excluded. In these trials gestation at recruitment was: before 13 weeks (<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>), before 18 weeks (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>), before 22 weeks (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>), and before 26 weeks (<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>). Of the cluster-randomisation trials, two recruited all women attending antenatal clinics (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>) while the third recruited all low-risk women (<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>). In the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> and <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK> trials, women with risk factors were not excluded but may have received additional visits, or referral to a higher level of care, depending on their individual needs. In these studies analyses were according to randomisation group (intention-to-treat), so women with risk factors were included in the results (although women with risk factors may have received more visits than specified in trial protocols).</P>
<P>For the individual-randomisation trials, standard care was specified as 13 visits for three trials. The fourth stated 14 visits (<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>). For the cluster-randomisation trials, one large international study stated standard as it was normally offered in that clinic (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>) and another stated standard care for rural areas (a survey indicated that the median number of visits before the intervention was seven) (<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>). The third study specified 14 visits, but with the proviso that before the trial standard care was actually seven visits (<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>). Reduced care was goal-orientated for the three cluster-randomised trials, with one trial using four visits (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>), one five visits (<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>) and the third six visits (<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>); assessment of risk factors at booking was an important part of these interventions. For the individual-randomised trials, one used seven visits for nulliparous women and six for multiparous (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>); two used eight visits for all women (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>; <LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>); and one nine visits for all women (<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>). In one study, women in the reduced visits group had a single care provider, whilst women in the standard care group had a mix of care providers (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>).</P>
<P>Outcomes reported in the trials varied, and for some outcomes there was no single clear definition. One of our primary outcomes was pre-eclampsia, however, pre-eclampsia and other hypertensive disorders of pregnancy were not consistently defined and measured in the included trials, and we have therefore reported these outcomes together in the results section, but have included a separate analysis setting out findings for different definitions.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-05-27 09:14:17 +0100" MODIFIED_BY="Heather Maxwell">
<P>Eighteen studies were excluded. Two studies were not RCTs (<LINK REF="STD-Berglund-1998" TYPE="STUDY">Berglund 1998</LINK>; <LINK REF="STD-Neilson-1998" TYPE="STUDY">Neilson 1998</LINK>). Several trials reported different models of antenatal care, but the focus of these trials was not on a reduction in the standard number of antenatal visits. Three trials examined continuity of antenatal caregivers (<LINK REF="STD-Biro-2000" TYPE="STUDY">Biro 2000</LINK>; <LINK REF="STD-Harvey-1996" TYPE="STUDY">Harvey 1996</LINK>; <LINK REF="STD-Waldenstrom-2000" TYPE="STUDY">Waldenstrom 2000</LINK>). Four trials compared antenatal care provided by different healthcare staff (e.g. midwife- versus obstetrician-led antenatal care) (<LINK REF="STD-Chambliss-1992" TYPE="STUDY">Chambliss 1992</LINK>; <LINK REF="STD-Giles-1992" TYPE="STUDY">Giles 1992</LINK>; <LINK REF="STD-Tucker-1996" TYPE="STUDY">Tucker 1996</LINK>; <LINK REF="STD-Turnbull-1996" TYPE="STUDY">Turnbull 1996</LINK>). Five trials examined different models of antenatal care where the focus was not on reduced versus standard packages of care (<LINK REF="STD-Clark-2013" TYPE="STUDY">Clark 2013</LINK>, <LINK REF="STD-Jewell-2000" TYPE="STUDY">Jewell 2000</LINK>; <LINK REF="STD-Kitzman-1997" TYPE="STUDY">Kitzman 1997</LINK>; <LINK REF="STD-Srinivasan-1995" TYPE="STUDY">Srinivasan 1995</LINK>; <LINK REF="STD-Tomlinson-2014" TYPE="STUDY">Tomlinson 2014</LINK>). No data were available for a trial registration by <LINK REF="STD-Flenady-1998" TYPE="STUDY">Flenady 1998</LINK> and in <LINK REF="STD-Hundley-1997" TYPE="STUDY">Hundley 1997</LINK>, the focus was on intrapartum care. One study was excluded for methodological reasons: the study reported by <LINK REF="STD-Kusulasai-1993" TYPE="STUDY">Kusulasai 1993</LINK> was a quasi-randomised trial where a reduced schedule of four antenatal visits (scheduled for less than 20 weeks, 28 weeks, 34 and 40 weeks) was compared with standard visits (approximately eight). The study was excluded as it was assessed as being at high risk of bias and results were therefore very difficult to interpret. Women who did not attend all visits according to the study protocol, or who did not deliver in the study hospital were excluded from the analysis. It was not clear how many women were randomised or how many women were excluded after randomisation.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<ALLOCATION MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>
<I>Random sequence generation:</I> Four studies were assessed as being at low risk of bias for random sequence generation (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>; <LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>; <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>). In two cluster-randomised trials sequence generation was not described (<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>) and the remaining trial was assessed as being at high risk of bias for this domain (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>)</P>
<P>
<I>Allocation concealment:</I> Of the seven included trials, one used quasi-randomisation (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>), in two concealment of allocation was not described (<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>), the other four studies were assessed as being at low risk of bias for concealment of allocation (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>; <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>).<BR/>
</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>Blinding of women and the providers of care was not feasible in any of these trials and all studies have been assessed as being at high risk of performance bias. Most outcomes were recorded by care providers in clinical notes and therefore these studies have also been assessed as being at high risk of bias for detection bias. (Information on perinatal death may have been derived from central registries and these outcomes may be less susceptible to bias and in the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial, there was an attempt to independently verify outcomes for a subset of the main sample.)</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>The study that used quasi-randomisation (<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>) also had large losses to follow-up (27%), and care providers in the intervention arm also participated in the pool of providers conducting antenatal care in the control arm of the trial. Attrition was high in another trial, with 30% of women lost to follow-up (<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>). Levels of attrition for other trials were less than 20%: 16% of women in one trial (<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>), 3% in two (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>) and 2% in one (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>). For one study, full records were available for 78% of the women, but some outcome data were available for a further 20% of the sample (<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>Most of these studies were assessed using published reports and detecting reporting bias is not simple. All studies were assessed as unclear for this bias domain. One potential problem with these studies is that women receiving more visits may have had outcomes measured on more occasions than those receiving fewer visits; this may have decreased the likelihood of detection in the reduced visits groups. This was acknowledged as a potential problem in the trials by <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> and <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>, but may also apply to other trials.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-05-27 09:14:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>We have noted concerns about other sources of bias. Full assessments of risk of bias are set out in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables and 'Risk of bias' summaries are set out in figures at the end of the review (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-07-07 15:03:16 +0100" MODIFIED_BY="Leanne V Jones">
<SUBSECTION>
<HEADING LEVEL="3">Comparison of reduced visits with standard care: seven trials with 60,724 women</HEADING>
<P>Where we have pooled results from individual- and cluster-randomised trials we have used the generic inverse variance method, and log risk ratios and standard errors/adjusted standard errors have been entered into the data and analyses tables. For these analyses, we have included additional tables where we have set out the original data from trials. We have also included in these tables the intracluster correlation co-efficient (ICCs) and details of the source of ICCs, used for calculating the design effect for the cluster-randomised trials. Where there were any differences in the way outcomes were defined in trials, we have provided details of the various definitions used. (<I>See </I>Additional tables.) In the results below all analyses have been adjusted for cluster-design effect.</P>
<P>To provide context, before describing results for primary and secondary outcomes, we have described the impact of planned interventions in the included trials in terms of the number of antenatal visits made by women.</P>
<SUBSECTION>
<HEADING LEVEL="4">Compliance with the allocated interventions: number of antenatal visits</HEADING>
<P>Six trials provided information on the number of antenatal visits women made, to assess compliance with the allocated intervention. Results are not simple to interpret, as the data were presented in different ways, and there was considerable variation within and between trials in the number of visits women received. In trials carried out in high-income countries, the reduced visits schedule generally involved considerably more visits than in trials in lower-resource settings. In three trials in high-income countries, the number of antenatal visits was reduced on average by 2.65 (95% confidence interval (CI) -3.18 to -2.12 (random-effects analysis)), and in the "reduced visits" groups women, on average, attended between 8.2 and 12 (<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>) times (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). There was considerable heterogeneity between these studies, and results should be interpreted with caution (I² = 88%, Tau² = 0.19 and Chi² test for heterogeneity P = 0.0002).</P>
<P>The reduction in the number of visits was of similar, or greater, magnitude in the trials carried out in low-resource settings where the standard number of visits was already relatively low, and where any reduction represented a considerably higher proportion of visits. Two trials show a relatively large reduction in the median number of visits: from six in the standard care group to four visits in the intervention group in the <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK> trial, and from eight in the standard care group to four visits in the intervention group in the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial. In the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial it was reported that for women randomised to the reduced visits schedule and assessed as being at low risk at the booking visit, 51% had fewer than five antenatal visits; of those women with at least one risk factor, 37% had fewer than five visits. In the <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK> trial, women in the reduced visits groups were more likely to attend on fewer than six occasions, but the difference between groups was not large, with 77% in the reduced visits group and 69% in the standard care group having five or fewer antenatal visits (risk ratio (RR) 1.12; 95% CI 1.01 to 1.25) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>For all outcomes, where data included results from cluster-randomised trials, the risk ratio has been adjusted to take account of the cluster-design effect.</P>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>For maternal mortality, two individual-randomisation trials (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>) reported this outcome, with one maternal death in 2405 deliveries in the reduced visits model and no maternal deaths in 2449 deliveries in the standard visits model. Three cluster-randomisation trials (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>) reported maternal mortality, with 17 maternal deaths in 27,762 deliveries in the reduced visits model with goal-oriented components, and 13 maternal deaths in 23,742 deliveries in the standard visits model; there was no statistically significant difference between groups (RR 1.13; 95% CI 0.50 to 2.57, three studies, 51,504 women, evidence graded low quality) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>) (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>Intervention and control groups had similar levels of hypertensive disorders of pregnancy (including pre-eclampsia) (average RR 0.95; 95% CI 0.80 to 1.12 (random-effects analysis), six studies, 54,108 women, evidence graded as low quality) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). However, these results should be interpreted with caution as definitions of pre-eclampsia varied between trials, and sometimes it was not clear whether the data were for gestational hypertension or pre-eclampsia; this clinical heterogeneity may possibly explain the high levels of statistical heterogeneity between the cluster-randomised studies for this outcome (I² = 70%, Tau² = 0.04 and Chi² test for heterogeneity P = 0.03). In additional <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>, we have set out the definitions of pre-eclampsia used in the various trials. (In <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>, we have separated those trials reporting pre-eclampsia from those where the definition was not clear, or where data were reported for hypertensive disorders (possibly without proteinuria and other markers of pre-eclampsia).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Neonatal outcomes</HEADING>
<P>Perinatal mortality was increased for those randomised to the reduced visits group, and overall, this difference was borderline for statistical significance (five trials, 56,431 babies; RR 1.14; 95% CI 1.00 to 1.31, evidence graded as moderate quality) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). There was no evidence of a difference in treatment effects between trials conducted in high-income and low-/middle-income countries (test for subgroup differences P = 0.49, I² = 0%). In the two individual-randomisation trials conducted in high-income countries the number of deaths was relatively low (15/2536 versus 17/2572). In the three cluster-randomised trials conducted in low- and middle-income countries, perinatal mortality was higher in the reduced visits group, and this difference was statistically significant (581/27,680 in the reduced visits group versus 439/23,643 in the standard care group: RR 1.15; 95% CI 1.01 to 1.32).</P>
<P>The ICC used in this analysis for the cluster-randomised trials was derived from the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial. We used the ICC representing the upper confidence limit for the average ICC for this outcome (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>). We also carried out a sensitivity analysis where the cluster design effect was not taken into account (the ICC was truncated to zero, as the average ICC had a negative value) and the difference between groups remained statistically significant for the cluster-randomised trials (RR 1.16; 95% CI 1.02 to 1.31) and the summary statistic (RR 1.15; 95% CI 1.02 to 1.30)) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK> ICC 0.0003, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK> ICC truncated to zero, <I>see</I> <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
<P>There was no clear difference in the number of preterm births in the two treatment groups (overall pooled RR 1.02; 95% CI 0.94 to 1.11, seven studies, 53,661 women, evidence graded moderate quality) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Although in the individual-randomised trials there appeared to be more preterm births in the reduced visits group (RR 1.24; 95% CI 1.01 to 1.52), no difference between groups was apparent in the cluster-randomised trials (RR 0.99; 95% CI 0.91 to 1.08) (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). The test of subgroup differences was of borderline statistical significance (P = 0.05) and the value of I² for between subgroup heterogeneity was 74.9%. 
</P>
<P>There was no clear difference between treatment groups for the numbers of babies that were small-for-gestational age (RR 0.99, 95% CI 0.91 to 1.09, four studies, 43,045 babies, evidence graded as moderate quality) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>There was no clear difference between the groups in vaginal bleeding during pregnancy overall (RR 1.13; 95% CI 0.92 to 1.40) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>) or in either the individual-randomisation trials (RR 1.01; 95% CI 0.77 to 1.33) or the cluster-randomisation trials (RR 1.33; 95% CI 0.96 to 1.85). This finding should be interpreted with caution as (like pre-eclampsia), there was no single, clear definition of what antepartum haemorrhage was in these studies. In additional <LINK REF="TBL-07" TYPE="TABLE">Table 7</LINK> we have set out the definitions used in each of the trials.</P>
<P>There was no clear difference between groups for postpartum haemorrhage (pooled RR 0.99; 95% CI 0.81 to 1.21) (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>) (<LINK REF="TBL-08" TYPE="TABLE">Table 8</LINK>). The authors of the trial report recommend that results for postpartum anaemia should be viewed cautiously because there was heterogeneity between countries included in the trial for this outcome.</P>
<P>Similar numbers of women in the reduced visits and routine care groups underwent caesarean section (RR 0.99; 95% CI 0.91 to 1.08) (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>), and the numbers of women undergoing induction of labour were similar in the two groups (average RR 0.97; 95% CI 0.86 to 1.09) (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>) (<LINK REF="TBL-09" TYPE="TABLE">Table 9</LINK>; <LINK REF="TBL-10" TYPE="TABLE">Table 10</LINK>). With respect to severe postpartum anaemia and treated urinary tract infections, only one trial contributed data (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>). There were no statistically significant differences between the groups for either outcome (RR 0.88, 95% CI 0.75 to 1.03) (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>) and (RR 0.80, 95% CI 0.64 to 1.00; one study) (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>), (<LINK REF="TBL-11" TYPE="TABLE">Table 11</LINK>; <LINK REF="TBL-12" TYPE="TABLE">Table 12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Neonatal outcomes</HEADING>
<P>There was no clear difference between groups when the results were pooled with respect to low birthweight (less than 2500 g) (overall RR 1.04; 95% CI 0.97 to 1.11) (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). The same pattern was observed for individual-randomisation trials (RR 1.00; 95% CI 0.81 to 1.24) and cluster-randomisation trials (RR 1.04; 95% CI 0.97 to 1.12) (<LINK REF="TBL-13" TYPE="TABLE">Table 13</LINK>).</P>
<P>Overall, there was no clear difference between groups for admission to neonatal intensive care unit (RR 0.89, 95% CI 0.79 to 1.02, five studies, 43,048 babies, evidence graded moderate quality) (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>).The number of babies admitted to neonatal intensive care units was similar in the two treatment groups in the trials carried out in high-resource settings (RR 1.06; 95% CI 0.80 to 1.41); for trials in low-resource settings, results appeared to favour the group having reduced visits (RR 0.86; 95% CI 0.74 to 0.99). Again, these results should be interpreted with caution as definitions of neonatal special care varied amongst the trials, and there were variations in how data on this outcome were reported (for example, the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial provided data for those babies who received care in special units for more than two days) (<LINK REF="TBL-14" TYPE="TABLE">Table 14</LINK>).</P>
<P>None of the studies included in the review provided information on breastfeeding at hospital discharge or in the postpartum period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Satisfaction outcomes</HEADING>
<P>There was considerable variation in the way satisfaction with care was measured between trials and in view of this variability, for most outcomes, results were not pooled.</P>
<P>In individual-randomisation trials, conducted in high-income countries, overall, women tended to be less satisfied with the reduced number of antenatal visits model compared with standard care, although in the <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK> trial, where routine care involved 14 visits, some women perceived that the routine schedule involved too many visits.</P>
<P>In the <LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK> study, women were asked about their overall satisfaction with the number of antenatal visits; those in reduced visits group were more likely to express dissatisfaction (32.5% were not satisfied compared with 16.2% in the routine care group). Women in the reduced visits group were also more likely to think that the gap between visits was too long (52.5%), although a third of those attending for the standard number of visits also perceived the gap was too long (33.4%). There was no difference between groups in terms of mean satisfaction with the general quality of antenatal care (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>) although after the birth, women in the reduced visits group were more likely to say they would opt for the same schedule again (RR 1.12, 95% CI 1.05 to 1.20) (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>).</P>
<P>In the <LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK> trial, overall, more women in the routine care group expressed satisfaction with the number of antenatal visits (84% were satisfied in the routine care group compared with 71% in the reduced visit group). In the routine care group 6% thought that there had been too few and 10% too many visits, while in the reduced visits group only 2% thought there had been too many visits, whereas 27% thought there had been too few. In terms of other aspects of antenatal care (the quality of care, the amount of visit time, the quality of education, and the attitude of staff), the two groups had similar levels of satisfaction (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>; <LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P>
<P>The <LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK> trial also collected data on satisfaction with care, although data were not collected until six weeks postpartum. There was considerable loss to follow-up with data on satisfaction outcomes available for only 43% of women randomised. Most women in both groups thought that the overall number of visits had been about right (89.2% in the reduced visit group and 82.8% in the routine care group agreeing). In the reduced visit group 8.8% thought they had too few, and 2% thought they had had too many visits; conversely, in the standard visits group 1.5% thought they had had too few and 16.1% thought they had had too many visits. Women were also asked about the quality of other aspects of antenatal care, and most women in both groups expressed satisfaction (data not shown).</P>
<P>Two cluster-randomised trial reported findings on maternal satisfaction with antenatal care. In the <LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK> trial satisfaction was measured in a subset of women (100 from each arm of the trial) and there were no clear differences between groups (data not shown). In the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> study 77.4% of women in the reduced visit group were satisfied with the number of visits compared with 85.2% of those in the standard visits group. Women in the reduced visits groups were less likely to be satisfied with the spacing between visits (72.7% satisfied compared with 81.0% in the standard visits group). Conversely, more women were satisfied with the amount of time spent during the visit in the reduced visits model (85.7% versus 79.1% in the standard visits group).</P>
<P>Only the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> study reported providers' perception of antenatal care and the results show that they were equally satisfied with the new model in respect to the number of visits (intervention group: 68.5%, control group: 64.5%) and information provided, but more satisfied with time spent with women (intervention group: 85.9%, control group: 69.5%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Cost outcomes</HEADING>
<P>Two trials (<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>; <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>) reported evaluation of the economic implications of the two models of antenatal care. The <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial included detailed economic analyses in two (Cuba and Thailand) of the four participating countries. The results obtained overall show that costs per pregnancy to women and providers were lower in the reduced visits model than in the standard visits model. The providers' cost differences in Cuba and Thailand were respectively (mean difference (MD) -71.4 US$; 95% CI -148.8 to 2.5) and (MD -38.9 US$; 95% CI -46.3 to 30.9) favouring the reduced visits model. The women's out of pocket costs were also less in the new model in both countries: Cuba (MD -68 US$; 95% CI -144.0 to 7.7) and Thailand (MD -6.5 US$; 95% CI -10.8 to -2.19). The average amount of time women spent attending visits was shorter in the reduced visits model in Cuba (MD -9.1 hours; 95% CI -13.5 to -4.7) and in Thailand (MD -14.9 hours; 95% CI -18 to 11.8).</P>
<P>An economic analysis using data from the <LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK> trial considered costs to the National Health Service only. Costs for the reduced number of visits model were £225 compared with £251 for the standard visits model, but there was an increase in the costs related to newborns' length of stay in the intensive care unit from £126 in the standard antenatal visits model to £181 in the reduced visits model. This increase was due to an observed higher rate of neonatal admissions to special care in the reduced visits model compared to the standard visits model (3.5% versus 3.2%), as well as longer mean days of stay.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Process outcomes</HEADING>
<P>There were few trials with data on indicators of service use. There was no evidence of differences between intervention and control groups in terms of use of prenatal diagnostic testing or use of other medical services. The mean number of ultrasound examinations was similar in the two trials providing such information (<LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>; <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Long-term outcomes</HEADING>
<P>Follow-up of 1117 women (60%) enrolled in the <LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK> trial at 2.7 years after delivery found no clear differences between the two groups in the mother-child relationship, maternal psychological wellbeing, health service use for the mother and her child, health-related behaviour and health beliefs about herself and her child (data not shown).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analysis</HEADING>
<P>We planned subgroup analysis by high- versus low-resource settings, by more than five versus five or fewer visits and by whether or not the reduced programme included specific "goal-oriented" components. We have set out results for all outcomes according to method of randomisation (individual- versus cluster-randomisation) in the data and analyses tables and in the text in the main results section. The trials carried out in high-resource settings were all studies where there was individual randomisation, whereas the cluster trials recruited women from low- or medium-resource settings. The number of antenatal visits also broadly corresponded to type of randomisation, with women in trials with individual-randomisation in the reduced visits groups attending on more than five occasions compared with women in trials with cluster-randomisation who had an average of five or fewer visits and with visits focused on particular key components of care. In view of the correspondence between method of randomisation, resource setting, and the number and focus of visits, we did not therefore carry out further subgroup analysis using these variables.</P>
<P>Separating the studies by method of randomisation revealed few important differences in findings between individual- and cluster-randomised trials; for one outcome (preterm birth <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>) there appeared to be limited overlapping of confidence intervals and the test for subgroup differences was of borderline statistical significance, but in view of the large number of outcomes examined, this finding may have occurred by chance.</P>
<P>We also planned subgroup analysis by parity but data were not available to allow us to perform this analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sensitivity analysis</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Study quality</HEADING>
<P>Two of the studies that we included were at high risk of bias. The <LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK> was quasi-randomised and had more than 20% loss to follow-up and the <LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK> trial also had high attrition. Temporarily removing these two studies from the analysis for all clinical outcomes to which they contributed data had very little impact on overall results, or on the magnitude of the P values for the overall treatment effect (data not shown).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Varying the ICCs for cluster-randomised trials</HEADING>
<P>In comparison two we have set out sensitivity analysis using conservative estimates of the ICC for clinical outcomes; we selected the upper 95% confidence limit for the ICCs used in the main analysis. Although selecting more conservative ICC values (assuming more clustering and thereby reducing the weight of cluster-randomised trials) broadened the confidence intervals slightly for some outcomes, overall, this did not have any serious impact on findings (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK> to <LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-05-27 09:17:36 +0100" MODIFIED_BY="Heather Maxwell">
<SUMMARY_OF_RESULTS MODIFIED="2015-05-27 09:17:04 +0100" MODIFIED_BY="Heather Maxwell">
<P>For most of the outcomes examined in this review, there were no significant differences between groups receiving a reduced schedule of antenatal visits with goal-oriented care compared with standard antenatal care. The key outcome for which there seems to be a difference is perinatal mortality, which was increased by 14% (95% confidence interval (CI) 0% to 31%) in the reduced visits group compared to standard antenatal care. In the subgroup analysis, the was no clear evidence of a difference in treatment effects between trials conducted in high- and low-resource settings (test for subgroup differences P = 0.49, I² = 0%), although the number of perinatal deaths in the high-resource setting studies was small and hence power was limited. Other clinical outcomes for mothers and babies, and interventions in labour, were similar for women in the two study groups.</P>
<P>Women in both low- and high-resource settings were less satisfied with the reduced schedule of visits; for some women the gap between visits was perceived as too long. Economic analyses in two trials suggest that reduced visits may be associated with lower costs.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-05-27 09:17:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>Antenatal care is a complex intervention, and understanding how the evidence presented in this review should be applied in practice is not simple. First, there were considerable differences between studies in what constituted standard care, as well as what constituted reduced visits care. These differences were particularly marked between trials carried out in high- rather than low-resource settings. In low-resource settings the standard number of antenatal visits was considerably lower than for standard care in studies carried out in high-income countries. For the reduced visits intervention, trials in low-resource settings combined reducing the number of visits (to between four and six) with a review of what activities should be conducted within those visits. The aim was to only include activities for which there was evidence of improved outcome.</P>
<P>For trials in higher-income countries, the focus was on simply reducing the number of visits: from 13 to 14 visits with standard care to between six and nine with reduced visits.The planned number of visits in the reduced arm was therefore relatively high compared to the trials in low-resource settings.</P>
<P>In the trials in high-income countries the recommended schedule of visits was not strictly followed in either group, so women in the intervention arm tended to have more visits than planned, and women in the control arm tended to have fewer visits than planned. In these trials, women in the reduced visits group may have attended for more visits than women in the standard care group in trials carried out in low- and middle-income countries.</P>
<P>Eligibility criteria varied between the different studies. Although the reduced visits schedule was intended for low-risk women, in two of the cluster trials women with risk factors identified at the booking visit were not excluded; although these women may have received individualised care (with referral or additional visits) they are included in the analyses. Separate results were not available for those women identified with risk factors.</P>
<P>Perinatal mortality in these trials was relatively low for the settings in which they were conducted. In the control groups, for the high-resource setting trials perinatal mortality was in the range of five to seven deaths per 1000 births, and for the low-resource setting trials it ranged from 14 to 25 deaths per 1000 births. The increase in perinatal mortality associated with reduced visits is concerning. The increase is borderline for statistical significance (point estimate 14% increase, 95% CI 0% to 31%), but is consistent in the sensitivity analyses using study quality and ICC. In the subgroup analysis by unit of randomisation, the increase in perinatal mortality is statistically significant in the cluster-randomised studies (15% increase, 95% CI 1% to 32%), but not in the individual-randomised studies where the confidence intervals are wide and cross the no effect line (10% reduction, 95% CI 55% reduction to 80% increase). The individual-randomised studies contribute just 4% of the weight in this analysis. As unit of randomisation also divides the trials based on low- and high-resource settings, it is impossible to disentangle these two characteristics.</P>
<P>For the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> study, data were available for fetal and neonatal deaths separately (for the other cluster-randomised trials data were either not available, or incomplete). Results from the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial indicate that the difference in perinatal deaths was due to increased stillbirths amongst the reduced visits group compared with the standard care group. The number of neonatal deaths was very similar in both arms of this trial (<I>see</I> <LINK REF="TBL-15" TYPE="TABLE">Table 15</LINK>).</P>
<P>There are a number of possible explanations for the observed increase in fetal deaths in the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> study and in perinatal deaths in the two other trials carried out in low-income settings (<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>; <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>). It is possible that with only two or three visits scheduled in the third trimester, staff caring for women receiving reduced visits may not have been able to pick up serious problems at a point where early detection and prompt treatment may have had an impact on outcome, and with so few visits subtle changes indicating changes over time may not have been easy to detect.</P>
<P>There were no clear differences in the reported measures of perinatal morbidity. There was no clear difference in preterm birth (risk ratio (RR) 1.02; 95% CI 0.94 to 1.11) or being small-for-gestational age (RR 0.99; 95% CI 0.91 to 1.09). For admission to neonatal intensive care, there was a reduction in admission that was borderline for statistical significance (point estimate 11% reduction; 95% CI 21% reduction to 2% increase). This difference was statistically significant in the cluster-randomised trials (14% reduction; 95% CI 26% reduction to 1% reduction) but not in the individual-randomised trials (6% increase; 95% CI 20% reduction to 41% increase). Perinatal death and admission to neonatal intensive care are related outcomes. For example, if more sick babies die before they can be admitted to a neonatal unit, perinatal mortality will go up and admission to neonatal intensive care will go down. Also, it is not clear in some trial reports whether babies who subsequently died were excluded from the data on admission to neonatal intensive care. Reduced admission, or shorter length of stay is not an advantage if this is due to an increase in mortality. No trials have reported long-term follow-up of babies, so there are no data on whether these alternative packages of antenatal care are associated with any changes in long-term outcome.</P>
<P>Although for most other outcomes the differences between groups were not statistically significant, results for some are difficult to interpret as the outcomes were not well defined, e.g. pre-eclampsia and antepartum bleeding. Furthermore, understanding the impact of antenatal visits on these outcomes may not be straightforward; it may be that a larger number of minor problems are detected with more visits, but higher levels of detection do not necessarily mean greater morbidity<I>.</I>
</P>
<P>It is not clear from the results of this review whether maternal dissatisfaction with the reduced visits related to women's expectations or to experience in a previous pregnancy; in the high-income countries in particular, it may be that dissatisfaction would not persist if a reduced schedule of visits was the norm. Nevertheless, our findings suggest that women seem to like attending for antenatal care. In the trials where they were asked, women tended to prefer standard care, and in the reduced visits group many perceived that the gap between visits was too long. Antenatal care may offer women reassurance and a source of support during what may be a time of major social upheaval. There is also an opportunity for women to discuss their psychological wellbeing with healthcare providers and other pregnant women, and this may help them to prepare for the transition to motherhood. These less tangible aspects of antenatal care may be important as far as women are concerned.</P>
<P>There was some evidence that a reduced schedule of visits may be associated with reduced costs to health services, although this was not generally measured in trials, and the data that are available are not consistent and not easy to interpret; apparent reductions in service utilisation (reduced visits) may not result in any cost savings to service providers unless resources and staff are redeployed.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-05-27 09:17:36 +0100" MODIFIED_BY="Heather Maxwell">
<P>In general, the trials were of acceptable quality with low or moderate risk of bias, except for the <LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK> trial where the possibility of bias was high. We conducted a sensitivity analysis excluding this trial, and this did not substantially alter the results. In several trials levels of attrition were high, and this was particularly true for data collected in the postpartum period; data on maternal satisfaction may be at higher risk of bias because of loss to follow-up. It was not possible to blind women or care providers, and due to the unblinded and pragmatic nature of these trials, some degree of protocol deviation, contamination and co-intervention should be expected in all of them.</P>
<P>For primary outcomes, we graded the quality of the evidence using the GRADE approach (<LINK REF="REF-Schunemann-2009" TYPE="REFERENCE">Schunemann 2009</LINK>); evidence was graded as moderate (perinatal death; preterm birth; small-for-gestational age; neonatal intensive care unit admission) or low quality (maternal death; hypertensive disorders of pregnancy (including pre-eclampsia)), with downgrading decisions due to risks of bias and imprecision of effects</P>
<P>Our meta-analysis included trials that used the individual as the unit of randomisation (individual-randomisation trials) and those that used clinics (cluster-randomisation trials). We presented both pooled and stratified meta-analyses by the two types of trials. The ICCs used in the primary analyses were predominantly from the <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> trial and have been published (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>). We stratified the meta-analyses in individual- and cluster-randomisation trials because in addition to the unit of randomisation being different, the reduced number of antenatal visits model in the cluster-randomisation trials contained goal-orientated components, while in individual-randomisation trials the aim was only to reduce the number of visits. Furthermore, the method of implementing the intervention (clinic policy versus individual schedule), the site of the trials (low-resource versus high-resource settings), the proportional reduction in the number of visits (large versus small) and the sample size (large versus small) are clearly different in the two types of trials. Although for some outcomes we have provided pooled estimates, in view of the differences between studies, these should be interpreted with caution.</P>
<P>For a small number of outcomes (e.g. hypertensive disorders and pre-eclampsia), there were high levels of statistical heterogeneity. The differences between trials may be partly explained by different outcome definitions in different trials. In the presence of heterogeneity we decided either not to combine trials (and have provided subtotals only), or to use a random-effects model to produce an average treatment effect. We are aware that where there are high levels of unexplained heterogeneity, pooled results must be interpreted with caution.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton">
<P>We are aware of potential biases in the reviewing process; and we took some steps to minimise bias (e.g. two authors independently carried out data extraction).</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-03-23 11:10:40 +0000" MODIFIED_BY="Sonja L Henderson">
<P>There are some differences between this updated review and an earlier version (<LINK REF="REF-Villar-2001" TYPE="REFERENCE">Villar 2001</LINK>). In this and the previous version of the review (<LINK REF="REF-Dowswell-2010" TYPE="REFERENCE">Dowswell 2010</LINK>), we used new methods for the assessment of risk of bias and in the analyses (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and this may have had an impact on results. For example, we used a new method of analysis for the cluster trials so that all cluster trials have been analysed in the same way, and data from individual- and cluster-randomised trials have been pooled in the analysis in <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>. We also used risk ratio rather than odds ratio, as risk ratio is easier to understand. The choice of statistical method may alter the way results are presented and the way results are interpreted.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-05-27 09:17:50 +0100" MODIFIED_BY="Heather Maxwell">
<IMPLICATIONS_PRACTICE MODIFIED="2010-07-26 13:41:57 +0100" MODIFIED_BY="[Empty name]">
<P>Reducing the number of antenatal care visits is an attractive option for providers of maternity care. The results of this updated review suggest that reduction in the number of visits, even when the content of visits is modified to be more 'goal-orientated', compared to standard care is associated with an increase in perinatal mortality in low- and middle-income settings. It would therefore seem prudent not to reduce the number of visits in settings where the standard number of visits is already low without very close monitoring of fetal and neonatal outcomes.</P>
<P>Results of this review underline the importance of rigorous evaluation of substantive changes in antenatal care programmes, before they are introduced into practice and policy.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-05-27 09:17:50 +0100" MODIFIED_BY="Heather Maxwell">
<P>Antenatal care is a complex intervention delivered in a wide variety of ways in different countries and different settings. Results from individual trials may not be generalisable to other types of population and settings.</P>
<P>Findings from this review suggest that future research comparing alternative programmes of antenatal care should include close monitoring of the fetus, and pay particular attention to fetal and newborn outcome. If studies include high-risk and low-risk women, outcome data for these groups should be presented separately. The interventions in both standard care and the new intervention should be clearly described, with information about the content of care as well as the number of visits. Outcomes should be clearly defined, using widely agreed definitions. Outcomes should include measures of mortality and morbidity for the woman and child, as well as costs to health services and families, and women's satisfaction with care. This would make results of such trials easier to interpret and apply in clinical practice and health policy.</P>
<P>Future trials should also plan long-term follow-up, to assess whether any differences in short-term outcomes are reflected in the longer-term health and wellbeing of the woman or her child. Ideally such follow-up should be when the children are at least 18 months of age, as this is the earliest that neurodevelopment can be assessed reliably.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-06-05 14:21:44 +0100" MODIFIED_BY="Leanne V Jones">
<P>We are grateful to the investigators of all the trials who provided additional unpublished information, particularly Dr Jim Sikorski, Dr Stephen Munjanja, Dr Gunilla Lindmark, and Dr Franz Majoko. We are also grateful to Prof Miranda Mugford, Dr Pisake Lumbiganon, Dr Ubaldo Farnot, and Dr Per Bersgjo for their comments and suggestions on the earlier drafts of the review. We thank José Villar for his contribution to the previous version of this review.</P>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-03-30 15:18:47 +0100" MODIFIED_BY="Leanne V Jones">
<P>G Piaggio, G Carroli and D Khan-Neelofur are the authors of one of the included trials (<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>) and were not involved in assessment or data extraction for this study.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-05-27 09:18:01 +0100" MODIFIED_BY="Heather Maxwell">
<P>G Carroli and D Khan-Neelofur were responsible for the idea, conception and preparation of the initial review, and also reviewed the quality of the trials and extracted the data. G Piaggio and G Carroli planned and conducted the initial analysis. G Carroli, D Khan-Neelofur, G Piaggio and M Gülmezoglu wrote the initial text.</P>
<P>In this updated version of the review, T Dowswell entered data, drafted text and prepared the 'Summary of findings' table. L Duley redrafted text, which was agreed by all review authors. G Piaggio and S Gates provided statistical advice on the analyses and commented on drafts. M Gülmezoglu, G Carroli, and D Khan-Neelofur all suggested analyses and commented on drafts.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-05-27 09:18:12 +0100" MODIFIED_BY="Heather Maxwell">
<P>We have changed the scope so that the review focuses on reduced schedules of antenatal visits and no longer includes studies looking at alternative care providers. We have updated the protocol in this version of the review using new methods: the evidence has been assessed using the GRADE approach and a 'Summary of findings' table has been added; subgroup and sensitivity analyses have been added.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-05-26 09:23:15 +0100" MODIFIED_BY="Heather Maxwell">
<STUDIES MODIFIED="2015-05-26 09:12:48 +0100" MODIFIED_BY="Heather Maxwell">
<INCLUDED_STUDIES MODIFIED="2015-01-14 10:35:54 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-England-1996" NAME="England 1996" YEAR="1993-">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clement S, Candy B, Sikorski J, Wilson J, Smeeton N</AU>
<TI>Does reducing the frequency of routine antenatal visits have long term effects? Follow up of participants in a randomised controlled trial</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1999</YR>
<VL>106</VL>
<NO>4</NO>
<PG>367-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Henderson J, Roberts T, Sikorski J, Wilson J, Clement S</AU>
<TI>An economic evaluation comparing two schedules of antenatal visits</TI>
<SO>Journal of Health Services Research and Policy</SO>
<YR>2000</YR>
<VL>5</VL>
<NO>2</NO>
<PG>69-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[9095]&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sikorski J, Wilson J, Clement S, Das S, Smeeton N</AU>
<TI>A randomised controlled trial comparing two schedules of antenatal visits: the antenatal care project</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<PG>546-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1995" MODIFIED="2010-06-08 11:18:47 +0100" MODIFIED_BY="Lynn Hampson" NAME="USA 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-06-08 11:18:47 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9128]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:18:47 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Binstock MA, Wolde-Tsadik G</AU>
<TI>Alternative prenatal care. Impact of reduced visit frequency, focused visits and continuity of care</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1995</YR>
<VL>40</VL>
<PG>507-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1996" MODIFIED="2010-06-08 11:16:08 +0100" MODIFIED_BY="Lynn Hampson" NAME="USA 1996" YEAR="1992-">
<REFERENCE NOTES="&lt;p&gt;[10149]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDuffie R, Bischoff K, Beck A, Orleans M</AU>
<TI>Does reducing the number of prenatal office visits for low-risk women result in increased use of other medical services?</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1997</YR>
<VL>90</VL>
<PG>68-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDuffie R, Bischoff K, Cross J, Beck A</AU>
<TI>An evaluation of risk-based prenatal care: a randomized controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>172</VL>
<PG>270</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:16:08 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9030]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:16:08 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McDuffie RS, Beck R, Bischoff K, Cross J, Orleans M</AU>
<TI>Effect of frequency of prenatal care visits on perinatal outcome among low-risk women</TI>
<SO>JAMA</SO>
<YR>1996</YR>
<VL>275</VL>
<PG>847-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1997" NAME="USA 1997" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;[9721]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker DS, Koniak-Griffin D</AU>
<TI>Evaluation of a reduced-frequency prenatal visit schedule for low-risk women at a free-standing birthing center</TI>
<SO>Journal of Nurse Midwifery</SO>
<YR>1997</YR>
<VL>42</VL>
<PG>295-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-WHO-2001" MODIFIED="2015-01-14 10:35:54 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-01-14 10:35:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hutton G, Fox-Rushby J, Mugford M, Thinkhamrop J, Thinkhamrop B, Galvez AM, et al</AU>
<TI>Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial</TI>
<SO>Applied Health Economics &amp; Health Policy</SO>
<YR>2004</YR>
<VL>3</VL>
<NO>3</NO>
<PG>161-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:50:32 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Villar J, Ba'aquel H, Piaggio G, Lumbiganon P, Belzian JM, Farnot U, et al</AU>
<TI>WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<PG>1551-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:15:41 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villar J, Bakketeig L, Donner A, Al-Mazrou Y, Ba'aqeel H, Belizan M, et al</AU>
<TI>The WHO Antenatal Care Randomised Controlled Trial: rationale and study design</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>Suppl 2</NO>
<PG>27-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:20:12 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Villar J, Merialdi M, Ba'aqeel H, Piaggio G, Lumbiganon P, Belizan JM, et al</AU>
<TI>Developments in antenatal care</TI>
<SO>XVIIIth European Congress of Obstetrics and Gynaecology; 2004 May 12-15; Athens, Greece</SO>
<YR>2004</YR>
<PG>82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-01-14 10:35:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vogel JP, Ndema HA, Souza JP, Gulmezoglu MA, Dowswell T, Carroli G, et al</AU>
<TI>Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial</TI>
<SO>Reproductive Health</SO>
<YR>2013</YR>
<VL>10</VL>
<NO>1</NO>
<PG>19</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimbabwe-1996" MODIFIED="2010-06-08 11:20:38 +0100" MODIFIED_BY="Lynn Hampson" NAME="Zimbabwe 1996" YEAR="1989">
<REFERENCE MODIFIED="2010-06-08 11:20:38 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9193]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:20:38 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Munjanja SP, Lindmark G, Nystrom L</AU>
<TI>Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe</TI>
<SO>Lancet</SO>
<YR>1996</YR>
<VL>348</VL>
<PG>364-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:15:41 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Munjanja SP</AU>
<TI>A randomized controlled trial of two programmes of antenatal care in Harare, Zimbabwe</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1994</YR>
<VL>46</VL>
<PG>31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[9972]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murira M, Munjanja SP, Zhanda I, Nystrom L, Lindmark G</AU>
<TI>Effect of a new antenatal care programme on the attitudes of pregnant women and midwives towards antenatal care in Harare</TI>
<SO>Central African Journal of Medicine</SO>
<YR>1997</YR>
<VL>43</VL>
<PG>131-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zimbabwe-2007" MODIFIED="2010-06-08 11:22:46 +0100" MODIFIED_BY="Lynn Hampson" NAME="Zimbabwe 2007" YEAR="1997">
<REFERENCE MODIFIED="2010-06-08 11:22:04 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Majoko F, Munjanja S, Lindmark G, Nystrom L, Mason E</AU>
<TI>A comparison of two antenatal packages in a rural area in Zimbabwe</TI>
<SO>Women's Health - into the new millennium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa</SO>
<YR>1999</YR>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:22:28 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9829]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:22:28 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Majoko F, Munjanja SP, Lindmark G, Nystrom L, Mason E</AU>
<TI>A study of two antenatal care models in a rural setting in Zimbabwe</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<NO>167</NO>
<PG>87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:22:46 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Majoko F, Munjanja SP, Nyström L, Mason E, Lindmark G</AU>
<TI>Randomised controlled trial of two antenatal care models in rural Zimbabwe</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>2007</YR>
<VL>114</VL>
<NO>7</NO>
<PG>802-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-05-26 09:12:48 +0100" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Berglund-1998" NAME="Berglund 1998" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berglund AC, Lindmark GC</AU>
<TI>Health services effects of a reduced routine programme for antenatal care. An area-based study</TI>
<SO>European Journal of Obstetric Gynecology and Reproductive Biology</SO>
<YR>1998</YR>
<VL>77</VL>
<PG>193-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Biro-2000" NAME="Biro 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Biro M, Waldenstrom U, Pannifex J</AU>
<TI>Team midwifery care in a tertiary level obstetric service: a randomized controlled trial</TI>
<SO>Birth</SO>
<YR>2000</YR>
<VL>27</VL>
<NO>3</NO>
<PG>168-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chambliss-1992" NAME="Chambliss 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chambliss LR, Daly C, Medearis AL, Ames M, Kayne M, Paul R</AU>
<TI>The role of selection bias in comparing cesarean birth rates between physician and midwifery management</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>80</VL>
<NO>2</NO>
<PG>161-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-2013" MODIFIED="2015-01-14 14:12:14 +0000" MODIFIED_BY="[Empty name]" NAME="Clark 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-01-14 14:12:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Clark EAS</AU>
<TI>Personalized prenatal care for low-risk pregnancies using telemedicine</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 5 February 2014]</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT01970436"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clement--1996" NAME="Clement  1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clement S, Sikorski J, Wilson J, Das S, Smeeton N</AU>
<TI>Women's satisfaction with traditional and reduced antenatal visit schedules</TI>
<SO>Midwifery</SO>
<YR>1996</YR>
<VL>12</VL>
<PG>120-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Flenady-1998" NAME="Flenady 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Flenady V</AU>
<TI>The maternity care study: a randomised controlled trial of a community midwifery service and standard shared care</TI>
<SO>Personal communication</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giles-1992" MODIFIED="2010-06-08 11:23:13 +0100" MODIFIED_BY="Lynn Hampson" NAME="Giles 1992" YEAR="1989">
<REFERENCE MODIFIED="2010-01-29 10:10:00 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[7518]&lt;/p&gt;" NOTES_MODIFIED="2010-01-29 10:10:00 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giles W, Collins J, Ong F, MacDonald R</AU>
<TI>Antenatal care of low risk obstetric patients by midwives. A randomised controlled trial</TI>
<SO>Medical Journal of Australia</SO>
<YR>1992</YR>
<VL>157</VL>
<PG>158-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harvey-1996" NAME="Harvey 1996" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harvey S, Jarrel J, Brant R, Stainton C, Rach D</AU>
<TI>A randomised controlled trial of nurse-midwifery care</TI>
<SO>Birth</SO>
<YR>1996</YR>
<VL>23</VL>
<PG>128-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hundley-1997" MODIFIED="2010-06-08 11:26:27 +0100" MODIFIED_BY="Lynn Hampson" NAME="Hundley 1997" YEAR="1992">
<REFERENCE MODIFIED="2010-06-08 11:26:27 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[10064]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:26:27 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hundley VA, Milne JM, Glazener CMA, Mollison J</AU>
<TI>Satisfaction and the three C's: continuity, choice and control. Women's views from a randomised controlled trial of midwife-led care</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<NO>11</NO>
<PG>1273-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jewell-2000" MODIFIED="2010-06-08 11:27:38 +0100" MODIFIED_BY="Lynn Hampson" NAME="Jewell 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-06-08 11:27:38 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jewell D, Sanders J, Sharp D</AU>
<TI>The views and anticipated needs of women in early pregnancy</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2000</YR>
<VL>107</VL>
<PG>1237-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:27:22 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jewell D, Sharp D, Sanders J, Peters TJ</AU>
<TI>A randomised controlled trial of flexibility in routine antenatal care</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2000</YR>
<VL>107</VL>
<PG>1241-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kitzman-1997" MODIFIED="2010-06-08 11:28:28 +0100" MODIFIED_BY="Lynn Hampson" NAME="Kitzman 1997" YEAR="1990">
<REFERENCE MODIFIED="2010-06-08 11:28:28 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9562]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:28:28 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kitzman H, Henderson CR, Hanks C, Cole R, Tatelbaum R, McConnochie KM, et al</AU>
<TI>Effect of prenatal and infancy home visitation by nurses on pregnancy outcomes, childhood injuries, and repeated childbearing. A randomised controlled trial</TI>
<SO>JAMA</SO>
<YR>1997</YR>
<VL>278</VL>
<PG>644-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kusulasai-1993" MODIFIED="2010-06-08 11:30:50 +0100" MODIFIED_BY="Lynn Hampson" NAME="Kusulasai 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-01-12 10:38:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kusulasai K, Somrit N</AU>
<TI>A comparative study of new antenatal care schedule versus conventional one in detection of pregnancy complications in Chon Buri Hospital</TI>
<SO>Chon Buri Hospital Journal</SO>
<YR>1993</YR>
<VL>18</VL>
<NO>2</NO>
<PG>17-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neilson-1998" NAME="Neilson 1998" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neilson BB, Hedegaard M, Thilsted SH, Joseph A, Liljestrand J</AU>
<TI>Does antenatal care influence postpartum health behaviour? Evidence from a community based cross-sectional study in rural Tamil Nadu, South India</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1998</YR>
<VL>105</VL>
<PG>697-703</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Srinivasan-1995" MODIFIED="2010-06-08 11:31:22 +0100" MODIFIED_BY="Lynn Hampson" NAME="Srinivasan 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-06-08 11:31:22 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Srinivasan V, Radhakrishna S, Sudha R, Malathi MV, Jabbar S, Ramakrishnan R, et al</AU>
<TI>Randomised controlled field trial of two antenatal care packages in rural south India</TI>
<SO>Indian Journal of Medical Research</SO>
<YR>1995</YR>
<VL>102</VL>
<PG>86-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tomlinson-2014" MODIFIED="2015-01-14 13:31:56 +0000" MODIFIED_BY="[Empty name]" NAME="Tomlinson 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-01-14 13:31:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tomlinson M, Doherty T, Ijumba P, Jackson D, Lawn J, Persson LA, et al</AU>
<TI>Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township</TI>
<SO>Tropical Medicine &amp; International Health</SO>
<YR>2014</YR>
<VL>19</VL>
<NO>3</NO>
<PG>256-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tucker-1996" MODIFIED="2015-05-26 09:12:48 +0100" MODIFIED_BY="Heather Maxwell" NAME="Tucker 1996" YEAR="1993">
<REFERENCE MODIFIED="2010-01-29 10:13:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ratcliffe J, Ryan M, Tucker J</AU>
<TI>The costs of alternative types of routine antenatal care for low-risk women: shared care vs care by general practitioners and community midwives</TI>
<SO>Journal of Health Services and Research Policy</SO>
<YR>1996</YR>
<VL>1</VL>
<NO>3</NO>
<PG>135-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-26 09:12:48 +0100" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[9083]&lt;/p&gt;" NOTES_MODIFIED="2015-05-26 09:12:48 +0100" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tucker JS, Hall MH, Howie PW, Reid ME, Barbour RS, Florey CD, et al</AU>
<TI>Should obstetricians see women with normal pregnancies? A multicentre randomised controlled trial of routine antenatal care by general practitioners and midwives compared with shared care led by obstetricians</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<NO>7030</NO>
<PG>554-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turnbull-1996" MODIFIED="2010-06-08 11:35:45 +0100" MODIFIED_BY="Lynn Hampson" NAME="Turnbull 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-06-08 11:29:19 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheyne H, McGinley M, Turnbull D, Holmes A, Shields N, Greer I, et al</AU>
<TI>Midwife managed care: results of a randomised controlled trial of 1299 women</TI>
<SO>Prenatal and Neonatal Medicine</SO>
<YR>1996</YR>
<VL>1</VL>
<NO>1 Suppl 1</NO>
<PG>129</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:32:35 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields N, Reid M, Cheyne H, Holmes A, McGinley M, Turnbull D, et al</AU>
<TI>Impact of midwife-managed care in the postnatal period: an exploration of psychosocial outcomes</TI>
<SO>Journal of Reproductive and Infant Psychology</SO>
<YR>1997</YR>
<VL>15</VL>
<PG>91-108</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:34:18 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields N, Turnbull D, Reid M, Holmes A, Cheyne H, McGinley M, et al</AU>
<TI>Women's satisfaction and continuity of care with midwife managed care</TI>
<SO>Prenatal and Neonatal Medicine</SO>
<YR>1996</YR>
<VL>1</VL>
<NO>Suppl 1</NO>
<PG>320</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-29 10:12:34 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[10217]&lt;/p&gt;" NOTES_MODIFIED="2010-01-29 10:12:34 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shields N, Turnbull D, Reid M, Holmes A, McGinley M, Smith LN</AU>
<TI>Satisfaction with midwife-managed care in different time periods: a randomised controlled trial of 1299 women</TI>
<SO>Midwifery</SO>
<YR>1998</YR>
<VL>14</VL>
<PG>85-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:35:45 +0100" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Turnbull D, Holmes A, Cheyne H, Shields N, McGinley M, McIlwaine G, et al</AU>
<TI>Does midwife-led care work? The results of randomised controlled trial of 1299 women [Abstract no: 527]</TI>
<SO>27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, Ireland</SO>
<YR>1995</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-06-08 11:32:18 +0100" MODIFIED_BY="Lynn Hampson" NOTES="&lt;p&gt;[9192]&lt;/p&gt;" NOTES_MODIFIED="2010-06-08 11:32:18 +0100" NOTES_MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Turnbull D, Holmes A, Shields N, Cheyne H, Twaddle S, Gilmour WH, et al</AU>
<TI>Randomised controlled trial of efficacy of midwife-managed care</TI>
<SO>Lancet</SO>
<YR>1996</YR>
<VL>348</VL>
<PG>213-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-29 10:12:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Young D, Lees A, Twaddle S</AU>
<TI>The costs to the NHS of maternity care: midwife-managed vs shared</TI>
<SO>British Journal of Midwifery</SO>
<YR>1997</YR>
<VL>5</VL>
<PG>465-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waldenstrom-2000" NAME="Waldenstrom 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waldenstrom U, Brown S, McLachlan H, Forster D, Brennecke S</AU>
<TI>Does team midwife care increase satisfaction with antenatal, intrapartum, and postpartum care ? A randomized controlled trial</TI>
<SO>Birth</SO>
<YR>2000</YR>
<VL>27</VL>
<NO>3</NO>
<PG>156-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-01-14 13:31:56 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2015-01-14 14:12:14 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Famuyide-2014" MODIFIED="2015-01-14 10:34:41 +0000" MODIFIED_BY="[Empty name]" NAME="Famuyide 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-01-14 10:34:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Famuyide A</AU>
<TI>OB Nest; redefining continuity of care for expectant mothers</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 24 March 2014]</SO>
<YR>2014</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="CTG" VALUE="NCT02082275"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-05-26 09:23:15 +0100" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_REFERENCES MODIFIED="2015-05-26 09:17:17 +0100" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Bergsjo-1997" NAME="Bergsjo 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bergsjo P, Villar J</AU>
<TI>Scientific basis for the content of routine antenatal care. II. Power to eliminate or alleviate adverse newborn outcomes; some special conditions and examinations</TI>
<SO>Acta Obstetrica et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<PG>15-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carroli-2001a" MODIFIED="2010-06-08 11:36:41 +0100" MODIFIED_BY="Lynn Hampson" NAME="Carroli 2001a" TYPE="JOURNAL_ARTICLE">
<AU>Carroli G, Rooney C, Villar J</AU>
<TI>How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>Suppl 1</NO>
<PG>1-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-De-Onis-1998" MODIFIED="2010-08-15 19:01:14 +0100" MODIFIED_BY="[Empty name]" NAME="De Onis 1998" TYPE="JOURNAL_ARTICLE">
<AU>De Onis M, Villar J, Gülmezoglu M</AU>
<TI>Nutritional interventions to prevent intrauterine growth retardation: evidence from randomised controlled trials</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1998</YR>
<VL>52</VL>
<PG>S83-S93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2014" MODIFIED="2015-03-23 13:00:28 +0000" MODIFIED_BY="[Empty name]" NAME="GRADE 2014" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro. [Computer program on www.gradepro.org]</TI>
<YR>2014</YR>
<EN>2015</EN>
<PB>McMaster University</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-G_x00fc_lmezoglu-1997" MODIFIED="2010-08-17 10:54:59 +0100" MODIFIED_BY="Denise Atherton" NAME="Gülmezoglu 1997" TYPE="JOURNAL_ARTICLE">
<AU>Gülmezoglu M, De Onis M, Villar J</AU>
<TI>Effectiveness of interventions to prevent or treat impaired fetal growth</TI>
<SO>Obstetrical and Gynecological Survey</SO>
<YR>1997</YR>
<VL>52</VL>
<PG>139-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-01-14 09:41:12 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hutton-2004" MODIFIED="2015-01-14 10:39:33 +0000" MODIFIED_BY="[Empty name]" NAME="Hutton 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hutton G, Fox-Rushby J, Mugford M, Thinkhamrop J, Thinkhamrop B, Galvez AM, et al</AU>
<TI>Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial</TI>
<SO>Applied Health Economics &amp; Health Policy</SO>
<YR>2004</YR>
<VL>3</VL>
<NO>3</NO>
<PG>161-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaunitz-1984" MODIFIED="2015-05-26 09:15:46 +0100" MODIFIED_BY="Heather Maxwell" NAME="Kaunitz 1984" TYPE="JOURNAL_ARTICLE">
<AU>Kaunitz AM, Spence C, Danielson TS, Rochat RW, Grimes DA</AU>
<TI>Perinatal and maternal mortality in a religious group avoiding obstetric care</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1984</YR>
<VL>150</VL>
<PG>826-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Loudon-1992" MODIFIED="2015-05-26 09:16:27 +0100" MODIFIED_BY="Heather Maxwell" NAME="Loudon 1992" TYPE="BOOK">
<AU>Loudon I</AU>
<SO>Death in Childbirth. An International Study of Maternal Care and Maternal Mortality 1800-1950</SO>
<YR>1992</YR>
<PB>Clarendon Press, Oxford</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oakley-1982" MODIFIED="2015-05-26 09:17:17 +0100" MODIFIED_BY="Heather Maxwell" NAME="Oakley 1982" TYPE="BOOK_SECTION">
<AU>Oakley A</AU>
<TI>The origins and development of antenatal care</TI>
<SO>Effectiveness and Satisfaction in Antenatal Care. Clinics in Developmental Medicine Nos. 81/82</SO>
<YR>1982</YR>
<PG>1-21</PG>
<ED>M Enkin, I Chalmers</ED>
<PB>Spastics International Medical Publications</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Piaggio-2001" MODIFIED="2010-06-08 11:39:28 +0100" MODIFIED_BY="Lynn Hampson" NAME="Piaggio 2001" TYPE="JOURNAL_ARTICLE">
<AU>Piaggio G, Carroli G, Villar J, Pinol A, Bakketeig L, Lumbiganon P, et al</AU>
<TI>Methodological considerations on the design and analysis of an equivalence stratified cluster randomisation trial</TI>
<SO>Statistics in Medicine</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>401-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-01-14 09:38:08 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schunemann-2009" MODIFIED="2015-02-09 13:53:44 +0000" MODIFIED_BY="[Empty name]" NAME="Schunemann 2009" TYPE="JOURNAL_ARTICLE">
<AU>Schunemann HJ</AU>
<TI>GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice</TI>
<TO>GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen</TO>
<SO>Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen</SO>
<YR>2009</YR>
<VL>103</VL>
<NO>6</NO>
<PG>391-400</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="19839216"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Villar--1997" MODIFIED="2010-06-08 11:41:41 +0100" MODIFIED_BY="Lynn Hampson" NAME="Villar  1997" TYPE="JOURNAL_ARTICLE">
<AU>Villar J, Bergsjo P</AU>
<TI>Scientific basis for the content of routine antenatal care. I: Philosophy, recent studies, and power to eliminate or alleviate adverse maternal outcomes</TI>
<SO>Acta Obstetrica et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<PG>1-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Villar-1998" MODIFIED="2010-08-17 10:54:47 +0100" MODIFIED_BY="Denise Atherton" NAME="Villar 1998" TYPE="JOURNAL_ARTICLE">
<AU>Villar J, Gülmezoglu M, De Onis M</AU>
<TI>Nutritional and antimicrobial interventions to prevent preterm birth: An overview of randomised controlled trials</TI>
<SO>Obstetrical and Gynecological Survey</SO>
<YR>1998</YR>
<VL>53</VL>
<PG>575-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vogel-2013" MODIFIED="2015-01-14 10:39:38 +0000" MODIFIED_BY="[Empty name]" NAME="Vogel 2013" TYPE="JOURNAL_ARTICLE">
<AU>Vogel JP, Ndema HA, Souza JP, Gulmezoglu MA, Dowswell T, Carroli G, et al</AU>
<TI>Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial</TI>
<SO>Reproductive Health</SO>
<YR>2013</YR>
<VL>10</VL>
<NO>1</NO>
<PG>19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2008" MODIFIED="2010-06-07 14:23:05 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2008" TYPE="JOURNAL_ARTICLE">
<AU>Taljaard M, Donner A, Villar J, Wojdyla D, Velazco A, Bataglia V, et al</AU>
<TI>Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>2</NO>
<PG>117-25</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-05-26 09:23:15 +0100" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Carroli-2001b" MODIFIED="2015-05-26 09:23:15 +0100" MODIFIED_BY="Heather Maxwell" NAME="Carroli 2001b" TYPE="JOURNAL_ARTICLE">
<AU>Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gulmezoglu M, Mugford M, et al; WHO Antenatal Care Trial Research Group</AU>
<TI>WHO Systematic review of randomised controlled trials of routine antenatal care</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>9268</NO>
<PG>1565-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dowswell-2010" MODIFIED="2015-05-26 09:20:42 +0100" MODIFIED_BY="Heather Maxwell" NAME="Dowswell 2010" TYPE="COCHRANE_REVIEW">
<AU>Dowswell T, Carroli G, Duley L, Gates S, Gülmezoglu AM, Khan-Neelofur D, et al</AU>
<TI>Alternative versus standard packages of antenatal care for low-risk pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2015-01-14 09:46:22 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-01-14 09:46:22 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000934.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Khan_x002d_Neelofur-1998" NAME="Khan-Neelofur 1998" TYPE="JOURNAL_ARTICLE">
<AU>Khan-Neelofur D, Gulmezoglu M, Villar J</AU>
<TI>Who should provide routine antenatal care for low risk women, and how often? A systematic review of randomised controlled trials. WHO Antenatal Care Trial Research Group</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>Suppl 2</NO>
<PG>7-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Villar-2001" MODIFIED="2015-05-26 09:21:35 +0100" MODIFIED_BY="Heather Maxwell" NAME="Villar 2001" TYPE="COCHRANE_REVIEW">
<AU>Villar J, Carroli G, Khan-Neelofur D, Piaggio GGP, Gülmezoglu AM</AU>
<TI>Patterns of routine antenatal care for low-risk pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-09-12 09:41:13 +0100" MODIFIED_BY="Sonja L  Henderson">
<IDENTIFIER MODIFIED="2012-09-12 09:41:13 +0100" MODIFIED_BY="Sonja L  Henderson" TYPE="DOI" VALUE="10.1002/14651858.CD000934"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-05-25 17:19:43 +0100" MODIFIED_BY="Heather Maxwell"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-05-26 10:38:31 +0100" MODIFIED_BY="Heather Maxwell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-05-26 10:38:31 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-05-26 09:49:26 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-England-1996">
<CHAR_METHODS MODIFIED="2010-06-07 14:02:53 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-26 09:46:44 +0100" MODIFIED_BY="Heather Maxwell">
<P>3252 low-risk women booked for ANC before 22 weeks' gestation in any of the sites participating in the study (clinics, hospitals etc).</P>
<P>Exclusions: women with a history of complications in a previous pregnancy, with a previous low birthweight baby, medical complication (including hypertension, diabetes, psychiatric, renal or cardiac disease), &lt; 16 or &gt; 39 years of age, known substance abuser, weighing &lt; 41 kg or &gt; 100 kg, or multiple pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-08 14:23:29 +0100" MODIFIED_BY="Denise Atherton">
<P>Reduced visits: for nulliparous women - 7 visits (at 24, 28, 32, 36, 38, 40 weeks + booking visit). Multiparous women: 6 visits (at 26, 32, 36, 38, 40 weeks + booking visit).<BR/>Standard ANC: 13 visits (at 16, 20, 24, 28, 30, 32, 34, 36, 37, 38, 39, 40 weeks + booking visit).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-26 09:49:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>Women: pre-eclampsia (defined according to the criteria of the International Society for the Study of Hypertension in Pregnancy (ISSHP)), hypertension, caesarean section, undiagnosed malpresentation, IOL, length of labour, APH, PPH.<BR/>Babies: perinatal death, small-for-gestational age (&lt; 3rd centile and &lt; 10th centile), Apgar at 1 and 5 minutes, admission to SCBU.<BR/>Health service use: antenatal or day admission, number of ultrasound scans, continuity of care.<BR/>Psychosocial: social support during or after pregnancy, worry about pregnancy and the wellbeing of the fetus, attitudes to fetus and baby.<BR/>Maternal and professional acceptability of the new style of care.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 14:03:29 +0100" MODIFIED_BY="[Empty name]">
<P>In the reduced visits group the mean number of visits was 8.6 (7 planned). In the control group the mean number of visits was 10.8 (13 planned).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-USA-1995">
<CHAR_METHODS MODIFIED="2010-06-08 14:24:20 +0100" MODIFIED_BY="Denise Atherton">
<P>'Quasi-random' trial. Randomisation was not 1-to-1, as the aim was to include more women in the intervention arm.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton">
<P>549 low-risk women &lt; 18 weeks' gestation.</P>
<P>1566 women were informed about the study, of whom 159 were ineligible because of risk factors, 809 declined to participate and 49 were beyond 18 weeks' gestation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-08 14:24:34 +0100" MODIFIED_BY="Denise Atherton">
<P>Reduced visits: 8 expected antenatal visits. Each woman assigned 1 care provider for the entirety of her antenatal care.<BR/>Control: 13 expected visits.<BR/>Each visit was potentially with a different care provider.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-08 14:24:43 +0100" MODIFIED_BY="Denise Atherton">
<P>Women: caesarean section, woman's satisfaction (scale 1-6).</P>
<P>Babies: preterm birth (&lt; 37 weeks), low birthweight (&lt; 2500 g), Apgar at 5 minutes &lt; 7.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Number of visits achieved: reduced visits group 8.2 (SD 1.9) and standard ANC group 11.3 (SD 2.1).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-26 09:51:30 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-USA-1996">
<CHAR_METHODS MODIFIED="2010-06-07 14:04:45 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-26 09:50:54 +0100" MODIFIED_BY="Heather Maxwell">
<P>2764 low-risk women aged 18-39 years booking at any of the participating sites before 13 completed weeks' gestation.<BR/>Excluded if past or current high-risk obstetric condition, current medical condition, non-English speaking or planning to change insurance carriers during pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Reduced visits: 9 visits (at 8, 12, 16, 24, 28, 32, 36, 38 and 40 weeks). For parous women a telephone call was scheduled at 12 weeks instead of a visit.<BR/>Standard ANC: 14 visits (visits every 4 weeks from 8 to 28 weeks, every 2 weeks until 36 weeks, and weekly thereafter).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-26 09:51:30 +0100" MODIFIED_BY="Heather Maxwell">
<P>Women: mild and severe pre-eclampsia, caesarean section, preterm labour, preterm premature rupture of membranes, gestational diabetes, chorioamnionitis (clinical), abruptio placentae, placenta previa, and PPH (&gt; 750 mL for vaginal delivery and &gt; 1500 mL for caesarean delivery).<BR/>Babies: stillbirth (&gt; 20 weeks), preterm birth (&lt; 37 weeks), and low birthweight (&lt; 2500 g), gestation at birth, birthweight, small-for-gestational age (&lt; 10th percentile), very low birthweight (&lt; 1500 g), Apgar score &lt; 7 at 5 minutes, and stillbirth.<BR/>Women's satisfaction: with prenatal care, education during prenatal visits and educational material.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-06-07 14:05:35 +0100" MODIFIED_BY="[Empty name]">
<P>Mean number of visits in the reduced visits group was 12.0 (SD 4.2) and in standard ANC group 14.7 (SD 4.2).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-26 09:52:55 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-USA-1997">
<CHAR_METHODS MODIFIED="2010-06-07 14:06:08 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-12 10:46:37 +0000" MODIFIED_BY="[Empty name]">
<P>122 women with a low-risk pregnancy (met criteria for birthing centre), booking before 26 weeks of gestation, older than 18 years of age, and who could read Spanish or English.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-07 14:06:40 +0100" MODIFIED_BY="[Empty name]">
<P>Reduced visits: 8 visits (booking + 15-19 weeks, 24-28 weeks, 32 weeks, 36 weeks, 38 weeks, then weekly until delivery) for all women regardless of parity.<BR/>Standard ANC: standard visits (booking, then every 4 weeks to 28 weeks, every 2 weeks to 36 weeks, then weekly to delivery).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-26 09:52:55 +0100" MODIFIED_BY="Heather Maxwell">
<P>Women: number of visits attended, maternal complications, preterm labour, anaemia, recurrent UTI, pregnancy-induced hypertension, fetal malposition, substance abuse, post dates and others.<BR/>Babies: gestational age at birth, birthweight, average weekly weight gain, type of birth, Ballard score, intrauterine growth restriction, days in the newborn nursery, days in the neonatal intensive care unit, neonatal complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Number of visits achieved: reduced visits group 7.6 (SD 1.6), standard ANC group 10.8 (SD 2.3).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-03-23 11:18:21 +0000" MODIFIED_BY="Sonja L Henderson" STUDY_ID="STD-WHO-2001">
<CHAR_METHODS MODIFIED="2015-03-19 13:24:58 +0000" MODIFIED_BY="Nancy  Medley">
<P>Cluster-randomised trial. Unit of randomisation was urban antenatal clinics located in Argentina, Cuba, Saudi Arabia and Thailand.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton">
<P>24,526 women attending 53 antenatal care clinics. All women attending the clinics were recruited. To be eligible clinics had to be able to recruit at least 150 women/year, women had to be traceable until delivery, high-risk women transferred to hospital had to be traceable. The clinics also had to be adequately staffed and with sufficient resources to provide the activities required by the protocol. Fee for service clinics were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-08 14:26:49 +0100" MODIFIED_BY="Denise Atherton">
<P>Reduced visits: 4 goal-oriented visits based on activities with demonstrated effectiveness for low-risk women. Women requiring further evaluation or special care were referred to higher level of care.<BR/>Standard ANC: standard care as it was normally offered in that clinic.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-23 11:18:21 +0000" MODIFIED_BY="Sonja L Henderson">
<P>Women: maternal death, maternal morbidity index (at least one of pre-eclampsia, eclampsia, severe postpartum anaemia, treated UTI, pyelonephritis), vaginal bleeding, caesarean section, postpartum syphilis referral to higher level care, hospital admission, length of stay in hospital, women's satisfaction.<BR/>Babies: stillbirths, neonatal death, perinatal death, low birthweight (for singleton births), premature ruptured membranes, congenital malformations.<BR/>Other: providers' satisfaction, economic outcomes.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Number of visits achieved: reduced visits group 5, and standard ANC group 8.<BR/>Recruitment in Argentina, Cuba, Saudi Arabia and Thailand. Of the 53 clinics, 39 were polyclinics and 14 were within a hospital. Most booked 33-38 women per month.<BR/>152 women subsequently found not to be pregnant were excluded from the analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-26 10:38:31 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Zimbabwe-1996">
<CHAR_METHODS MODIFIED="2010-06-08 14:27:22 +0100" MODIFIED_BY="Denise Atherton">
<P>Cluster-randomised trial with clinic as the unit of randomisation.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton">
<P>15,994 low-risk women at 7 clinics.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-26 10:38:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>Reduced visits: 6 visits, all goal-oriented which directed the provider towards a certain purpose.<BR/>Standard ANC: 14 visits , but before the trial standard care was 7.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-08 14:27:41 +0100" MODIFIED_BY="Denise Atherton">
<P>Women: maternal death, maternal morbidity, emergency caesarean section, referral patterns during antenatal period and during labour, obstetric intervention.<BR/>Babies: perinatal death, preterm birth (&lt; 37weeks), low birthweight (&lt; 2500 g), small-for-gestational age (SGA).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Number of visits achieved: reduced visits group 4, and standard ANC 6.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-26 09:56:56 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Zimbabwe-2007">
<CHAR_METHODS MODIFIED="2010-06-08 14:27:50 +0100" MODIFIED_BY="Denise Atherton">
<P>Cluster-randomised trial. Unit of randomisation was rural health centres in Gutu district, Zimbabwe.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-17 10:54:25 +0100" MODIFIED_BY="Denise Atherton">
<P>13,517 women attending 23 rural clinics. All women booking for care were eligible for recruitment. (The sample included both low- and high-risk women although women in high-risk groups may have been referred for a higher level of care or received additional visits.)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-06-08 14:28:08 +0100" MODIFIED_BY="Denise Atherton">
<P>Reduced visits: 5 visits with a goal-oriented programme and reduced routine procedures at these visits.<BR/>Standard ANC: standard care for rural areas.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-06-08 14:28:23 +0100" MODIFIED_BY="Denise Atherton">
<P>Women: number and timing of the visits, utilisation of rural health centres for delivery, eclampsia, hypertensive disorders, labour interventions.<BR/>Babies: perinatal mortality (stillbirths after 28 weeks' gestation plus early neonatal deaths), low birthweight (&lt; 2500 g and &lt; 1500 g).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-26 09:56:56 +0100" MODIFIED_BY="Heather Maxwell">
<P>68.7% of women in the control group and 77.1% in the experimental group had 5 or less visits. Data from pregnancy health records for 78% of participants. For women whose records were not retrieved, maternal and neonatal outcome was from birth registers in the health centres or follow-up in the community. Some deaths identified through follow-up in the community and included in the calculation of perinatal mortality may have been late neonatal deaths.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ANC: antenatal care<BR/>APCVS: alternative prenatal care visit schedule<BR/>APH: antepartum haemorrhage<BR/>IOL: induction of labour<BR/>PI: principal investigator<BR/>PPH: postpartum haemorrhage<BR/>SCBU: special care baby unit<BR/>SD: standard deviation<BR/>UTI: urinary tract infection</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-05-26 09:41:37 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-08-15 18:37:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berglund-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-15 18:37:31 +0100" MODIFIED_BY="[Empty name]">
<P>This study is not an RCT, but an area-based, before and after evaluation. The study compared 2 programmes of antenatal care during 2 different time periods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:31:08 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Biro-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:31:08 +0100" MODIFIED_BY="Denise Atherton">
<P>In this RCT continuity of caregiver was assessed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:31:12 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Chambliss-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:31:12 +0100" MODIFIED_BY="Denise Atherton">
<P>This RCT compared physician versus midwifery management in labour.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:41:37 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Clark-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:41:37 +0100" MODIFIED_BY="Heather Maxwell">
<P>(Trial registration: ongoing study). This study focuses on antenatal care where women are monitored remotely in addition to standard care versus standard antenatal care alone. Women in the intervention group are trained to carry out checks at home using automatic blood pressure monitors and other technology and to use web-based video conferencing to interact with health care providers. It appears that the telemedicine intervention is in addition to standard care, as it is stated that women in both groups had the same number of antenatal visits.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:31:17 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Clement--1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:31:17 +0100" MODIFIED_BY="Denise Atherton">
<P>This study does not report results from a RCT rather it is a secondary analysis, focusing on variables that can predict women's satisfaction in 2 antenatal visits models.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-03-23 13:06:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flenady-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-03-23 13:06:49 +0000" MODIFIED_BY="[Empty name]">
<P>Personal communication with the Cochrane Pregnancy and Childbirth Group in 1998 about a planned trial but there are no data available.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:41:04 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Giles-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:41:04 +0100" MODIFIED_BY="Heather Maxwell">
<P>In this RCT, midwife-managed care was compared with standard shared care (obstetricians and midwives). The study focused on alternative care providers and examined the economic implications of different care packages; there was no planned alteration in the schedule of visits or in the number of antenatal visits.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:38:09 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Harvey-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:38:09 +0100" MODIFIED_BY="Heather Maxwell">
<P>RCT but the intervention focused on continuity of care up to postpartum period rather than on antenatal care models.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:31:27 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Hundley-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:31:27 +0100" MODIFIED_BY="Denise Atherton">
<P>RCT comparing delivery care by midwives versus standard care in the labour ward. The antenatal care was otherwise identical.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:31:33 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Jewell-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:31:33 +0100" MODIFIED_BY="Denise Atherton">
<P>In this RCT the intervention group was not a fixed reduction in the number of visits.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:38:23 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kitzman-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:38:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>RCT examining an increase in antenatal care by home visits during which basic care was provided.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:39:06 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kusulasai-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:39:06 +0100" MODIFIED_BY="Heather Maxwell">
<P>This quasi-RCT examined 771 low-risk women attending an antenatal clinic in Thailand 1991-2. A reduced schedule of 4 antenatal visits (scheduled for less than 20 weeks, 28 weeks, 34 and 40 weeks) was compared with standard visits (approximately 8). The study was excluded as it was assessed as being at high risk of bias and results were therefore very difficult to interpret. Women who did not attend all visits according to the study protocol, or who did not deliver in the study hospital were excluded from the analysis. It was not clear how many women were randomised or how many women were excluded after randomisation. (Data extraction from translation notes.)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:30:42 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Neilson-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:30:42 +0100" MODIFIED_BY="Denise Atherton">
<P>This study was not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:30:05 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Srinivasan-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:30:05 +0100" MODIFIED_BY="Denise Atherton">
<P>A randomised community intervention trial introducing a high-risk package.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:39:34 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Tomlinson-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:39:34 +0100" MODIFIED_BY="Heather Maxwell">
<P>This cluster-randomised trial examines a community-based intervention to promote appropriate infant feeding and to improve newborn care and HIV transmission and survival. The intervention mainly took place during the postnatal period. Women in the intervention group received home visits in the antenatal (two visits) and postnatal (five visits) periods while women in the control group received one antenatal and two postnatal visits with different content. It appeared that the visits were in addition to standard antenatal care (not described).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:40:14 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Tucker-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:40:14 +0100" MODIFIED_BY="Heather Maxwell">
<P>This RCT compared routine antenatal care provided by general practitioners and midwives in community-based clinics with standard shared care provided by obstetricians and midwives. The study focused on alternative care providers; there was no planned alteration in the number of antenatal visits.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-26 09:40:32 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Turnbull-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-26 09:40:32 +0100" MODIFIED_BY="Heather Maxwell">
<P>In this RCT, midwife-managed care carried out by a small team of midwives was compared with standard shared care (obstetricians and midwives). The study focused on alternative care providers; there was no planned alteration in the schedule of visits or in the number of antenatal visits.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-06-08 14:30:33 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Waldenstrom-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-06-08 14:30:33 +0100" MODIFIED_BY="Denise Atherton">
<P>RCT assessing the effectiveness of continuity of caregiver.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-01-14 13:31:56 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-05-26 09:42:20 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-05-26 09:42:20 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Famuyide-2014">
<CHAR_STUDY_NAME MODIFIED="2015-04-30 03:01:25 +0100" MODIFIED_BY="[Empty name]">
<P>OB Nest; redefining continuity of care for expectant mothers</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-01-14 14:22:31 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trial (not blinded).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-26 09:42:20 +0100" MODIFIED_BY="Heather Maxwell">
<P>300 low-risk pregnant women. Inclusion criteria: women aged 18 or over, gestational age &lt; 13 weeks at recruitment, able to read and speak English and provide informed consent. Women with high-risk pregnancies were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-14 14:29:25 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention: reduced number of antenatal clinic visits (from 11 to 6), assignment to a specific nursing team and maternal self-monitoring between office visits.</P>
<P>Control: Standard antenatal care (11 visits).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-01-14 14:27:36 +0000" MODIFIED_BY="[Empty name]">
<P>Satisfaction with care. Reduction in the number of antenatal visits.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-01-14 14:28:39 +0000" MODIFIED_BY="[Empty name]">
<P>February 2014 (expected to complete data collection by March 2016)</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-01-14 14:30:17 +0000" MODIFIED_BY="[Empty name]">
<P>Misty M Baker RN baker.misty@mayo.edu </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-01-14 10:34:41 +0000" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-05-26 09:56:00 +0100" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-04-01 11:38:29 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-01 11:38:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Random permuted blocks of 8 and 16, stratifying by the 6 offices at which the recruiting midwives were based.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-23 10:34:02 +0100" MODIFIED_BY="Therese Dowswell" RESULT="NO" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Quasi-random by birth date.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 14:05:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Random number tables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-08 14:26:21 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Computer-generated sequence stratified by 11 personal, clinical and demographic characteristics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-08 14:27:12 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Cluster randomisation with computer-generated sequence, stratified by study site and clinic characteristics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 14:09:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-24 09:43:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Method not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-06-07 14:24:02 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-03 13:53:47 +0100" MODIFIED_BY="Therese Dowswell" RESULT="YES" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Concealment of allocation: sequentially numbered, non-resealable opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-23 10:34:06 +0100" MODIFIED_BY="Therese Dowswell" RESULT="NO" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Based on date of birth.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-12 10:46:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Concealment of allocation: sealed, opaque envelopes contained details of group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 14:07:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Concealment of allocation: not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-06-07 14:24:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Concealment of allocation: allocation sent to each PI by facsimile, after introductory training in each site.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-03 14:10:39 +0100" MODIFIED_BY="Therese Dowswell" RESULT="YES" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Concealment of allocation: sequentially numbered envelopes containing either of the programme types.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-24 09:43:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-05-26 09:54:45 +0100" MODIFIED_BY="Heather Maxwell" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-15 13:55:27 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. Case notes were labelled with allocation and women and staff would be aware of treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-15 13:57:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. Staff would be aware of number of visits. Different staff provided care to women in each arm of this trial and there was an attempt to have a single care provider for women in the intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 09:52:00 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. It was stated that women and staff providing care were not blinded to treatment allocation or study hypotheses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-15 14:00:01 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 09:54:45 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. Although this was a cluster-randomised trial those delivering care in the intervention arms received specific training. The content in addition to the frequency of visits was different in the two arms of the trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-15 14:03:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. This was a cluster trial. Staff in intervention clinics received special training and would be aware of treatment allocation. Content of visits was specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-01-15 14:05:04 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Blinding not feasible with this type of intervention. It was stated that women and care providers were aware of which model of care they were receiving or providing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-01-15 14:11:39 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 13:56:02 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Clinical outcomes were measured by and recorded in maternity notes by staff that were not blind to treatment allocation. There was an attempt to blind research staff collecting data from case notes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 13:57:20 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Outcomes were recorded by staff aware of group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 13:59:02 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Outcomes were recorded by staff aware of group allocation and data were extracted from case notes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 14:00:26 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Outcomes were measured and recorded by staff aware of group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 14:11:39 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Care providers recorded outcomes in maternity case notes. However, there was an attempt reduce detection bias by independent data checking.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 14:04:10 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Outcomes were recorded in case notes completed by staff aware of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-01-15 14:05:18 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Most outcomes were recorded in maternity care notes completed by staff aware of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-05-26 09:56:00 +0100" MODIFIED_BY="Heather Maxwell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:48:22 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Loss to follow-up: 68/1446 (4.7%) in reduced visits group and 30/1446 (2.1%) in the standard ANC group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:50:30 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Loss to follow-up: 93/320 (29%) in the reduced visits group and 55/229 (24%) in the standard ANC group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:52:12 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Loss to follow-up: 217/1382 (15.7%) in the reduced visits group and 219/1382 (15.8%) in the standard ANC group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:53:13 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Loss to follow-up: 37 (30%) withdrew, 18/61 (30%) in reduced visits group and 19/61 (31%) in standard ANC group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:55:01 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Loss to follow-up: reduced visits group:253/12,568 (2.0%) and standard ANC group 290/11958 (2.4%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 09:56:00 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Loss to follow-up: 462/15,994 (2.9%) of participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-24 09:44:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>13,517 were randomised. Full records were available for 78%; some outcome data were available for a further 20%. There was no information for 2% of those randomised.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-01-15 14:21:20 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:56:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Assessment from published study report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:57:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>Assessment from published study report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:59:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Assessment from published study report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:00:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Assessment from published study report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:03:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>The study protocol was available. All main outcomes appeared to be reported. It was stated that there may have been reporting of less severe cases of some outcomes. Increased measurement of some outcomes in the group receiving more visits may have increased detection.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:04:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>It was stated that there was more referral for pre-eclampsia in the group receiving more visits. This may be due to increased opportunities for detection and reporting in this group. All relevant outcomes appeared to have been reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:21:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Main data extraction was from the published study report. The investigators provided further information on outcomes relating to perinatal death..</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-01-15 14:06:15 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:56:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-England-1996">
<DESCRIPTION>
<P>Other risk of bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:57:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-USA-1995">
<DESCRIPTION>
<P>As care was provided by different staff in the two arms of this trial, other aspects of care as well as the frequency of visits may have been different in the two arms and may have had an impact on outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 13:59:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-USA-1996">
<DESCRIPTION>
<P>Other bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:00:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-USA-1997">
<DESCRIPTION>
<P>Other bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:02:47 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-WHO-2001">
<DESCRIPTION>
<P>Other bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:04:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimbabwe-1996">
<DESCRIPTION>
<P>Other bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-15 14:06:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zimbabwe-2007">
<DESCRIPTION>
<P>Other bias not apparent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-07-07 15:10:00 +0100" MODIFIED_BY="Leanne V Jones">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-07-07 15:10:00 +0100" MODIFIED_BY="Leanne V Jones" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-05-26 10:38:48 +0100" MODIFIED_BY="Heather Maxwell">Reduced number of antenatal care visits/goal-oriented compared with standard antenatal care visits for low-risk pregnancy</TITLE>
<TABLE COLS="7" ROWS="19">
<TR>
<TD COLSPAN="7">
<P>
<B>Reduced number of antenatal care visits/goal-oriented compared with standard antenatal care visits for low-risk pregnancy</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>low-risk pregnancy<BR/>
<B>Settings: </B>7 randomised trials (most of the data from 3 large cluster-randomised trials carried out in low- and middle-income countries, including Argentina, Cuba, Saudi Arabia, Thailand and Zimbabwe.<B>)</B>
<BR/>
<B>Intervention: </B>Reduced number of antenatal care visits/goal-oriented<BR/>
<B>Comparison: </B>Standard antenatal care visits</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)**</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>standard antenatal care visits</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Reduced number of antenatal care visits/goal-oriented</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Maternal death</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.13<BR/>(0.5 to 2.57)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>51504<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>This analysis includes only the cluster-randomised trials.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>55 per 100000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>62 per 100000<BR/>(27 to 141)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Hypertensive disorders of pregnancy (including pre-eclampsia)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.95<BR/>(0.8 to 1.12)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>54108<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Hypertensive disorders and pre-eclampsia were defined in various ways in trials.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>46 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>44 per 1000<BR/>(37 to 51)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Perinatal death</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.14<BR/>(1 to 1.31)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>56431<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Adjusted with an ICC of 0.0003 reported in one of the cluster-randomised trials.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>17 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20 per 1000<BR/>(17 to 23)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Preterm birth</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.02<BR/>(0.94 to 1.11)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>53661<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>92 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>94 per 1000<BR/>(87 to 103)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Small-for-gestational age</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.99<BR/>(0.91 to 1.09)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>43045<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>110 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>109 per 1000<BR/>(100 to 120)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Neonatal intensive care unit admission</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.89<BR/>(0.79 to 1.02)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>43048<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>71 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>63 per 1000<BR/>(56 to 72)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>* The illustrative comparative risks have NOT been adjusted for cluster design effect (estimates based on raw data from trials)</P>
<P>** The relative effect and 95% CI have been adjusted for cluster design effect.<BR/>
<B>CI: </B>Confidence interval;<B> ICC:</B>intracluster correlation co-efficient; <B>RR: </B>risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>All of the studies had risk of bias due to lack of blinding</P>
<P>
<SUP>2</SUP>Downgraded for imprecision (wide 95% CI crossing the line of no effect)</P>
<P>
<SUP>3</SUP>The definitions of hypertension and pre-eclampsia varied considerably in these studies</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2015-05-27 08:48:49 +0100" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-05-26 10:41:50 +0100" MODIFIED_BY="Heather Maxwell" NO="1">
<TITLE MODIFIED="2015-05-26 10:41:50 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Fewer than five antenatal visits</TITLE>
<TABLE COLS="4" ROWS="3">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard visits</P>
</TD>
<TD>
<P>Source of ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>4106/5327</P>
</TD>
<TD>
<P>3561/5182</P>
</TD>
<TD>
<P>ICC 0.041 taken from the <LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK> trial.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2015-05-26 10:42:00 +0100" MODIFIED_BY="Heather Maxwell" NO="2">
<TITLE MODIFIED="2015-05-26 10:42:00 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Maternal death</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard visits</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomised trials</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>1/1416</P>
</TD>
<TD>
<P>0/1378</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>0/1175</P>
</TD>
<TD>
<P>0/1176</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster-randomised trials</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>7/11672</P>
</TD>
<TD>
<P>6/11121</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0003 (<LINK REF="REF-WHO-2008" TYPE="REFERENCE">WHO 2008</LINK>).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>6/9394</P>
</TD>
<TD>
<P>5/6138</P>
</TD>
<TD>
<P>7 clinics. ICC 0.0003 (<LINK REF="REF-WHO-2008" TYPE="REFERENCE">WHO 2008</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>4/6696</P>
</TD>
<TD>
<P>2/6483</P>
</TD>
<TD>
<P>23 clinics, ICC 0.0003 (<LINK REF="REF-WHO-2008" TYPE="REFERENCE">WHO 2008</LINK>)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2015-05-26 10:42:12 +0100" MODIFIED_BY="Heather Maxwell" NO="3">
<TITLE MODIFIED="2015-05-26 10:42:12 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard care: pre-eclampsia</TITLE>
<TABLE COLS="5" ROWS="9">
<TR>
<TD>
<P>STUDY ID</P>
</TD>
<TD>
<P>Definition of pre-eclampsia</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>
</P>
</TD>
<TD>
<P>PI hypertension</P>
</TD>
<TD>
<P>9/227</P>
</TD>
<TD>
<P>4/174</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>Mild and severe pre-eclampsia (BP &gt; 140/90 (160/110) with proteinuria or edema)</P>
</TD>
<TD>
<P>69/1165</P>
</TD>
<TD>
<P>75/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>Pre-eclampsia (ISSHP definition)</P>
</TD>
<TD>
<P>9/1240</P>
</TD>
<TD>
<P>11/1286</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>Referred to hospital for PI hypertension/ hypertension/eclampsia</P>
</TD>
<TD>
<P>442/9394</P>
</TD>
<TD>
<P>396/6138</P>
</TD>
<TD>
<P>7 clinics</P>
<P>.0098 ( hypertension <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>Pre-eclampsia (hypertension with proteinuria)</P>
<P>PI hypertension </P>
</TD>
<TD>
<P>189/11672</P>
<P/>
<P>(402/11672)</P>
</TD>
<TD>
<P>144/11121</P>
<P/>
<P>(554/11121)</P>
</TD>
<TD>
<P>53 clinics (pre-eclampsia 0.0018)</P>
<P>(.0098 hypertension) <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>Hypertensive disorders - referred to hospital</P>
</TD>
<TD>
<P>492/5324</P>
</TD>
<TD>
<P>522/5204</P>
</TD>
<TD>
<P>23 clinics</P>
<P>.0098 (hypertension <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>; <LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2015-05-26 10:42:29 +0100" MODIFIED_BY="Heather Maxwell" NO="4">
<TITLE MODIFIED="2015-05-26 10:42:29 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Perinatal death</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>7/1361</P>
</TD>
<TD>
<P>10/1396</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>8/1175</P>
</TD>
<TD>
<P>7/1176</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>234/11672</P>
</TD>
<TD>
<P>190/11121</P>
</TD>
<TD>
<P>53 clinics (ICC from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study -0.0006, truncated to zero to calculate design effect) Primary analysis uses upper confidence interval 0.0003 from the same source.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>162/9394</P>
</TD>
<TD>
<P>88/6138</P>
</TD>
<TD>
<P>7 clinics (ICC from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study -0.0006, truncated to zero to calculate design effect). Primary analysis uses upper confidence interval 0.0003 from the same source.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>185/6614</P>
</TD>
<TD>
<P>161/6384</P>
</TD>
<TD>
<P>23 clinics (ICC from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study -0.0006, truncated to zero to calculate design effect). Primary analysis uses upper confidence interval 0.0003 from the same source.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2015-05-26 10:42:43 +0100" MODIFIED_BY="Heather Maxwell" NO="5">
<TITLE MODIFIED="2015-05-26 10:42:43 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Preterm birth</TITLE>
<TABLE COLS="4" ROWS="10">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>98/1361</P>
</TD>
<TD>
<P>82/1396</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>
</P>
</TD>
<TD>
<P>17/227</P>
</TD>
<TD>
<P>7/174</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>73/1165</P>
</TD>
<TD>
<P>63/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>
</P>
</TD>
<TD>
<P>5/43</P>
</TD>
<TD>
<P>2/38</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>910/11534</P>
</TD>
<TD>
<P>852/11040</P>
</TD>
<TD>
<P>53 clinics. ICC 0.002 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>945/9394</P>
</TD>
<TD>
<P>705/6138</P>
</TD>
<TD>
<P>7 clinics. ICC 0.002 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>599/5058</P>
</TD>
<TD>
<P>588/4930</P>
</TD>
<TD>
<P>23 clinics. ICC 0.002 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2015-05-27 08:48:49 +0100" MODIFIED_BY="Heather Maxwell" NO="6">
<TITLE MODIFIED="2015-05-27 08:48:48 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Small-for-gestational age</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>277/1355</P>
</TD>
<TD>
<P>302/1393</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>36/1175</P>
</TD>
<TD>
<P>28/1176</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>
</P>
</TD>
<TD>
<P>0/43</P>
</TD>
<TD>
<P>1/38</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>1743/11440</P>
</TD>
<TD>
<P>1657/10974</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0065 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>304/9394</P>
</TD>
<TD>
<P>182/6138</P>
</TD>
<TD>
<P>7 clinics. ICC 0.0065 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-07" MODIFIED="2015-05-26 10:43:12 +0100" MODIFIED_BY="Heather Maxwell" NO="7">
<TITLE MODIFIED="2015-05-26 10:43:12 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard care: Antepartum haemorrhage</TITLE>
<TABLE COLS="5" ROWS="9">
<TR>
<TD>
<P>STUDY ID</P>
</TD>
<TD>
<P>Definition</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>
</P>
</TD>
<TD>
<P>Third trimester bleeding</P>
</TD>
<TD>
<P>5/227</P>
</TD>
<TD>
<P>4/174</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>Placental abruption plus placenta previa</P>
</TD>
<TD>
<P>24/1165</P>
</TD>
<TD>
<P>20/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>Antepartum haemorrhage</P>
</TD>
<TD>
<P>70/1360</P>
</TD>
<TD>
<P>74/1391</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster trials</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>Referral to hospital for antepartum haemorrhage</P>
</TD>
<TD>
<P>81/9394</P>
</TD>
<TD>
<P>46/6138</P>
</TD>
<TD>
<P>7 Clinics</P>
<P>0.0034 ( <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>)).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>Second and third trimester bleeding</P>
</TD>
<TD>
<P>180/11672</P>
</TD>
<TD>
<P>122/11121</P>
</TD>
<TD>
<P>53 clinics</P>
<P>0.0034 ( <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>)).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>Antepartum bleeding</P>
</TD>
<TD>
<P>9/5239</P>
</TD>
<TD>
<P>12/5126</P>
</TD>
<TD>
<P>23 clinics 0.0034 ( <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>))</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-08" MODIFIED="2015-05-26 10:43:36 +0100" MODIFIED_BY="Heather Maxwell" NO="8">
<TITLE MODIFIED="2015-05-26 10:43:36 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Postpartum haemorrhage</TITLE>
<TABLE COLS="5" ROWS="7">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Definition</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>Primary post-partum haemorrhage</P>
</TD>
<TD>
<P>135/1358</P>
</TD>
<TD>
<P>137/1390</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>34/1165</P>
</TD>
<TD>
<P>36/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>66/9394</P>
</TD>
<TD>
<P>49/6138</P>
</TD>
<TD>
<P>7 clinics. There was no published ICC for this outcome and so we used an estimated value of 0.01 and carried out sensitivity analysis using other values.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>34/5238</P>
</TD>
<TD>
<P>34/5123</P>
</TD>
<TD>
<P>23 clinics</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-09" MODIFIED="2015-05-26 10:43:54 +0100" MODIFIED_BY="Heather Maxwell" NO="9">
<TITLE MODIFIED="2015-05-26 10:43:54 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Caesarean section</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TD>
<P>STUDY ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>
</P>
</TD>
<TD>
<P>37/227</P>
</TD>
<TD>
<P>25/174</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>151/1165</P>
</TD>
<TD>
<P>140/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>189/1360</P>
</TD>
<TD>
<P>215/1396</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>
</P>
</TD>
<TD>
<P>0/43</P>
</TD>
<TD>
<P>3/38</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>1640/11672</P>
</TD>
<TD>
<P>1569/11121</P>
</TD>
<TD>
<P>53 clinics ICC from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) 0.0044.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-10" MODIFIED="2015-05-26 10:44:08 +0100" MODIFIED_BY="Heather Maxwell" NO="10">
<TITLE MODIFIED="2015-05-26 10:44:08 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard antenatal care: Induction of labour</TITLE>
<TABLE COLS="4" ROWS="6">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced Visits</P>
</TD>
<TD>
<P>Standard Care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>258/1165</P>
</TD>
<TD>
<P>268/1163</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>244/1359</P>
</TD>
<TD>
<P>236/1395</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>300/9394</P>
</TD>
<TD>
<P>213/6138</P>
</TD>
<TD>
<P>7 clinics ICC from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>). There was no published ICC for induction of labour and so we used the ICC for elective CS (0.0044).</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-11" MODIFIED="2015-05-26 10:44:28 +0100" MODIFIED_BY="Heather Maxwell" NO="11">
<TITLE MODIFIED="2015-05-26 10:44:28 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard antenatal care: Postnatal anaemia</TITLE>
<TABLE COLS="4" ROWS="3">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard visits</P>
</TD>
<TD>
<P>Number of clusters and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomised trial</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>822/10720</P>
</TD>
<TD>
<P>876/10050</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0052 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-12" MODIFIED="2015-05-26 10:44:46 +0100" MODIFIED_BY="Heather Maxwell" NO="12">
<TITLE MODIFIED="2015-05-26 10:44:46 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard antenatal care: Treated urinary tract infection</TITLE>
<TABLE COLS="4" ROWS="3">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced Visits</P>
</TD>
<TD>
<P>Standard visits</P>
</TD>
<TD>
<P>Number of clusters and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>695/11672</P>
</TD>
<TD>
<P>824/11121</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0098 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-13" MODIFIED="2015-05-26 10:45:10 +0100" MODIFIED_BY="Heather Maxwell" NO="13">
<TITLE MODIFIED="2015-05-26 10:45:10 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Low birthweight</TITLE>
<TABLE COLS="4" ROWS="10">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>85/1356</P>
</TD>
<TD>
<P>82/1395</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1995" TYPE="STUDY">USA 1995</LINK>
</P>
</TD>
<TD>
<P>64/1175</P>
</TD>
<TD>
<P>72/1176</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>12/227</P>
</TD>
<TD>
<P>7/174</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Thailand 1993a</P>
</TD>
<TD>
<P>31/380</P>
</TD>
<TD>
<P>28/391</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>886/11534</P>
</TD>
<TD>
<P>788/11040</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0003 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>723/9394</P>
</TD>
<TD>
<P>491/6138</P>
</TD>
<TD>
<P>7 clinics. ICC 0.0003 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-2007" TYPE="STUDY">Zimbabwe 2007</LINK>
</P>
</TD>
<TD>
<P>267/4280</P>
</TD>
<TD>
<P>227/3834</P>
</TD>
<TD>
<P>23 clinics. ICC 0.0003 from <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) study</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-14" MODIFIED="2015-05-26 10:45:24 +0100" MODIFIED_BY="Heather Maxwell" NO="14">
<TITLE MODIFIED="2015-05-26 10:45:24 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard ANC: Admission to NICU</TITLE>
<TABLE COLS="5" ROWS="8">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Definition</P>
</TD>
<TD>
<P>Reduced visits</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Cluster number and ICC</P>
</TD>
</TR>
<TR>
<TD>
<P>Individual randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1996" TYPE="STUDY">USA 1996</LINK>
</P>
</TD>
<TD>
<P>NICU admission</P>
</TD>
<TD>
<P>42/1175</P>
</TD>
<TD>
<P>42/1176</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-England-1996" TYPE="STUDY">England 1996</LINK>
</P>
</TD>
<TD>
<P>Admission to special care unit/ NICU</P>
</TD>
<TD>
<P>47/1359</P>
</TD>
<TD>
<P>45/1394</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-USA-1997" TYPE="STUDY">USA 1997</LINK>
</P>
</TD>
<TD>
<P>NICU admission</P>
</TD>
<TD>
<P>4/43</P>
</TD>
<TD>
<P>1/38</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cluster randomisation</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK>
</P>
</TD>
<TD>
<P>Admission to NICU for more than two days</P>
</TD>
<TD>
<P>617/11397</P>
</TD>
<TD>
<P>700/10934</P>
</TD>
<TD>
<P>53 clinics. ICC 0.0024 ( <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) value for ICU stay of more than 2 days)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Zimbabwe-1996" TYPE="STUDY">Zimbabwe 1996</LINK>
</P>
</TD>
<TD>
<P>Not clear</P>
</TD>
<TD>
<P>257/9394</P>
</TD>
<TD>
<P>171/6138</P>
</TD>
<TD>
<P>7 clinics. ICC 0.0024 ( <LINK REF="STD-WHO-2001" TYPE="STUDY">WHO 2001</LINK> (<LINK REF="REF-Piaggio-2001" TYPE="REFERENCE">Piaggio 2001</LINK>) value for ICU stay of more than 2 days)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-15" MODIFIED="2015-05-26 10:45:51 +0100" MODIFIED_BY="Heather Maxwell" NO="15">
<TITLE MODIFIED="2015-05-26 10:45:51 +0100" MODIFIED_BY="Heather Maxwell">Reduced visits/goal-oriented visits vs standard care: fetal and neonatal deaths in the WHO 2001trial</TITLE>
<TABLE COLS="3" ROWS="5">
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Reduced visits</P>
<P>N = 11672</P>
</TD>
<TD>
<P>Standard visits</P>
<P>N = 11121</P>
</TD>
</TR>
<TR>
<TD>
<P>Fetal death &#8804; 36 weeks</P>
</TD>
<TD>
<P>122</P>
</TD>
<TD>
<P>77</P>
</TD>
</TR>
<TR>
<TD>
<P>Fetal death &gt; 36 weeks</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD>
<P>42</P>
</TD>
</TR>
<TR>
<TD>
<P>Neonatal death before hospital discharge </P>
</TD>
<TD>
<P>73</P>
</TD>
<TD>
<P>71</P>
</TD>
</TR>
<TR>
<TD>
<P>Perinatal mortality </P>
</TD>
<TD>
<P>234</P>
</TD>
<TD>
<P>190</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-05-26 10:46:24 +0100" MODIFIED_BY="Heather Maxwell">
<COMPARISON ID="CMP-001" MODIFIED="2015-05-26 10:46:24 +0100" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Reduced number of antenatal care visits/goal-oriented versus standard antenatal care visits</NAME>
<CONT_OUTCOME CHI2="17.084372037483398" CI_END="-2.115230756177449" CI_START="-3.178561023376841" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.646895889777145" ESTIMABLE="YES" I2="88.2933947141167" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2010-03-22 12:41:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.9506402543012502E-4" P_Q="1.0" P_Z="1.7101518022419338E-22" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.19329589599350752" TOTALS="YES" TOTAL_1="2682" TOTAL_2="2677" UNITS="" WEIGHT="100.0" Z="9.757684465154984">
<NAME>Mean number of antenatal visits</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Reduced (less visits)</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Routine (less visits)</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.9790428262571838" CI_START="-2.4209571737428184" EFFECT_SIZE="-2.200000000000001" ESTIMABLE="YES" MEAN_1="8.6" MEAN_2="10.8" MODIFIED="2009-05-20 11:40:13 +0100" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="2.77" SD_2="3.01" SE="0.11273532344762421" STUDY_ID="STD-England-1996" TOTAL_1="1290" TOTAL_2="1340" WEIGHT="35.71923120874268"/>
<CONT_DATA CI_END="-2.7019395113210813" CI_START="-3.4980604886789215" EFFECT_SIZE="-3.1000000000000014" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="11.3" MODIFIED="2010-03-22 12:41:56 +0000" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="1.9" SD_2="2.1" SE="0.2030958179939888" STUDY_ID="STD-USA-1995" TOTAL_1="227" TOTAL_2="174" WEIGHT="31.3730114552145"/>
<CONT_DATA CI_END="-2.358778765897136" CI_START="-3.0412212341028626" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="14.7" MODIFIED="2009-05-20 11:38:41 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="4.2" SD_2="4.2" SE="0.17409566542771837" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="32.907757336042835"/>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="6.768901261750624E-32" CI_END="1.2452763073398432" CI_START="1.0103174224192064" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="1.1216614235281954" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.09526572527841787" LOG_CI_START="0.004457842245170582" LOG_DATA="YES" LOG_EFFECT_SIZE="0.04986178376179421" MODIFIED="2015-03-30 11:53:57 +0100" MODIFIED_BY="Leanne V Jones" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.03136611214847417" Q="0.0" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.152396842953825">
<NAME>Five or fewer antenatal visits</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>More visits-experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>More visits-routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.2452763073398432" CI_START="1.0103174224192064" EFFECT_SIZE="1.1216614235281954" ESTIMABLE="YES" ESTIMATE="0.114811" LOG_CI_END="0.09526572527841787" LOG_CI_START="0.004457842245170582" LOG_EFFECT_SIZE="0.04986178376179421" MODIFIED="2009-05-20 11:51:46 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.053341" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.5597757238224477" CI_END="2.5661059817563885" CI_START="0.4950736038475462" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="1.1271252531297846" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.4092745890387114" LOG_CI_START="-0.3053302286048066" LOG_DATA="YES" LOG_EFFECT_SIZE="0.05197218021695244" MODIFIED="2015-03-30 14:15:04 +0100" MODIFIED_BY="Leanne V Jones" NO="3" P_CHI2="0.7558685192599552" P_Q="1.0" P_Z="0.7755746389617956" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.28509072121611895">
<NAME>Maternal death (cluster-randomised trials)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="3.539344704745779" CI_START="0.349114406437453" EFFECT_SIZE="1.1115917531966784" ESTIMABLE="YES" ESTIMATE="0.105793" LOG_CI_END="0.5489228616142786" LOG_CI_START="-0.45703222936629717" LOG_EFFECT_SIZE="0.045945316123990755" MODIFIED="2009-05-20 12:45:00 +0100" MODIFIED_BY="[Empty name]" ORDER="148" SE="0.590903" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="50.4631891927489"/>
<IV_DATA CI_END="3.62465889812979" CI_START="0.16960888198320936" EFFECT_SIZE="0.784075470399556" ESTIMABLE="YES" ESTIMATE="-0.24325" LOG_CI_END="0.559267143146973" LOG_CI_START="-0.770551408592905" LOG_EFFECT_SIZE="-0.10564213272296605" MODIFIED="2009-05-20 12:45:32 +0100" MODIFIED_BY="[Empty name]" ORDER="149" SE="0.781142" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="28.876669671729715"/>
<IV_DATA CI_END="11.83246162637106" CI_START="0.31688804440059165" EFFECT_SIZE="1.9363795147712575" ESTIMABLE="YES" ESTIMATE="0.66082" LOG_CI_END="1.0730751046902263" LOG_CI_START="-0.4990941456276126" LOG_EFFECT_SIZE="0.28699047953130685" MODIFIED="2009-05-20 12:50:43 +0100" MODIFIED_BY="[Empty name]" ORDER="150" SE="0.9235" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.660141135521382"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="7.85125172038715" CI_END="1.1211092732395254" CI_START="0.7974043365529513" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.9455037790675007" ESTIMABLE="YES" I2="36.315887223222965" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.04964794484483229" LOG_CI_START="-0.09832140682775517" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.02433673099146142" MODIFIED="2015-03-30 14:14:50 +0100" MODIFIED_BY="Leanne V Jones" NO="4" P_CHI2="0.16462630235855258" P_Q="0.9828569823671531" P_Z="0.5191111446970988" Q="4.6170148259107335E-4" RANDOM="YES" SCALE="3.89" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.014984362722575714" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.6447161619015298">
<NAME>Hypertensive disorders of pregnancy (various definitions)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.1201279201919387" CI_END="1.2633822922923785" CI_START="0.7094365518405128" DF="2" EFFECT_SIZE="0.9467257137631089" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.10153478548093792" LOG_CI_START="-0.1490864394139895" LOG_EFFECT_SIZE="-0.02377582696652577" MODIFIED="2010-03-22 12:42:15 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5711726766027438" P_Z="0.7099866300312945" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.956265818413495" Z="0.37187404679379127">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="2.0405672559452013" CI_START="0.3528444975915833" EFFECT_SIZE="0.8485298628957147" ESTIMABLE="YES" ESTIMATE="-0.16425" LOG_CI_END="0.3097509134462251" LOG_CI_START="-0.4524166507514434" LOG_EFFECT_SIZE="-0.07133286865260911" ORDER="133" SE="0.447701" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.5069665161564143"/>
<IV_DATA CI_END="5.507732113515704" CI_START="0.5400557285159264" EFFECT_SIZE="1.7246687447261537" ESTIMABLE="YES" ESTIMATE="0.545035" LOG_CI_END="0.7409728087723975" LOG_CI_START="-0.2675614228841197" LOG_EFFECT_SIZE="0.2367056929441389" MODIFIED="2010-03-22 12:42:15 +0000" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.592418" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.064451899067901"/>
<IV_DATA CI_END="1.260601541161496" CI_START="0.669121901697862" EFFECT_SIZE="0.9184204377654256" ESTIMABLE="YES" ESTIMATE="-0.0851" LOG_CI_END="0.10057783374114647" LOG_CI_START="-0.17449475456108" LOG_EFFECT_SIZE="-0.03695846040996671" ORDER="134" SE="0.161579" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.38484740318918"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="6.726293804733538" CI_END="1.219310236591288" CI_START="0.7288748764411822" DF="2" EFFECT_SIZE="0.9427219091752052" ESTIMABLE="YES" I2="70.26594350379807" ID="CMP-001.04.02" LOG_CI_END="0.08611421989042654" LOG_CI_START="-0.13734701919246295" LOG_EFFECT_SIZE="-0.025616399651018192" MODIFIED="2009-07-06 09:50:51 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.03462622985739405" P_Z="0.653172308667191" STUDIES="3" TAU2="0.035991125022016776" TOTAL_1="0" TOTAL_2="0" WEIGHT="76.0437341815865" Z="0.4493595483103578">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.6654858033321858" CI_START="0.9389764737681061" EFFECT_SIZE="1.2505406777565042" ESTIMABLE="YES" ESTIMATE="0.223576" LOG_CI_END="0.22154093509938372" LOG_CI_START="-0.02734528892738084" LOG_EFFECT_SIZE="0.0970978230860014" MODIFIED="2009-07-06 09:50:51 +0100" MODIFIED_BY="[Empty name]" ORDER="135" SE="0.146197" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.778761112356023"/>
<IV_DATA CI_END="0.9789067521435122" CI_START="0.5433285318653536" EFFECT_SIZE="0.7292927865235033" ESTIMABLE="YES" ESTIMATE="-0.31568" LOG_CI_END="-0.00925867587640896" LOG_CI_START="-0.26493748821802815" LOG_EFFECT_SIZE="-0.13709808204721852" MODIFIED="2009-07-06 09:25:26 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.150187" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.124204409015434"/>
<IV_DATA CI_END="1.0791769779750215" CI_START="0.7864873085812243" EFFECT_SIZE="0.9212811714619994" ESTIMABLE="YES" ESTIMATE="-0.08199" LOG_CI_END="0.03309267198162338" LOG_CI_START="-0.10430828112411862" LOG_EFFECT_SIZE="-0.035607804571247605" MODIFIED="2009-07-06 09:25:45 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SE="0.08071" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="35.140768660215045"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="7.843772491785818" CI_END="1.1249336054766996" CI_START="0.795646764305543" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.9460707073237731" ESTIMABLE="YES" I2="36.25516286664208" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.05112689077981907" LOG_CI_START="-0.09927969904811898" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.024076404134149975" MODIFIED="2015-03-30 14:14:34 +0100" MODIFIED_BY="Leanne V Jones" NO="5" P_CHI2="0.16505849449799093" P_Q="0.5993121425698982" P_Z="0.5303418443988515" Q="1.0239456691168105" RANDOM="YES" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.015498366608514646" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000003" Z="0.6274842749130638">
<NAME>Hypertensive disorders (breakdown by pre-eclampsia and hypertension)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="2.2986096442843644" CI_END="1.3437329677176184" CI_START="0.8475943459781634" DF="2" EFFECT_SIZE="1.0672115375790834" ESTIMABLE="YES" I2="12.99088103223076" ID="CMP-001.05.01" LOG_CI_END="0.12831297246107048" LOG_CI_START="-0.07181194898657824" LOG_EFFECT_SIZE="0.02825051173724611" MODIFIED="2010-01-11 12:29:10 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.316857356433601" P_Z="0.5800208785120025" STUDIES="3" TAU2="0.006067522696504313" TOTAL_1="0" TOTAL_2="0" WEIGHT="43.54524801435449" Z="0.553354226443136">
<NAME>Pre-eclampsia (various definitions)</NAME>
<IV_DATA CI_END="2.0405672559452013" CI_START="0.3528444975915833" EFFECT_SIZE="0.8485298628957147" ESTIMABLE="YES" ESTIMATE="-0.16425" LOG_CI_END="0.3097509134462251" LOG_CI_START="-0.4524166507514434" LOG_EFFECT_SIZE="-0.07133286865260911" MODIFIED="2009-03-11 14:42:43 +0000" MODIFIED_BY="[Empty name]" ORDER="68" SE="0.447701" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.614820971852277"/>
<IV_DATA CI_END="1.260601541161496" CI_START="0.669121901697862" EFFECT_SIZE="0.9184204377654256" ESTIMABLE="YES" ESTIMATE="-0.0851" LOG_CI_END="0.10057783374114647" LOG_CI_START="-0.17449475456108" LOG_EFFECT_SIZE="-0.03695846040996671" MODIFIED="2009-03-11 15:06:59 +0000" MODIFIED_BY="[Empty name]" ORDER="71" SE="0.161579" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.760806697635168"/>
<IV_DATA CI_END="1.6654858033321858" CI_START="0.9389764737681061" EFFECT_SIZE="1.2505406777565042" ESTIMABLE="YES" ESTIMATE="0.223576" LOG_CI_END="0.22154093509938372" LOG_CI_START="-0.02734528892738084" LOG_EFFECT_SIZE="0.0970978230860014" MODIFIED="2009-07-06 10:05:28 +0100" MODIFIED_BY="[Empty name]" ORDER="70" SE="0.146197" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.16962034486705"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.9834005903885337" CI_END="1.9738496876388132" CI_START="0.4351008336392259" DF="1" EFFECT_SIZE="0.9267273841697856" ESTIMABLE="YES" I2="49.58154167917701" ID="CMP-001.05.02" LOG_CI_END="0.2953140772522841" LOG_CI_START="-0.36141008461220403" LOG_EFFECT_SIZE="-0.033048003679959935" MODIFIED="2010-01-11 12:31:05 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15903295321659738" P_Z="0.843623620110582" STUDIES="2" TAU2="0.18365754476600024" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.64178682731628" Z="0.19726058742767635">
<NAME>Hypertension/ pre-eclampsia (not clear/various definitions)</NAME>
<IV_DATA CI_END="5.507732113515704" CI_START="0.5400557285159264" EFFECT_SIZE="1.7246687447261537" ESTIMABLE="YES" ESTIMATE="0.545035" LOG_CI_END="0.7409728087723975" LOG_CI_START="-0.2675614228841197" LOG_EFFECT_SIZE="0.2367056929441389" MODIFIED="2009-07-06 10:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="65" SE="0.592418" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.130028302203078"/>
<IV_DATA CI_END="0.9789067521435122" CI_START="0.5433285318653536" EFFECT_SIZE="0.7292927865235033" ESTIMABLE="YES" ESTIMATE="-0.31568" LOG_CI_END="-0.00925867587640896" LOG_CI_START="-0.26493748821802815" LOG_EFFECT_SIZE="-0.13709808204721852" MODIFIED="2009-07-06 10:03:56 +0100" MODIFIED_BY="[Empty name]" ORDER="64" SE="0.150187" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.5117585251132"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.0927777652639814" CI_START="0.7766986333999575" DF="0" EFFECT_SIZE="0.9212811714619994" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="0.03853184984276632" LOG_CI_START="-0.10974745898526156" LOG_EFFECT_SIZE="-0.035607804571247605" MODIFIED="2010-01-11 12:30:15 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.34653486142878853" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="33.81296515832925" Z="0.9413318025258324">
<NAME>Hospital referral for hypertension</NAME>
<IV_DATA CI_END="1.0927777652639814" CI_START="0.7766986333999575" EFFECT_SIZE="0.9212811714619994" ESTIMABLE="YES" ESTIMATE="-0.08199" LOG_CI_END="0.03853184984276632" LOG_CI_START="-0.10974745898526156" LOG_EFFECT_SIZE="-0.035607804571247605" MODIFIED="2010-01-11 12:30:15 +0000" MODIFIED_BY="[Empty name]" ORDER="144" SE="0.0871" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="33.81296515832925"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.1218012275955271" CI_END="1.3064400036984987" CI_START="0.999999990486699" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="1.1429960591664092" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.11608947019732048" LOG_CI_START="-4.131574164195276E-9" LOG_DATA="YES" LOG_EFFECT_SIZE="0.058044733032873164" MODIFIED="2015-03-30 14:14:14 +0100" MODIFIED_BY="Leanne V Jones" NO="6" P_CHI2="0.8907979612205523" P_Q="0.48568677224371004" P_Z="0.05000001630908478" Q="0.48606758541306" RANDOM="NO" SCALE="1.29" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="1.9599638450315147">
<NAME>Perinatal death with ICC 0.0003</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.4272208595309098" CI_END="1.799555247624568" CI_START="0.4461303201802798" DF="1" EFFECT_SIZE="0.8960112492624471" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="0.25516518434273494" LOG_CI_START="-0.350538259969516" LOG_EFFECT_SIZE="-0.047686537813390543" MODIFIED="2010-06-07 14:19:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5133558099925375" P_Z="0.7576161368186928" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.6733778485385233" Z="0.30861272967591236">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.8808260421966225" CI_START="0.27409759099648995" EFFECT_SIZE="0.718004099744254" ESTIMABLE="YES" ESTIMATE="-0.33128" LOG_CI_END="0.2743486294643891" LOG_CI_START="-0.5620947813942077" LOG_EFFECT_SIZE="-0.14387307596490928" ORDER="128" SE="0.491331" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.926249596007376"/>
<IV_DATA CI_END="3.144117666242121" CI_START="0.4161251180009078" EFFECT_SIZE="1.1438296791366018" ESTIMABLE="YES" ESTIMATE="0.134382" LOG_CI_END="0.4974987908162966" LOG_CI_START="-0.380776068682051" LOG_EFFECT_SIZE="0.058361361067122815" ORDER="129" SE="0.515903" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.7471282525311473"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.20851278265155754" CI_END="1.3219587151548335" CI_START="1.0067823994159075" DF="2" EFFECT_SIZE="1.1536571272143008" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.12121789232026202" LOG_CI_START="0.0029356146004370655" LOG_EFFECT_SIZE="0.06207675346034953" MODIFIED="2010-06-07 14:19:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9009943548041202" P_Z="0.039662032803666966" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="96.32662215146149" Z="2.0572515748750226">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.4353456021282294" CI_START="0.9593228020869798" EFFECT_SIZE="1.1734392890119523" ESTIMABLE="YES" ESTIMATE="0.159939" LOG_CI_END="0.15695648296972248" LOG_CI_START="-0.018035232687474048" LOG_EFFECT_SIZE="0.06946062514112418" MODIFIED="2010-01-04 10:48:52 +0000" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.102791" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="44.00993337654497"/>
<IV_DATA CI_END="1.677072732733958" CI_START="0.8627107150224622" EFFECT_SIZE="1.2028418916888404" ESTIMABLE="YES" ESTIMATE="0.184687" LOG_CI_END="0.22455189787146826" LOG_CI_START="-0.06413480791293655" LOG_EFFECT_SIZE="0.08020854497926591" MODIFIED="2010-01-04 10:49:52 +0000" MODIFIED_BY="[Empty name]" ORDER="131" SE="0.169576" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.170822858668753"/>
<IV_DATA CI_END="1.385225573067566" CI_START="0.8880324489755296" EFFECT_SIZE="1.109110119886534" ESTIMABLE="YES" ESTIMATE="0.103558" LOG_CI_END="0.14152050059299554" LOG_CI_START="-0.05157116467912164" LOG_EFFECT_SIZE="0.04497466795693695" MODIFIED="2009-07-06 10:20:24 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.113423" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="36.14586591624776"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.1948419218528286" CI_END="1.2962474818945076" CI_START="1.0170091013084896" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="1.148170495455673" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.11268792573238576" LOG_CI_START="0.007324839481612636" LOG_DATA="YES" LOG_EFFECT_SIZE="0.060006382606999184" MODIFIED="2010-03-22 14:07:59 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.8789471450935288" P_Q="0.4791031283753384" P_Z="0.02558343439353495" Q="0.5009042422852059" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.2324772923284826">
<NAME>Perinatal death with ICC truncated to zero</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.4272208595309098" CI_END="1.799555247624568" CI_START="0.4461303201802798" DF="1" EFFECT_SIZE="0.8960112492624471" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.25516518434273494" LOG_CI_START="-0.350538259969516" LOG_EFFECT_SIZE="-0.047686537813390543" MODIFIED="2010-01-12 10:38:35 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5133558099925375" P_Z="0.7576161368186928" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.025916085831334" Z="0.30861272967591236">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.8808260421966225" CI_START="0.27409759099648995" EFFECT_SIZE="0.718004099744254" ESTIMABLE="YES" ESTIMATE="-0.33128" LOG_CI_END="0.2743486294643891" LOG_CI_START="-0.5620947813942077" LOG_EFFECT_SIZE="-0.14387307596490928" MODIFIED="2009-03-12 13:29:46 +0000" MODIFIED_BY="[Empty name]" ORDER="106" SE="0.491331" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.586732941236579"/>
<IV_DATA CI_END="3.144117666242121" CI_START="0.4161251180009078" EFFECT_SIZE="1.1438296791366018" ESTIMABLE="YES" ESTIMATE="0.134382" LOG_CI_END="0.4974987908162966" LOG_CI_START="-0.380776068682051" LOG_EFFECT_SIZE="0.058361361067122815" MODIFIED="2009-03-12 13:31:05 +0000" MODIFIED_BY="[Empty name]" ORDER="108" SE="0.515903" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.4391831445947552"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.2667168200367127" CI_END="1.3087717499823386" CI_START="1.0229858167097394" DF="2" EFFECT_SIZE="1.1570889929224621" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.1168639121224837" LOG_CI_START="0.009869612434157944" LOG_EFFECT_SIZE="0.06336676227832085" MODIFIED="2009-07-23 13:47:10 +0100" MODIFIED_BY="Therese Dowswell" NO="2" P_CHI2="0.8751513798420332" P_Z="0.020256913186876575" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="96.97408391416866" Z="2.321554928518707">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.4184594600329197" CI_START="0.970743122235527" EFFECT_SIZE="1.1734392890119523" ESTIMABLE="YES" ESTIMATE="0.159939" LOG_CI_END="0.15181692805179117" LOG_CI_START="-0.012895677769542792" LOG_EFFECT_SIZE="0.06946062514112418" MODIFIED="2009-05-20 09:13:07 +0100" MODIFIED_BY="[Empty name]" ORDER="124" SE="0.096753" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="40.91883785246302"/>
<IV_DATA CI_END="1.5561800110876676" CI_START="0.9297308833766278" EFFECT_SIZE="1.2028418916888404" ESTIMABLE="YES" ESTIMATE="0.184687" LOG_CI_END="0.19205983256387074" LOG_CI_START="-0.031642742605339044" LOG_EFFECT_SIZE="0.08020854497926591" MODIFIED="2009-07-23 13:47:08 +0100" MODIFIED_BY="Therese Dowswell" ORDER="125" SE="0.131404" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.183751901663726"/>
<IV_DATA CI_END="1.3661361817696547" CI_START="0.9004411671765051" EFFECT_SIZE="1.109110119886534" ESTIMABLE="YES" ESTIMATE="0.103558" LOG_CI_END="0.13549399366703438" LOG_CI_START="-0.04554465775316047" LOG_EFFECT_SIZE="0.04497466795693695" MODIFIED="2009-07-23 13:47:10 +0100" MODIFIED_BY="Therese Dowswell" ORDER="126" SE="0.106343" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="33.871494160041905"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="7.052643663466763" CI_END="1.105939073284788" CI_START="0.9431671529175446" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_SIZE="1.0213155276653152" ESTIMABLE="YES" I2="14.92551890746357" I2_Q="74.89912723158903" ID="CMP-001.08" LOG_CI_END="0.043731202135899636" LOG_CI_START="-0.025411332547253217" LOG_DATA="YES" LOG_EFFECT_SIZE="0.009159934794323202" MODIFIED="2010-03-22 14:08:22 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.3160063943112522" P_Q="0.045936473232290886" P_Z="0.6035458445146737" Q="3.9839252173672746" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.5193081908228983">
<NAME>Preterm birth</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.5544695066712233" CI_END="1.5233049819563769" CI_START="1.008632806755047" DF="3" EFFECT_SIZE="1.2395383735466226" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="0.1827868624435263" LOG_CI_START="0.003733089899826831" LOG_EFFECT_SIZE="0.09325997617167654" MODIFIED="2010-03-22 12:42:41 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.669757075290037" P_Z="0.04118224027157502" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.911579248922266" Z="2.041690514517802">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.62793996001466" CI_START="0.9230836803673159" EFFECT_SIZE="1.225856765575552" ESTIMABLE="YES" ESTIMATE="0.20364" LOG_CI_END="0.2116383836519804" LOG_CI_START="-0.034758927062424005" LOG_EFFECT_SIZE="0.08843972829477821" MODIFIED="2009-03-12 12:20:22 +0000" MODIFIED_BY="[Empty name]" ORDER="90" SE="0.144735" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.874421639089886"/>
<IV_DATA CI_END="4.389277689947244" CI_START="0.7895053426090379" EFFECT_SIZE="1.8615472560233342" ESTIMABLE="YES" ESTIMATE="0.621408" LOG_CI_END="0.6423930575815423" LOG_CI_START="-0.10264492676047042" LOG_EFFECT_SIZE="0.26987406541053593" MODIFIED="2010-03-22 12:42:39 +0000" MODIFIED_BY="[Empty name]" ORDER="91" SE="0.437639" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.8612589786200868"/>
<IV_DATA CI_END="1.604338094390449" CI_START="0.8340205227836948" EFFECT_SIZE="1.1567414993010838" ESTIMABLE="YES" ESTIMATE="0.145607" LOG_CI_END="0.20529589577824373" LOG_CI_START="-0.07882326252527021" LOG_EFFECT_SIZE="0.06323631662648682" MODIFIED="2009-03-12 12:21:48 +0000" MODIFIED_BY="[Empty name]" ORDER="92" SE="0.166893" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.922288414042144"/>
<IV_DATA CI_END="10.73350667778134" CI_START="0.4547459744472223" EFFECT_SIZE="2.2093028206706844" ESTIMABLE="YES" ESTIMATE="0.792677" LOG_CI_END="1.0307416308205164" LOG_CI_START="-0.3422311367572684" LOG_EFFECT_SIZE="0.3442552470316239" MODIFIED="2010-03-22 12:42:41 +0000" MODIFIED_BY="[Empty name]" ORDER="93" SE="0.806491" STUDY_ID="STD-USA-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.25361021717014953"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.514248939428264" CI_END="1.0762170872588144" CI_START="0.905614257239804" DF="2" EFFECT_SIZE="0.9872373261311975" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.02" LOG_CI_END="0.031899883123318644" LOG_CI_START="-0.04305674892983845" LOG_EFFECT_SIZE="-0.005578432903259926" MODIFIED="2009-05-20 08:48:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4690132655815047" P_Z="0.7704935099194241" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="85.08842075107775" Z="0.2917294248975572">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.1553229008568122" CI_START="0.9046457279575868" EFFECT_SIZE="1.0223296565549107" ESTIMABLE="YES" ESTIMATE="0.022084" LOG_CI_END="0.06270338203032877" LOG_CI_START="-0.043521463353625986" LOG_EFFECT_SIZE="0.009590959338351369" ORDER="119" SE="0.062397" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="42.3680403653951"/>
<IV_DATA CI_END="1.0855606862203344" CI_START="0.706609842332813" EFFECT_SIZE="0.8758241063894341" ESTIMABLE="YES" ESTIMATE="-0.13259" LOG_CI_END="0.0356541068820303" LOG_CI_START="-0.1508203175931346" LOG_EFFECT_SIZE="-0.05758310535555215" ORDER="120" SE="0.109536" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.748396277474384"/>
<IV_DATA CI_END="1.1511840742095503" CI_START="0.856422848927618" EFFECT_SIZE="0.9929251454538985" ESTIMABLE="YES" ESTIMATE="-0.0071" LOG_CI_END="0.06114477282330704" LOG_CI_START="-0.06731175446633324" LOG_EFFECT_SIZE="-0.0030834908215130693" ORDER="121" SE="0.075456" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="28.97198410820826"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.71223809744261" CI_END="1.0861547443792012" CI_START="0.9066024612068356" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.9923258358551716" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.03589170356078961" LOG_CI_START="-0.042583106271047465" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0033457013551289713" MODIFIED="2010-06-08 14:32:43 +0100" MODIFIED_BY="Denise Atherton" NO="9" P_CHI2="0.6342165159562543" P_Q="0.6319277510318209" P_Z="0.8672736434341823" Q="0.22945567699088437" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.16712252436499078">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.4373157137976353" CI_END="1.1111573744097267" CI_START="0.8416679302178837" DF="1" EFFECT_SIZE="0.9670705907356364" ESTIMABLE="YES" I2="30.425863267171277" ID="CMP-001.09.01" LOG_CI_END="0.04577557289000411" LOG_CI_START="-0.07485922028132772" LOG_EFFECT_SIZE="-0.014541823695661794" MODIFIED="2010-03-22 11:55:45 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2305744771065782" P_Z="0.6365524239033393" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="42.31704916074341" Z="0.4725245505672478">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.0899678249523774" CI_START="0.8157493197428064" EFFECT_SIZE="0.9429424753114307" ESTIMABLE="YES" ESTIMATE="-0.05875" LOG_CI_END="0.037413678076515064" LOG_CI_START="-0.0884432797001471" LOG_EFFECT_SIZE="-0.02551480081181603" MODIFIED="2010-01-15 12:23:52 +0000" MODIFIED_BY="[Empty name]" ORDER="97" SE="0.073929" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="38.878194167579224"/>
<IV_DATA CI_END="2.0946091388186043" CI_START="0.7905416248319427" EFFECT_SIZE="1.2868083431457444" ESTIMABLE="YES" ESTIMATE="0.252165" LOG_CI_END="0.32110299403685266" LOG_CI_START="-0.10207525797858576" LOG_EFFECT_SIZE="0.1095138680291335" MODIFIED="2009-03-12 12:47:08 +0000" MODIFIED_BY="[Empty name]" ORDER="98" SE="0.248577" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.438854993164185"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.04546670665409003" CI_END="1.1390179545116084" CI_START="0.8978531335591513" DF="1" EFFECT_SIZE="1.0112718920440646" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.05653056998240108" LOG_CI_START="-0.04679469729843329" LOG_EFFECT_SIZE="0.004867936341983876" MODIFIED="2010-01-11 12:40:31 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8311483159734354" P_Z="0.8534811769485056" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="57.68295083925659" Z="0.18467854302065448">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.13845411515607" CI_START="0.8943596400061127" EFFECT_SIZE="1.0090527303339802" ESTIMABLE="YES" ESTIMATE="0.009012" LOG_CI_END="0.05631553127430504" LOG_CI_START="-0.04848780753248083" LOG_EFFECT_SIZE="0.003913861870912074" MODIFIED="2010-01-11 12:40:18 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.061562" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="56.06738575597113"/>
<IV_DATA CI_END="2.221670384608186" CI_START="0.5361392598771948" EFFECT_SIZE="1.0913866023068617" ESTIMABLE="YES" ESTIMATE="0.087449" LOG_CI_END="0.34667962581797324" LOG_CI_START="-0.27072238952205835" LOG_EFFECT_SIZE="0.037978618147957485" MODIFIED="2010-01-11 12:40:31 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SE="0.362665" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.615565083285462"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.8193549170328516" CI_END="1.396422809818398" CI_START="0.91691730322052" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="1.1315494849693082" ESTIMABLE="YES" I2="0.0" I2_Q="35.12054201981307" ID="CMP-001.10" LOG_CI_END="0.14501693416774772" LOG_CI_START="-0.0376698315868237" LOG_DATA="YES" LOG_EFFECT_SIZE="0.05367355129046203" MODIFIED="2010-03-22 14:09:10 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.7278118451509016" P_Q="0.21442190760310087" P_Z="0.24945315218679576" Q="1.5413199048385744" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="1.1516786891174848">
<NAME>Antepartum haemorrhage</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Traditional/routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.40140611572282414" CI_END="1.331551402112225" CI_START="0.7707570923856771" DF="2" EFFECT_SIZE="1.0130659835638003" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.12435793624458827" LOG_CI_START="-0.11308247027347311" LOG_EFFECT_SIZE="0.005637732985557569" MODIFIED="2009-05-20 08:35:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8181554167401223" P_Z="0.9258448436344451" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="59.19771181196069" Z="0.09307391078195265">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.3298892582039405" CI_START="0.7038741702365227" EFFECT_SIZE="0.9675095338676324" ESTIMABLE="YES" ESTIMATE="-0.03303" LOG_CI_END="0.12381547814502535" LOG_CI_START="-0.15250497161955412" LOG_EFFECT_SIZE="-0.014344746737264385" MODIFIED="2009-03-12 11:04:05 +0000" MODIFIED_BY="[Empty name]" ORDER="67" SE="0.162312" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="43.710736099625336"/>
<IV_DATA CI_END="3.5152748448132667" CI_START="0.2611611278158611" EFFECT_SIZE="0.9581508978517731" ESTIMABLE="YES" ESTIMATE="-0.04275" LOG_CI_END="0.5459592863741606" LOG_CI_START="-0.5830914645768887" LOG_EFFECT_SIZE="-0.01856608910136401" MODIFIED="2009-03-12 11:04:42 +0000" MODIFIED_BY="[Empty name]" ORDER="68" SE="0.66321" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.618106123902185"/>
<IV_DATA CI_END="2.153095612445955" CI_START="0.6665096730033954" EFFECT_SIZE="1.1979395028950328" ESTIMABLE="YES" ESTIMATE="0.180603" LOG_CI_END="0.333063315952465" LOG_CI_START="-0.176193543322119" LOG_EFFECT_SIZE="0.07843488631517297" MODIFIED="2009-03-12 11:08:45 +0000" MODIFIED_BY="[Empty name]" ORDER="69" SE="0.29914" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.868869588433165"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.8766288964714545" CI_END="1.846569178222143" CI_START="0.9557985693205299" DF="2" EFFECT_SIZE="1.3285135222104856" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.2663655823132212" LOG_CI_START="-0.01963362388497196" LOG_EFFECT_SIZE="0.12336597921412457" MODIFIED="2010-01-11 13:26:52 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.645122916111833" P_Z="0.09086278664008607" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="40.80228818803933" Z="1.6908639670114494">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="2.0110944968916584" CI_START="0.9826295369678285" EFFECT_SIZE="1.4057598850014175" ESTIMABLE="YES" ESTIMATE="0.340578" LOG_CI_END="0.3034324776153456" LOG_CI_START="-0.007610185500054237" LOG_EFFECT_SIZE="0.1479111460576457" MODIFIED="2010-01-11 13:26:52 +0000" MODIFIED_BY="[Empty name]" ORDER="109" SE="0.182708" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="34.49643781735625"/>
<IV_DATA CI_END="3.2987324379381384" CI_START="0.401291860410945" EFFECT_SIZE="1.1505452955091025" ESTIMABLE="YES" ESTIMATE="0.140236" LOG_CI_END="0.5183470911017369" LOG_CI_START="-0.3965396491733681" LOG_EFFECT_SIZE="0.06090372096418445" ORDER="110" SE="0.537409" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.98730546398854"/>
<IV_DATA CI_END="2.920633363291766" CI_START="0.18437556306210434" EFFECT_SIZE="0.7338211095729579" ESTIMABLE="YES" ESTIMATE="-0.30949" LOG_CI_END="0.46547704198106193" LOG_CI_START="-0.7342966403895368" LOG_EFFECT_SIZE="-0.13440979920423735" MODIFIED="2009-05-20 09:43:24 +0100" MODIFIED_BY="[Empty name]" ORDER="111" SE="0.704753" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.3185449066945316"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.08535892567735703" CI_END="1.2112908432347527" CI_START="0.8148667628039266" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.9934991938802676" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.08324843418053171" LOG_CI_START="-0.08891339605684286" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0028324809381555256" MODIFIED="2015-03-30 14:22:01 +0100" MODIFIED_BY="Leanne V Jones" NO="11" P_CHI2="0.9935345598682469" P_Q="0.922782174839942" P_Z="0.9485781971416349" Q="0.009395378564959934" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="0.06449235138853565">
<NAME>Postpartum haemorrhage</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.06623067663369896" CI_END="1.2193003515929193" CI_START="0.8129189302857236" DF="1" EFFECT_SIZE="0.9955864289522647" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.08611069903288086" LOG_CI_START="-0.08995276299768641" LOG_EFFECT_SIZE="-0.001921031982402742" MODIFIED="2010-01-15 12:22:33 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7969061208023728" P_Z="0.9658845493472762" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="95.61703383205818" Z="0.042770413068502725">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.263897719316539" CI_START="0.8049055205817923" EFFECT_SIZE="1.0086219567948236" ESTIMABLE="YES" ESTIMATE="0.008585" LOG_CI_END="0.10171193016968791" LOG_CI_START="-0.09425509391540905" LOG_EFFECT_SIZE="0.003728418127139441" MODIFIED="2009-03-12 11:47:45 +0000" MODIFIED_BY="[Empty name]" ORDER="80" SE="0.115112" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="77.1805282633778"/>
<IV_DATA CI_END="1.495915744574761" CI_START="0.5942242191697943" EFFECT_SIZE="0.9428199007571588" ESTIMABLE="YES" ESTIMATE="-0.05888" LOG_CI_END="0.1749071331696723" LOG_CI_START="-0.22604965135859925" LOG_EFFECT_SIZE="-0.02557125909446348" MODIFIED="2010-01-15 12:22:33 +0000" MODIFIED_BY="[Empty name]" ORDER="81" SE="0.235524" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.436505568680396"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.00973287047869813" CI_END="2.445992019182954" CI_START="0.36822425483325566" DF="1" EFFECT_SIZE="0.949038244009025" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="0.38845503568045525" LOG_CI_START="-0.4338876080283445" LOG_EFFECT_SIZE="-0.022716286173944576" MODIFIED="2010-01-11 13:32:35 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9214119526777638" P_Z="0.9137707472220982" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.382966167941807" Z="0.10828358009657763">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="5.180463581814026" CI_START="0.14951260926091464" EFFECT_SIZE="0.8800821707648432" ESTIMABLE="YES" ESTIMATE="-0.12774" LOG_CI_END="0.714368624999145" LOG_CI_START="-0.8253221792357877" LOG_EFFECT_SIZE="-0.05547677711832139" MODIFIED="2010-01-11 13:32:21 +0000" MODIFIED_BY="[Empty name]" ORDER="114" SE="0.904422" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2502783472386136"/>
<IV_DATA CI_END="2.997146597596992" CI_START="0.31916064873273575" EFFECT_SIZE="0.9780446065677002" ESTIMABLE="YES" ESTIMATE="-0.0222" LOG_CI_END="0.47670798584533364" LOG_CI_START="-0.49599066084183796" LOG_EFFECT_SIZE="-0.00964133749825221" MODIFIED="2010-01-11 13:32:35 +0000" MODIFIED_BY="[Empty name]" ORDER="115" SE="0.571368" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.132687820703193"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.9349240249494368" CI_END="1.0777265588715121" CI_START="0.91065268373313" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.9906738026044767" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.032508585491627294" LOG_CI_START="-0.0406472281847264" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.004069321346549567" MODIFIED="2015-03-30 14:26:17 +0100" MODIFIED_BY="Leanne V Jones" NO="12" P_CHI2="0.5860229793372638" P_Q="0.8814033250289798" P_Z="0.8273920566347378" Q="0.02225780656347306" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.2180475584904931">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.9126662183859637" CI_END="1.1223948463526683" CI_START="0.8608776357935396" DF="2" EFFECT_SIZE="0.9829774268796503" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" LOG_CI_END="0.0501456638954493" LOG_CI_START="-0.06505857430273232" LOG_EFFECT_SIZE="-0.007456455203641507" MODIFIED="2010-03-22 12:43:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3842995638957216" P_Z="0.7997175960146561" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="40.323737354635114" Z="0.2537126043285497">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.0809485269613854" CI_START="0.7532493820190901" EFFECT_SIZE="0.9023435099384876" ESTIMABLE="YES" ESTIMATE="-0.10276" LOG_CI_END="0.033805014037611575" LOG_CI_START="-0.12306121595836787" LOG_EFFECT_SIZE="-0.04462810096037813" MODIFIED="2009-03-12 11:38:06 +0000" MODIFIED_BY="[Empty name]" ORDER="76" SE="0.092144" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.74897389029034"/>
<IV_DATA CI_END="1.8104348243780188" CI_START="0.7108647794440786" EFFECT_SIZE="1.1344489200177148" ESTIMABLE="YES" ESTIMATE="0.126147" LOG_CI_END="0.2577828948407012" LOG_CI_START="-0.1482130028234022" LOG_EFFECT_SIZE="0.054784946008649506" MODIFIED="2010-03-22 12:43:12 +0000" MODIFIED_BY="[Empty name]" ORDER="77" SE="0.238484" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.2467914944968697"/>
<IV_DATA CI_END="1.335151337623639" CI_START="0.8683098595785308" EFFECT_SIZE="1.076719587677344" ESTIMABLE="YES" ESTIMATE="0.073919" LOG_CI_END="0.125530495191069" LOG_CI_START="-0.06132526757545615" LOG_EFFECT_SIZE="0.0321026138078065" MODIFIED="2009-03-12 11:39:15 +0000" MODIFIED_BY="[Empty name]" ORDER="78" SE="0.10976" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.327971969847907"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.1106294387785371" CI_START="0.8930373116925667" DF="0" EFFECT_SIZE="0.995908393524931" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" LOG_CI_END="0.04556918086860946" LOG_CI_START="-0.0491303956202161" LOG_EFFECT_SIZE="-0.0017806073758033466" MODIFIED="2009-05-20 08:42:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9412449490348599" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="59.6762626453649" Z="0.0737052150933899">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.1106294387785371" CI_START="0.8930373116925667" EFFECT_SIZE="0.995908393524931" ESTIMABLE="YES" ESTIMATE="-0.0041" LOG_CI_END="0.04556918086860946" LOG_CI_START="-0.0491303956202161" LOG_EFFECT_SIZE="-0.0017806073758033466" ORDER="113" SE="0.055627" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="59.6762626453649"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.183062123530077" CI_END="1.0874359148876112" CI_START="0.8630255578676254" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="0.9687543481663307" ESTIMABLE="YES" I2="8.385566382053293" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.03640367240298484" LOG_CI_START="-0.06397634278244575" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.013786335189730459" MODIFIED="2015-03-30 14:26:20 +0100" MODIFIED_BY="Leanne V Jones" NO="13" P_CHI2="0.33570236568651" P_Q="0.850245958673227" P_Z="0.5903226526196458" Q="0.035647211587225135" RANDOM="YES" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0010348062467171629" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.5383685268577398">
<NAME>Induction of labour</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="2.1513500646762687" CI_END="1.1438530721334184" CI_START="0.829317531358607" DF="1" EFFECT_SIZE="0.9739699204896652" ESTIMABLE="YES" I2="53.51756013959178" ID="CMP-001.13.01" LOG_CI_END="0.05837024293627824" LOG_CI_START="-0.08127915375209692" LOG_EFFECT_SIZE="-0.011454455407909401" MODIFIED="2009-05-20 08:39:21 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14244465377792104" P_Z="0.7478132874131378" STUDIES="2" TAU2="0.0072174182514999985" TOTAL_1="0" TOTAL_2="0" WEIGHT="95.88594823748105" Z="0.3215240537289234">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.24868182140091" CI_START="0.9020147089492598" EFFECT_SIZE="1.0612866576477693" ESTIMABLE="YES" ESTIMATE="0.059482" LOG_CI_END="0.09645178920384653" LOG_CI_START="-0.04478638045870805" LOG_EFFECT_SIZE="0.025832704372569227" MODIFIED="2009-03-12 11:22:46 +0000" MODIFIED_BY="[Empty name]" ORDER="73" SE="0.082964" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="43.910002367485944"/>
<IV_DATA CI_END="1.0435511789636616" CI_START="0.7771440977513691" EFFECT_SIZE="0.9005496318543983" ESTIMABLE="YES" ESTIMATE="-0.10475" LOG_CI_END="0.018513753062675428" LOG_CI_START="-0.10949844702140668" LOG_EFFECT_SIZE="-0.04549234697936561" MODIFIED="2009-03-12 11:23:23 +0000" MODIFIED_BY="[Empty name]" ORDER="74" SE="0.075195" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="51.97594586999511"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.6212360862276607" CI_START="0.5223858047745281" DF="0" EFFECT_SIZE="0.9202775220733922" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.2098462619060276" LOG_CI_START="-0.282008633019072" LOG_EFFECT_SIZE="-0.03608118555652218" MODIFIED="2010-01-11 13:50:12 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7736869067336414" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.114051762518953" Z="0.2875556386241079">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.6212360862276607" CI_START="0.5223858047745281" EFFECT_SIZE="0.9202775220733922" ESTIMABLE="YES" ESTIMATE="-0.08308" LOG_CI_END="0.2098462619060276" LOG_CI_START="-0.282008633019072" LOG_EFFECT_SIZE="-0.03608118555652218" MODIFIED="2010-01-11 13:50:12 +0000" MODIFIED_BY="[Empty name]" ORDER="112" SE="0.288918" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.114051762518953"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="1.0311386958277649" CI_START="0.7505239461242591" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.013317085052151874" LOG_CI_START="-0.12463544665359336" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2015-03-30 14:26:24 +0100" MODIFIED_BY="Leanne V Jones" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.11375042661619522" Q="0.0" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5815583582200066">
<NAME>Severe postnatal anaemia</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard visits</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.0311386958277649" CI_START="0.7505239461242591" DF="0" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" I2="0.0" ID="CMP-001.14.01" LOG_CI_END="0.013317085052151874" LOG_CI_START="-0.12463544665359336" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2010-06-07 14:20:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.11375042661619522" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5815583582200066">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.0311386958277649" CI_START="0.7505239461242591" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" ESTIMATE="-0.12816" LOG_CI_END="0.013317085052151874" LOG_CI_START="-0.12463544665359336" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2010-01-15 12:21:07 +0000" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.081034" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="1.0039219817247382" CI_START="0.6432934317864643" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.001699963582925778" LOG_CI_START="-0.19159088285030362" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2015-03-30 14:26:24 +0100" MODIFIED_BY="Leanne V Jones" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.05416823399012947" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.9254888145147084">
<NAME>Treated urinary tract infections</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard visits</GROUP_LABEL_2>
<GRAPH_LABEL_1>Reduced more treated UTI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Routine more treated UTI</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.0039219817247382" CI_START="0.6432934317864643" DF="0" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" I2="0.0" ID="CMP-001.15.01" LOG_CI_END="0.001699963582925778" LOG_CI_START="-0.19159088285030362" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2010-06-07 14:20:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.05416823399012947" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.9254888145147084">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.0039219817247382" CI_START="0.6432934317864643" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" ESTIMATE="-0.21862" LOG_CI_END="0.001699963582925778" LOG_CI_START="-0.19159088285030362" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2010-01-11 12:39:41 +0000" MODIFIED_BY="[Empty name]" ORDER="134" SE="0.11354" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.787089815359515" CI_END="1.1107664102112684" CI_START="0.9661236032709524" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="1.0359235718071345" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.045622738128578255" LOG_CI_START="-0.01496730755498126" LOG_DATA="YES" LOG_EFFECT_SIZE="0.01532771528679846" MODIFIED="2015-03-30 14:30:41 +0100" MODIFIED_BY="Leanne V Jones" NO="16" P_CHI2="0.732769674623754" P_Q="0.7232679369296471" P_Z="0.3213729654335372" Q="0.1253831011435936" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.9916404448449045">
<NAME>Low birthweight (&gt; 2500 g)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.0203920664799315" CI_END="1.23563264387675" CI_START="0.8077126905950622" DF="2" EFFECT_SIZE="0.9990176011326227" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="0.09188937330072147" LOG_CI_START="-0.09274309353056955" LOG_EFFECT_SIZE="-4.2686011492403707E-4" MODIFIED="2010-01-11 15:09:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6003779456981413" P_Z="0.9927691440784377" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.769273718986636" Z="0.009062658004263383">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.4309189740060044" CI_START="0.794737921607247" EFFECT_SIZE="1.0663984111906328" ESTIMABLE="YES" ESTIMATE="0.064287" LOG_CI_END="0.15561504246812063" LOG_CI_START="-0.0997760637518919" LOG_EFFECT_SIZE="0.027919489358114332" MODIFIED="2009-03-12 12:04:13 +0000" MODIFIED_BY="[Empty name]" ORDER="84" SE="0.150018" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.628478628345553"/>
<IV_DATA CI_END="3.26771609846792" CI_START="0.5284076123351577" EFFECT_SIZE="1.3140342694848528" ESTIMABLE="YES" ESTIMATE="0.273102" LOG_CI_END="0.5142443176814637" LOG_CI_START="-0.27703093448798" LOG_EFFECT_SIZE="0.11860669159674188" MODIFIED="2009-03-12 12:05:17 +0000" MODIFIED_BY="[Empty name]" ORDER="85" SE="0.464799" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.5863371259398349"/>
<IV_DATA CI_END="1.233598063050666" CI_START="0.6415968361268494" EFFECT_SIZE="0.8896474663064673" ESTIMABLE="YES" ESTIMATE="-0.11693" LOG_CI_END="0.09117367879453747" LOG_CI_START="-0.19273778633243197" LOG_EFFECT_SIZE="-0.05078205376894727" MODIFIED="2009-03-12 12:05:47 +0000" MODIFIED_BY="[Empty name]" ORDER="86" SE="0.166771" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.554457964701249"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.6413146477359892" CI_END="1.1202120857824045" CI_START="0.9664024498559955" DF="2" EFFECT_SIZE="1.04046898274692" ESTIMABLE="YES" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.049300253889134636" LOG_CI_START="-0.014841977773448627" LOG_EFFECT_SIZE="0.01722913805784304" MODIFIED="2009-05-20 08:45:52 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.44014246632634424" P_Z="0.2923752333378772" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="89.23072628101336" Z="1.0529253255695257">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.1871609697356627" CI_START="0.9756272153721507" EFFECT_SIZE="1.0762093435302011" ESTIMABLE="YES" ESTIMATE="0.073445" LOG_CI_END="0.07450960987980647" LOG_CI_START="-0.01071609343303778" LOG_EFFECT_SIZE="0.03189675822338432" ORDER="116" SE="0.050062" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="50.543041440644714"/>
<IV_DATA CI_END="1.1088861813237794" CI_START="0.8347891747902536" EFFECT_SIZE="0.9621258650735846" ESTIMABLE="YES" ESTIMATE="-0.03861" LOG_CI_END="0.04488697143339711" LOG_CI_START="-0.07842319132596623" LOG_EFFECT_SIZE="-0.016768109946284537" ORDER="117" SE="0.072433" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="24.14375513833002"/>
<IV_DATA CI_END="1.2651208343680689" CI_START="0.8775163960519413" EFFECT_SIZE="1.053643333934635" ESTIMABLE="YES" ESTIMATE="0.052254" LOG_CI_END="0.10213200787789896" LOG_CI_START="-0.05674476016315391" LOG_EFFECT_SIZE="0.022693623857372495" ORDER="118" SE="0.093325" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.543929702038627"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="3.3092359874997204" CI_END="1.015679836736926" CI_START="0.7864052871046431" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="0.893720310620442" ESTIMABLE="YES" I2="0.0" I2_Q="40.69024969652284" ID="CMP-001.17" LOG_CI_END="0.0067568309290927135" LOG_CI_START="-0.10435357534803037" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.04879837220946882" MODIFIED="2010-03-22 14:11:24 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.5074704215956487" P_Q="0.1941207934367417" P_Z="0.08514456689809745" Q="1.6860634126483127" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.7215858575153353">
<NAME>Neonatal intensive care unit admission</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.282898509850195" CI_END="1.4136104325054464" CI_START="0.7950504290116128" DF="2" EFFECT_SIZE="1.0601375292002198" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.01" LOG_CI_END="0.15032974162238413" LOG_CI_START="-0.09960532373739216" LOG_EFFECT_SIZE="0.02536220894249601" MODIFIED="2010-03-22 12:43:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5265288248722346" P_Z="0.6907957189148726" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.763100958411073" Z="0.3977754463873785">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.6012804893730814" CI_START="0.7167862392146198" EFFECT_SIZE="1.071342998252883" ESTIMABLE="YES" ESTIMATE="0.068913" LOG_CI_END="0.204467412067605" LOG_CI_START="-0.1446103408048074" LOG_EFFECT_SIZE="0.02992853563139879" MODIFIED="2010-01-15 12:18:55 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SE="0.20505" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.131298890978117"/>
<IV_DATA CI_END="1.5232404223165457" CI_START="0.6576134893404973" EFFECT_SIZE="1.0008513622032378" ESTIMABLE="YES" ESTIMATE="8.51E-4" LOG_CI_END="0.18276845609035183" LOG_CI_START="-0.18202928688215253" LOG_EFFECT_SIZE="3.6958460409970364E-4" MODIFIED="2010-01-12 11:36:14 +0000" MODIFIED_BY="[Empty name]" ORDER="102" SE="0.214284" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.276949359304696"/>
<IV_DATA CI_END="30.268177103222424" CI_START="0.4128227726696686" EFFECT_SIZE="3.5348822887627898" ESTIMABLE="YES" ESTIMATE="1.26268" LOG_CI_END="1.480986266419066" LOG_CI_START="-0.3842363535998701" LOG_EFFECT_SIZE="0.548374956409598" MODIFIED="2010-03-22 12:43:39 +0000" MODIFIED_BY="[Empty name]" ORDER="103" SE="1.095641" STUDY_ID="STD-USA-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.3548527081282614"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.34027406500121204" CI_END="0.9884530024640623" CI_START="0.7428725944197534" DF="1" EFFECT_SIZE="0.8569099406603198" ESTIMABLE="YES" I2="0.0" ID="CMP-001.17.02" LOG_CI_END="-0.0050439750662866585" LOG_CI_START="-0.12908566306981809" LOG_EFFECT_SIZE="-0.0670648190680524" MODIFIED="2010-01-12 11:36:16 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5596712460337276" P_Z="0.03405987200776952" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="80.23689904158893" Z="2.119362161523237">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="0.9820768167605638" CI_START="0.728131036988077" EFFECT_SIZE="0.8456243911984913" ESTIMABLE="YES" ESTIMATE="-0.16768" LOG_CI_END="-0.007854540939663403" LOG_CI_START="-0.13779045651141114" LOG_EFFECT_SIZE="-0.07282249872553725" ORDER="122" SE="0.076325" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="73.12250305292044"/>
<IV_DATA CI_END="1.5863430952814417" CI_START="0.6078960225199179" EFFECT_SIZE="0.9820038991641141" ESTIMABLE="YES" ESTIMATE="-0.01816" LOG_CI_END="0.2003971226240529" LOG_CI_START="-0.21617069820677903" LOG_EFFECT_SIZE="-0.007886787791363061" MODIFIED="2010-01-12 11:36:16 +0000" MODIFIED_BY="[Empty name]" ORDER="123" SE="0.244694" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.114395988668487"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="8.169731882235475" CI_END="-0.05612968708477678" CI_START="-0.20869201332136006" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.13241085020306842" ESTIMABLE="YES" I2="51.03878489944417" I2_Q="60.23923017043165" ID="CMP-001.18" MODIFIED="2015-04-01 11:53:57 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.08555494773904992" P_Q="0.05641029781410267" P_Z="6.685620429253456E-4" Q="7.545125541731917" RANDOM="NO" SCALE="0.34" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1650" TOTAL_2="1541" UNITS="" WEIGHT="400.0" Z="3.402157058852072">
<NAME>Patient satisfaction with; (mean) score range 1 to 6</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours routine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours reduced visits</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.27014922989771306" CI_START="-0.27014922989771306" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.01" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0" Z="0.0">
<NAME>Amount of visit time</NAME>
<CONT_DATA CI_END="0.27014922989771306" CI_START="-0.27014922989771306" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="4.5" ORDER="7" SD_1="1.3" SD_2="1.2" SE="0.13783377247164524" STUDY_ID="STD-USA-1995" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.624606340503558" CI_END="-0.10632291080864921" CI_START="-0.28490634152533906" DF="1" EFFECT_SIZE="-0.19561462616699413" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.02" NO="2" P_CHI2="0.4293408853513523" P_Z="1.7566859085377005E-5" STUDIES="2" TAU2="0.0" TOTAL_1="1095" TOTAL_2="1103" WEIGHT="100.0" Z="4.293764775353751">
<NAME>Quality of prenatal care</NAME>
<CONT_DATA CI_END="-0.11004841204041971" CI_START="-0.28995158795957976" EFFECT_SIZE="-0.19999999999999973" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.8" ORDER="8" SD_1="1.02" SD_2="0.96" SE="0.0458945106487194" STUDY_ID="STD-England-1996" TOTAL_1="910" TOTAL_2="957" WEIGHT="98.53820872233146"/>
<CONT_DATA CI_END="0.8385305807047757" CI_START="-0.6385305807047764" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.0" ORDER="9" SD_1="5.0" SD_2="1.0" SE="0.3768082406259559" STUDY_ID="STD-USA-1995" TOTAL_1="185" TOTAL_2="146" WEIGHT="1.461791277668542"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.25870638415710756" CI_START="-0.25870638415710756" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.03" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0" Z="0.0">
<NAME>Get questions answered</NAME>
<CONT_DATA CI_END="0.25870638415710756" CI_START="-0.25870638415710756" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="4.7" ORDER="10" SD_1="1.3" SD_2="1.1" SE="0.13199547858927535" STUDY_ID="STD-USA-1995" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3370916419028055" CI_START="-0.13709164190280618" DF="0" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" I2="0.0" ID="CMP-001.18.04" NO="4" P_CHI2="1.0" P_Z="0.40842449426794114" STUDIES="1" TAU2="0.0" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0" Z="0.8266693708855084">
<NAME>Attitude of care giver (friendliness and courtesy)</NAME>
<CONT_DATA CI_END="0.3370916419028055" CI_START="-0.13709164190280618" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="4.9" ORDER="11" SD_1="1.2" SD_2="1.0" SE="0.12096734622317269" STUDY_ID="STD-USA-1995" TOTAL_1="185" TOTAL_2="146" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="31.349465577718373" CI_END="1.0636031033869893" CI_START="1.0086115628246624" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0357424333937044" ESTIMABLE="YES" EVENTS_1="1743" EVENTS_2="1724" I2="93.62030591863902" I2_Q="84.55731692130692" ID="CMP-001.19" LOG_CI_END="0.026779595848207847" LOG_CI_START="0.0037239426473873708" LOG_EFFECT_SIZE="0.015251769247797621" METHOD="MH" MODIFIED="2015-04-01 12:22:26 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.5579504719642756E-7" P_Q="0.0015406442258507624" P_Z="0.009511244048920389" Q="12.951117301367695" RANDOM="NO" SCALE="2.03" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2093" TOTAL_2="2147" WEIGHT="300.0" Z="2.5931096521815333">
<NAME>Perception of care (rated as satisfied)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours routine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours reduced visits</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5283837147896312E-28" CI_END="1.0138733503428439" CI_START="0.9786688957804771" DF="0" EFFECT_SIZE="0.9961156118851284" ESTIMABLE="YES" EVENTS_1="574" EVENTS_2="587" I2="100.0" ID="CMP-001.19.01" LOG_CI_END="0.005983707775911494" LOG_CI_START="-0.009364214282109522" LOG_EFFECT_SIZE="-0.0016902532530990177" NO="1" P_CHI2="0.0" P_Z="0.665960745056415" STUDIES="1" TAU2="0.0" TOTAL_1="589" TOTAL_2="600" WEIGHT="100.0" Z="0.43169824401009577">
<NAME>Quality of prenatal care</NAME>
<DICH_DATA CI_END="1.0138733503428439" CI_START="0.9786688957804772" EFFECT_SIZE="0.9961156118851285" ESTIMABLE="YES" EVENTS_1="574" EVENTS_2="587" LOG_CI_END="0.005983707775911494" LOG_CI_START="-0.009364214282109474" LOG_EFFECT_SIZE="-0.0016902532530989692" ORDER="1" O_E="0.0" SE="0.009015445390321" STUDY_ID="STD-USA-1995" TOTAL_1="589" TOTAL_2="600" VAR="8.127825558586015E-5" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0230677873379324" CI_START="0.94829004093789" DF="0" EFFECT_SIZE="0.984969539598522" ESTIMABLE="YES" EVENTS_1="526" EVENTS_2="544" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="0.009904410536662153" LOG_CI_START="-0.023058810432459755" LOG_EFFECT_SIZE="-0.006577199947898832" NO="2" P_CHI2="1.0" P_Z="0.43412702450530316" STUDIES="1" TAU2="0.0" TOTAL_1="589" TOTAL_2="600" WEIGHT="100.0" Z="0.7821489913911072">
<NAME>Quality of pregnancy education</NAME>
<DICH_DATA CI_END="1.0230677873379324" CI_START="0.94829004093789" EFFECT_SIZE="0.984969539598522" ESTIMABLE="YES" EVENTS_1="526" EVENTS_2="544" LOG_CI_END="0.009904410536662153" LOG_CI_START="-0.023058810432459755" LOG_EFFECT_SIZE="-0.006577199947898832" ORDER="2" O_E="0.0" SE="0.019362759167837567" STUDY_ID="STD-USA-1995" TOTAL_1="589" TOTAL_2="600" VAR="3.749164425916778E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1973533732013577" CI_START="1.0518358937212822" DF="0" EFFECT_SIZE="1.1222385020134722" ESTIMABLE="YES" EVENTS_1="643" EVENTS_2="593" I2="0.0" ID="CMP-001.19.03" LOG_CI_END="0.07822234203779982" LOG_CI_START="0.021947986955769303" LOG_EFFECT_SIZE="0.05008516449678457" MODIFIED="2015-04-01 12:22:26 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="4.8518541208587455E-4" STUDIES="1" TAU2="0.0" TOTAL_1="915" TOTAL_2="947" WEIGHT="100.00000000000001" Z="3.488804747042154">
<NAME>Would choose same schedule in future (answered yes)</NAME>
<DICH_DATA CI_END="1.1973533732013577" CI_START="1.0518358937212822" EFFECT_SIZE="1.1222385020134722" ESTIMABLE="YES" EVENTS_1="643" EVENTS_2="593" LOG_CI_END="0.07822234203779982" LOG_CI_START="0.021947986955769303" LOG_EFFECT_SIZE="0.05008516449678457" ORDER="6" O_E="0.0" SE="0.03305583473773499" STUDY_ID="STD-England-1996" TOTAL_1="915" TOTAL_2="947" VAR="0.0010926882102084475" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="20.914714398090382" CI_END="1.0048340613269526" CI_START="0.9775581945089697" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9911023008609612" ESTIMABLE="YES" EVENTS_1="4372" EVENTS_2="4309" I2="76.09338619294498" I2_Q="37.94964571058973" ID="CMP-001.20" LOG_CI_END="0.0020943481244330053" LOG_CI_START="-0.00985737940336485" LOG_EFFECT_SIZE="-0.003881515639465917" METHOD="MH" MODIFIED="2015-04-01 12:11:47 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="8.406728809973174E-4" P_Q="0.18430279269100003" P_Z="0.20299691148494858" Q="4.834783031225964" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5114" TOTAL_2="5000" WEIGHT="400.0" Z="1.2730596210611358">
<NAME>Process outcome; prenatal diagnostic testing</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours routine care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours reduced visits</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.844726327322692E-5" CI_END="1.029410099517591" CI_START="0.9756116459529092" DF="1" EFFECT_SIZE="1.0021499296766452" ESTIMABLE="YES" EVENTS_1="1233" EVENTS_2="1185" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="0.012588424787711364" LOG_CI_START="-0.010723024119994871" LOG_EFFECT_SIZE="9.327003338582254E-4" NO="1" P_CHI2="0.9957444250046361" P_Z="0.8753726218089063" STUDIES="2" TAU2="0.0" TOTAL_1="1392" TOTAL_2="1337" WEIGHT="99.99999999999999" Z="0.15683787566943508">
<NAME>Alpha-feto protein</NAME>
<DICH_DATA CI_END="1.0986175316906333" CI_START="0.9145582992183314" EFFECT_SIZE="1.002372077261945" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="143" LOG_CI_END="0.040846525193030676" LOG_CI_START="-0.038788604871202344" LOG_EFFECT_SIZE="0.0010289601609141596" ORDER="12" O_E="0.0" SE="0.04677806959998189" STUDY_ID="STD-USA-1995" TOTAL_1="227" TOTAL_2="174" VAR="0.0021881877955007498" WEIGHT="13.437986584200107"/>
<DICH_DATA CI_END="1.030101775260019" CI_START="0.9748894581860607" EFFECT_SIZE="1.0021154432298403" ESTIMABLE="YES" EVENTS_1="1046" EVENTS_2="1042" LOG_CI_END="0.012880135627717186" LOG_CI_START="-0.01104462575939642" LOG_EFFECT_SIZE="9.177549341603915E-4" ORDER="13" O_E="0.0" SE="0.014053523268269428" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="1.9750151625179022E-4" WEIGHT="86.56201341579988"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1152471037831899E-29" CI_END="0.9984022642959817" CI_START="0.8622532920217831" DF="0" EFFECT_SIZE="0.927833842426117" ESTIMABLE="YES" EVENTS_1="619" EVENTS_2="666" I2="100.0" ID="CMP-001.20.02" LOG_CI_END="-6.944427156024241E-4" LOG_CI_START="-0.06436513885194255" LOG_EFFECT_SIZE="-0.03252979078377251" NO="2" P_CHI2="0.0" P_Z="0.04520758672918432" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="2.002717803627958">
<NAME>Obstetric ultrasound at 15 to 24 weeks</NAME>
<DICH_DATA CI_END="0.9984022642959818" CI_START="0.8622532920217832" EFFECT_SIZE="0.9278338424261171" ESTIMABLE="YES" EVENTS_1="619" EVENTS_2="666" LOG_CI_END="-6.944427156023758E-4" LOG_CI_START="-0.06436513885194249" LOG_EFFECT_SIZE="-0.03252979078377245" ORDER="14" O_E="0.0" SE="0.03740048208551514" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="0.0013987960602289394" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0132473497140988" CI_START="0.9972837964079766" DF="0" EFFECT_SIZE="1.005233885035317" ESTIMABLE="YES" EVENTS_1="1157" EVENTS_2="1149" I2="0.0" ID="CMP-001.20.03" LOG_CI_END="0.0057154764590820716" LOG_CI_START="-0.0011812371993320649" LOG_EFFECT_SIZE="0.0022671196298749813" NO="3" P_CHI2="1.0" P_Z="0.19754523156302586" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="1.2885768623372216">
<NAME>Haematocrit</NAME>
<DICH_DATA CI_END="1.0132473497140988" CI_START="0.9972837964079766" EFFECT_SIZE="1.005233885035317" ESTIMABLE="YES" EVENTS_1="1157" EVENTS_2="1149" LOG_CI_END="0.0057154764590820716" LOG_CI_START="-0.0011812371993320649" LOG_EFFECT_SIZE="0.0022671196298749813" ORDER="15" O_E="0.0" SE="0.004051163742235651" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="1.641192766640477E-5" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2614380967525678" CI_END="1.0115117885475118" CI_START="0.9897413901201995" DF="1" EFFECT_SIZE="1.0005673808994493" ESTIMABLE="YES" EVENTS_1="1363" EVENTS_2="1309" I2="20.725400431904752" ID="CMP-001.20.04" LOG_CI_END="0.004970948571282634" LOG_CI_START="-0.004478267539436616" LOG_EFFECT_SIZE="2.4634051592302983E-4" NO="4" P_CHI2="0.2613791489501246" P_Z="0.9186040436166547" STUDIES="2" TAU2="0.0" TOTAL_1="1392" TOTAL_2="1337" WEIGHT="100.00000000000001" Z="0.10219229478611266">
<NAME>Diabetic screening</NAME>
<DICH_DATA CI_END="1.0178609979000355" CI_START="0.9492343662767837" EFFECT_SIZE="0.9829489505053123" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="170" LOG_CI_END="0.007688473514683546" LOG_CI_START="-0.022626546883067724" LOG_EFFECT_SIZE="-0.0074690366841920885" ORDER="16" O_E="0.0" SE="0.01780719304341026" STUDY_ID="STD-USA-1995" TOTAL_1="227" TOTAL_2="174" VAR="3.1709612408527873E-4" WEIGHT="14.444760454633732"/>
<DICH_DATA CI_END="1.0149241052025246" CI_START="0.9922875364760827" EFFECT_SIZE="1.0035419971588662" ESTIMABLE="YES" EVENTS_1="1145" EVENTS_2="1139" LOG_CI_END="0.0064335674471643935" LOG_CI_START="-0.0033624635207302007" LOG_EFFECT_SIZE="0.0015355519632170933" ORDER="17" O_E="0.0" SE="0.005754237081676635" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="3.311124439214243E-5" WEIGHT="85.55523954536628"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.952706258937935" CI_END="1.0671980252932929" CI_START="0.9813709967457451" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.02338516200264" ESTIMABLE="YES" EVENTS_1="2120" EVENTS_2="2068" I2="19.23607436275122" I2_Q="19.23347603646044" ID="CMP-001.21" LOG_CI_END="0.028245012969569213" LOG_CI_START="-0.008166781223054727" LOG_EFFECT_SIZE="0.010039115873257218" METHOD="MH" MODIFIED="2015-04-01 12:13:01 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.29218470460089485" P_Q="0.2922012863601181" P_Z="0.27980145339757" Q="4.952546926255883" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5825" TOTAL_2="5815" WEIGHT="500.0" Z="1.0807655038429511">
<NAME>Process outcome; use of other medical services</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine care</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0297588511737146" CI_START="0.8580705795258954" DF="0" EFFECT_SIZE="0.9400030713771894" ESTIMABLE="YES" EVENTS_1="500" EVENTS_2="531" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="0.012735533572744704" LOG_CI_START="-0.06647698833082388" LOG_EFFECT_SIZE="-0.026870727379039602" NO="1" P_CHI2="1.0" P_Z="0.18360704262564767" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="1.3297306192428995">
<NAME>Visit to a non-obstetric clinic</NAME>
<DICH_DATA CI_END="1.0297588511737146" CI_START="0.8580705795258954" EFFECT_SIZE="0.9400030713771894" ESTIMABLE="YES" EVENTS_1="500" EVENTS_2="531" LOG_CI_END="0.012735533572744704" LOG_CI_START="-0.06647698833082388" LOG_EFFECT_SIZE="-0.026870727379039602" ORDER="18" O_E="0.0" SE="0.04652982747446344" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="0.0021650248448033325" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2474051004089488" CI_START="0.9104255005692918" DF="0" EFFECT_SIZE="1.065677912388403" ESTIMABLE="YES" EVENTS_1="253" EVENTS_2="237" I2="0.0" ID="CMP-001.21.02" LOG_CI_END="0.09600751546862683" LOG_CI_START="-0.04075558640437734" LOG_EFFECT_SIZE="0.02762596453212472" NO="2" P_CHI2="1.0" P_Z="0.4284655106675278" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="0.7918202319134926">
<NAME>Emergency visit</NAME>
<DICH_DATA CI_END="1.2474051004089488" CI_START="0.9104255005692918" EFFECT_SIZE="1.065677912388403" ESTIMABLE="YES" EVENTS_1="253" EVENTS_2="237" LOG_CI_END="0.09600751546862683" LOG_CI_START="-0.04075558640437734" LOG_EFFECT_SIZE="0.02762596453212472" ORDER="19" O_E="0.0" SE="0.08033532302847524" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="0.0064537641260894625" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0783362238728875" CI_START="0.9844766803538054" DF="0" EFFECT_SIZE="1.030338228924676" ESTIMABLE="YES" EVENTS_1="900" EVENTS_2="872" I2="0.0" ID="CMP-001.21.03" LOG_CI_END="0.03275419443686101" LOG_CI_START="-0.006794566690524473" LOG_EFFECT_SIZE="0.012979813873168261" NO="3" P_CHI2="1.0" P_Z="0.198264612945133" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="1.2865114856822812">
<NAME>Telephone calls</NAME>
<DICH_DATA CI_END="1.0783362238728875" CI_START="0.9844766803538054" EFFECT_SIZE="1.030338228924676" ESTIMABLE="YES" EVENTS_1="900" EVENTS_2="872" LOG_CI_END="0.03275419443686101" LOG_CI_START="-0.006794566690524473" LOG_EFFECT_SIZE="0.012979813873168261" ORDER="20" O_E="0.0" SE="0.023231138055751117" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="5.396857753653678E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2116632762609887" CI_START="0.9664419777795394" DF="0" EFFECT_SIZE="1.0821285751298255" ESTIMABLE="YES" EVENTS_1="413" EVENTS_2="381" I2="0.0" ID="CMP-001.21.04" LOG_CI_END="0.08338194525954491" LOG_CI_START="-0.014824214565160209" LOG_EFFECT_SIZE="0.03427886534719236" NO="4" P_CHI2="1.0" P_Z="0.17123350162744969" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="99.99999999999999" Z="1.3682510675770003">
<NAME>"Outpatient" antepartum admission</NAME>
<DICH_DATA CI_END="1.2116632762609887" CI_START="0.9664419777795394" EFFECT_SIZE="1.0821285751298255" ESTIMABLE="YES" EVENTS_1="413" EVENTS_2="381" LOG_CI_END="0.08338194525954491" LOG_CI_START="-0.014824214565160209" LOG_EFFECT_SIZE="0.03427886534719236" ORDER="21" O_E="0.0" SE="0.05768678440936308" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="0.0033277650954923357" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6813078035613613" CI_START="0.782441998739829" DF="0" EFFECT_SIZE="1.1469637476029586" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="47" I2="0.0" ID="CMP-001.21.05" LOG_CI_END="0.2256472286988659" LOG_CI_START="-0.10654784619154255" LOG_EFFECT_SIZE="0.05954969125366166" NO="5" P_CHI2="1.0" P_Z="0.48224832212196256" STUDIES="1" TAU2="0.0" TOTAL_1="1165" TOTAL_2="1163" WEIGHT="100.0" Z="0.7026910328888004">
<NAME>Inpatient antepartum admission</NAME>
<DICH_DATA CI_END="1.6813078035613613" CI_START="0.782441998739829" EFFECT_SIZE="1.1469637476029586" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="47" LOG_CI_END="0.2256472286988659" LOG_CI_START="-0.10654784619154255" LOG_EFFECT_SIZE="0.05954969125366166" ORDER="22" O_E="0.0" SE="0.19513303138276702" STUDY_ID="STD-USA-1996" TOTAL_1="1165" TOTAL_2="1163" VAR="0.03807689993662794" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="15.95995491641993" CI_END="0.012590135222124214" CI_START="-0.050089845691153115" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.01874985523451445" ESTIMABLE="YES" I2="56.14022698273254" I2_Q="64.48672048071222" ID="CMP-001.22" MODIFIED="2015-04-01 12:17:19 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.025484799749514342" P_Q="0.015113844697838608" P_Z="0.2409592378373978" Q="14.079240407195929" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="4464" TOTAL_2="4477" UNITS="" WEIGHT="600.0" Z="1.1725926025993312">
<NAME>Process outcome; mean (SD)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Higher in routine care</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Higher in reduced visits</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.1959965668711754" CI_END="-0.04890638502806788" CI_START="-0.1881088785082938" DF="1" EFFECT_SIZE="-0.11850763176818084" ESTIMABLE="YES" I2="16.387719856413835" ID="CMP-001.22.01" NO="1" P_CHI2="0.2741233684613761" P_Z="8.463836107294429E-4" STUDIES="2" TAU2="0.0" TOTAL_1="1539" TOTAL_2="1525" WEIGHT="100.0" Z="3.3371627813802616">
<NAME>Obstetric ultrasound</NAME>
<CONT_DATA CI_END="-0.02289925943013016" CI_START="-0.17710074056986957" EFFECT_SIZE="-0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.7" ORDER="23" SD_1="1.0" SD_2="1.03" SE="0.03933783537760413" STUDY_ID="STD-England-1996" TOTAL_1="1312" TOTAL_2="1351" WEIGHT="81.49236823181906"/>
<CONT_DATA CI_END="-0.03821375549457098" CI_START="-0.36178624450542896" EFFECT_SIZE="-0.19999999999999996" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.8" ORDER="24" SD_1="0.7" SD_2="0.9" SE="0.0825455190919722" STUDY_ID="STD-USA-1995" TOTAL_1="227" TOTAL_2="174" WEIGHT="18.50763176818095"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.160504273123849" CI_START="-0.040504273123848994" DF="0" EFFECT_SIZE="0.06" ESTIMABLE="YES" I2="0.0" ID="CMP-001.22.02" NO="2" P_CHI2="1.0" P_Z="0.24196960064883577" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="38" WEIGHT="99.99999999999999" Z="1.1700780018327208">
<NAME>Emergency room visits</NAME>
<CONT_DATA CI_END="0.160504273123849" CI_START="-0.040504273123848994" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.09" MEAN_2="0.03" ORDER="25" SD_1="0.29" SD_2="0.16" SE="0.051278632626218575" STUDY_ID="STD-USA-1997" TOTAL_1="43" TOTAL_2="38" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.4032383798905218" CI_START="-0.32323837989052173" DF="0" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-001.22.03" NO="3" P_CHI2="1.0" P_Z="0.8291185035137116" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="38" WEIGHT="100.0" Z="0.21583225705728337">
<NAME>Telephone calls</NAME>
<CONT_DATA CI_END="0.4032383798905218" CI_START="-0.32323837989052173" EFFECT_SIZE="0.040000000000000036" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.47" ORDER="26" SD_1="0.8" SD_2="0.86" SE="0.1853291094916538" STUDY_ID="STD-USA-1997" TOTAL_1="43" TOTAL_2="38" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.04095498751429111" CI_START="-0.04095498751429111" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.22.04" NO="4" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="1289" TOTAL_2="1335" WEIGHT="100.0" Z="0.0">
<NAME>In-patient admissions</NAME>
<CONT_DATA CI_END="0.04095498751429111" CI_START="-0.04095498751429111" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="1.1" ORDER="27" SD_1="0.54" SD_2="0.53" SE="0.020895785757972504" STUDY_ID="STD-England-1996" TOTAL_1="1289" TOTAL_2="1335" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2573510325842311" CI_START="-0.057351032584231104" DF="0" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.22.05" NO="5" P_CHI2="1.0" P_Z="0.2129114177755166" STUDIES="1" TAU2="0.0" TOTAL_1="1280" TOTAL_2="1329" WEIGHT="100.0" Z="1.2455996966469678">
<NAME>Number of nights in the hospital</NAME>
<CONT_DATA CI_END="0.2573510325842311" CI_START="-0.057351032584231104" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="0.9" ORDER="28" SD_1="2.28" SD_2="1.78" SE="0.0802826142854644" STUDY_ID="STD-England-1996" TOTAL_1="1280" TOTAL_2="1329" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6847179423528243" CI_END="0.04917305498420259" CI_START="-0.19240215160812185" DF="1" EFFECT_SIZE="-0.07161454831195962" ESTIMABLE="YES" I2="0.0" ID="CMP-001.22.06" NO="6" P_CHI2="0.407967210909453" P_Z="0.2452128182276977" STUDIES="2" TAU2="0.0" TOTAL_1="270" TOTAL_2="212" WEIGHT="100.0" Z="1.1620558039916362">
<NAME>Prenatal visits, non attendance</NAME>
<CONT_DATA CI_END="0.0382390576393673" CI_START="-0.23823905763936737" EFFECT_SIZE="-0.10000000000000003" ESTIMABLE="YES" MEAN_1="0.3" MEAN_2="0.4" ORDER="29" SD_1="0.7" SD_2="0.7" SE="0.07053142748018809" STUDY_ID="STD-USA-1995" TOTAL_1="227" TOTAL_2="174" WEIGHT="76.345456926633"/>
<CONT_DATA CI_END="0.26835052492485456" CI_START="-0.22835052492485453" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.28" MEAN_2="0.26" ORDER="30" SD_1="0.59" SD_2="0.55" SE="0.12671177985096246" STUDY_ID="STD-USA-1997" TOTAL_1="43" TOTAL_2="38" WEIGHT="23.654543073366995"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-03-30 14:57:40 +0100" MODIFIED_BY="Leanne V Jones" NO="2">
<NAME>Sensitivity analysis with most conservative ICC estimate: reduced antenatal visits versus standard visits</NAME>
<IV_OUTCOME CHI2="0.20136928356146772" CI_END="4.347907203618526" CI_START="0.3336775125416822" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="1.204491120957515" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.6382802664661247" LOG_CI_START="-0.4766730606755551" LOG_DATA="YES" LOG_EFFECT_SIZE="0.08080360289528485" MODIFIED="2015-03-30 14:55:08 +0100" MODIFIED_BY="Leanne V Jones" NO="1" P_CHI2="0.904218219844521" P_Q="1.0" P_Z="0.776343326633635" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.28408749970160846">
<NAME>Maternal death (cluster-randomised trials)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="5.78006394419081" CI_START="0.213775528732122" EFFECT_SIZE="1.1115917531966784" ESTIMABLE="YES" ESTIMATE="0.105793" LOG_CI_END="0.7619326429976236" LOG_CI_START="-0.6700420107496422" LOG_EFFECT_SIZE="0.045945316123990755" MODIFIED="2010-03-22 11:26:38 +0000" MODIFIED_BY="[Empty name]" ORDER="111" SE="0.841149" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="60.62373838878474"/>
<IV_DATA CI_END="20.88192868890671" CI_START="0.0294404962511378" EFFECT_SIZE="0.784075470399556" ESTIMABLE="YES" ESTIMATE="-0.24325" LOG_CI_END="1.3197706083276564" LOG_CI_START="-1.5310548737735885" LOG_EFFECT_SIZE="-0.10564213272296605" MODIFIED="2010-03-22 11:26:54 +0000" MODIFIED_BY="[Empty name]" ORDER="112" SE="1.674589" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.29579701195554"/>
<IV_DATA CI_END="26.486962017433257" CI_START="0.141562691212298" EFFECT_SIZE="1.9363795147712575" ESTIMABLE="YES" ESTIMATE="0.66082" LOG_CI_END="1.4230321487567796" LOG_CI_START="-0.8490511896941659" LOG_EFFECT_SIZE="0.28699047953130685" MODIFIED="2010-03-22 11:27:11 +0000" MODIFIED_BY="[Empty name]" ORDER="110" SE="1.334633" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="24.080464599259727"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="5.236124197959668" CI_END="1.0951176234019335" CI_START="0.8196561781145905" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.9474280583683187" ESTIMABLE="YES" I2="4.50952248328406" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.039460767989795094" LOG_CI_START="-0.08636828330030359" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.023453757655254245" MODIFIED="2015-03-30 14:55:31 +0100" MODIFIED_BY="Leanne V Jones" NO="2" P_CHI2="0.38774827867561124" P_Q="0.9825615936866142" P_Z="0.46499275378121896" Q="4.777521329781177E-4" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0017236580818750565" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999997" Z="0.7306503519675852">
<NAME>Hypertensive disorders of pregnancy (various definitions)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.1201279201919387" CI_END="1.2633822922923785" CI_START="0.7094365518405128" DF="2" EFFECT_SIZE="0.9467257137631089" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.10153478548093792" LOG_CI_START="-0.1490864394139895" LOG_EFFECT_SIZE="-0.02377582696652577" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5711726766027438" P_Z="0.7099866300312945" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.88050911028794" Z="0.37187404679379127">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="2.0405672559452013" CI_START="0.3528444975915833" EFFECT_SIZE="0.8485298628957147" ESTIMABLE="YES" ESTIMATE="-0.16425" LOG_CI_END="0.3097509134462251" LOG_CI_START="-0.4524166507514434" LOG_EFFECT_SIZE="-0.07133286865260911" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="114" SE="0.447701" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.7023534777620126"/>
<IV_DATA CI_END="5.507732113515704" CI_START="0.5400557285159264" EFFECT_SIZE="1.7246687447261537" ESTIMABLE="YES" ESTIMATE="0.545035" LOG_CI_END="0.7409728087723975" LOG_CI_START="-0.2675614228841197" LOG_EFFECT_SIZE="0.2367056929441389" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="115" SE="0.592418" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.5490050594918447"/>
<IV_DATA CI_END="1.260601541161496" CI_START="0.669121901697862" EFFECT_SIZE="0.9184204377654256" ESTIMABLE="YES" ESTIMATE="-0.0851" LOG_CI_END="0.10057783374114647" LOG_CI_START="-0.17449475456108" LOG_EFFECT_SIZE="-0.03695846040996671" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="113" SE="0.161579" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.62915057303408"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="4.115969787079967" CI_END="1.225442755821637" CI_START="0.737695925304884" DF="2" EFFECT_SIZE="0.9507913165695244" ESTIMABLE="YES" I2="51.40877840556552" ID="CMP-002.02.02" LOG_CI_END="0.08829302883865746" LOG_CI_START="-0.13212261537921235" LOG_EFFECT_SIZE="-0.021914793270277427" MODIFIED="2010-03-22 11:30:45 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1277113472128284" P_Z="0.6967300979791939" STUDIES="3" TAU2="0.026147970803183724" TOTAL_1="0" TOTAL_2="0" WEIGHT="76.11949088971204" Z="0.3897382664537952">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.7729791465689444" CI_START="0.8820475919020545" EFFECT_SIZE="1.2505406777565042" ESTIMABLE="YES" ESTIMATE="0.223576" LOG_CI_END="0.248703627544913" LOG_CI_START="-0.05450798137291013" LOG_EFFECT_SIZE="0.0970978230860014" MODIFIED="2010-03-22 11:30:09 +0000" MODIFIED_BY="[Empty name]" ORDER="117" SE="0.178108" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.33395422005737"/>
<IV_DATA CI_END="1.0929088885488774" CI_START="0.4866535299034946" EFFECT_SIZE="0.7292927865235033" ESTIMABLE="YES" ESTIMATE="-0.31568" LOG_CI_END="0.03858395806152523" LOG_CI_START="-0.3127801221559623" LOG_EFFECT_SIZE="-0.13709808204721852" MODIFIED="2010-03-22 11:30:28 +0000" MODIFIED_BY="[Empty name]" ORDER="116" SE="0.206393" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.325948788734792"/>
<IV_DATA CI_END="1.1184135377067799" CI_START="0.7588954964106642" EFFECT_SIZE="0.9212811714619994" ESTIMABLE="YES" ESTIMATE="-0.08199" LOG_CI_END="0.04860241530054129" LOG_CI_START="-0.11981802444303655" LOG_EFFECT_SIZE="-0.035607804571247605" MODIFIED="2010-03-22 11:30:45 +0000" MODIFIED_BY="[Empty name]" ORDER="118" SE="0.098931" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="47.459587880919884"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.1218012275955271" CI_END="1.3064400036984987" CI_START="0.999999990486699" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="1.1429960591664092" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.11608947019732048" LOG_CI_START="-4.131574164195276E-9" LOG_DATA="YES" LOG_EFFECT_SIZE="0.058044733032873164" MODIFIED="2015-03-30 14:55:52 +0100" MODIFIED_BY="Leanne V Jones" NO="3" P_CHI2="0.8907979612205523" P_Q="0.48568677224371004" P_Z="0.05000001630908478" Q="0.48606758541306" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="1.9599638450315147">
<NAME>Perinatal death with ICC 0.0003</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.4272208595309098" CI_END="1.799555247624568" CI_START="0.4461303201802798" DF="1" EFFECT_SIZE="0.8960112492624471" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.25516518434273494" LOG_CI_START="-0.350538259969516" LOG_EFFECT_SIZE="-0.047686537813390543" MODIFIED="2010-06-07 14:21:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5133558099925375" P_Z="0.7576161368186928" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.6733778485385233" Z="0.30861272967591236">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.8808260421966225" CI_START="0.27409759099648995" EFFECT_SIZE="0.718004099744254" ESTIMABLE="YES" ESTIMATE="-0.33128" LOG_CI_END="0.2743486294643891" LOG_CI_START="-0.5620947813942077" LOG_EFFECT_SIZE="-0.14387307596490928" MODIFIED="2010-03-22 11:23:53 +0000" MODIFIED_BY="[Empty name]" ORDER="162" SE="0.491331" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.926249596007376"/>
<IV_DATA CI_END="3.144117666242121" CI_START="0.4161251180009078" EFFECT_SIZE="1.1438296791366018" ESTIMABLE="YES" ESTIMATE="0.134382" LOG_CI_END="0.4974987908162966" LOG_CI_START="-0.380776068682051" LOG_EFFECT_SIZE="0.058361361067122815" MODIFIED="2010-03-22 11:23:53 +0000" MODIFIED_BY="[Empty name]" ORDER="161" SE="0.515903" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.7471282525311473"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.20851278265155754" CI_END="1.3219587151548335" CI_START="1.0067823994159075" DF="2" EFFECT_SIZE="1.1536571272143008" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.12121789232026202" LOG_CI_START="0.0029356146004370655" LOG_EFFECT_SIZE="0.06207675346034953" MODIFIED="2010-06-07 14:21:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9009943548041202" P_Z="0.039662032803666966" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="96.32662215146149" Z="2.0572515748750226">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.4353456021282294" CI_START="0.9593228020869798" EFFECT_SIZE="1.1734392890119523" ESTIMABLE="YES" ESTIMATE="0.159939" LOG_CI_END="0.15695648296972248" LOG_CI_START="-0.018035232687474048" LOG_EFFECT_SIZE="0.06946062514112418" MODIFIED="2010-03-22 11:23:53 +0000" MODIFIED_BY="[Empty name]" ORDER="163" SE="0.102791" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="44.00993337654497"/>
<IV_DATA CI_END="1.677072732733958" CI_START="0.8627107150224622" EFFECT_SIZE="1.2028418916888404" ESTIMABLE="YES" ESTIMATE="0.184687" LOG_CI_END="0.22455189787146826" LOG_CI_START="-0.06413480791293655" LOG_EFFECT_SIZE="0.08020854497926591" MODIFIED="2010-03-22 11:23:53 +0000" MODIFIED_BY="[Empty name]" ORDER="165" SE="0.169576" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.170822858668753"/>
<IV_DATA CI_END="1.385225573067566" CI_START="0.8880324489755296" EFFECT_SIZE="1.109110119886534" ESTIMABLE="YES" ESTIMATE="0.103558" LOG_CI_END="0.14152050059299554" LOG_CI_START="-0.05157116467912164" LOG_EFFECT_SIZE="0.04497466795693695" MODIFIED="2010-03-22 11:23:53 +0000" MODIFIED_BY="[Empty name]" ORDER="164" SE="0.113423" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="36.14586591624776"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="5.965831051062368" CI_END="1.1431025785415068" CI_START="0.9451966997978135" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_SIZE="1.0394502319821777" ESTIMABLE="YES" I2="0.0" I2_Q="71.89595100508215" ID="CMP-002.04" LOG_CI_END="0.05808520440719715" LOG_CI_START="-0.024477803398218013" LOG_DATA="YES" LOG_EFFECT_SIZE="0.016803700504489545" MODIFIED="2010-03-22 14:14:14 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4270287106337568" P_Q="0.059251890550497954" P_Z="0.4249828569914139" Q="3.5582061509387253" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.7978063946850773">
<NAME>Preterm birth</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.554469506671223" CI_END="1.5233049819563769" CI_START="1.0086328067550467" DF="3" EFFECT_SIZE="1.2395383735466226" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.1827868624435263" LOG_CI_START="0.003733089899826735" LOG_EFFECT_SIZE="0.09325997617167654" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6697570752900371" P_Z="0.04118224027157508" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.261997401014852" Z="2.0416905145178017">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.62793996001466" CI_START="0.9230836803673159" EFFECT_SIZE="1.225856765575552" ESTIMABLE="YES" ESTIMATE="0.20364" LOG_CI_END="0.2116383836519804" LOG_CI_START="-0.034758927062424005" LOG_EFFECT_SIZE="0.08843972829477821" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="122" SE="0.144735" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.227914202107398"/>
<IV_DATA CI_END="4.389277689947244" CI_START="0.7895053426090379" EFFECT_SIZE="1.8615472560233342" ESTIMABLE="YES" ESTIMATE="0.621408" LOG_CI_END="0.6423930575815423" LOG_CI_START="-0.10264492676047042" LOG_EFFECT_SIZE="0.26987406541053593" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="121" SE="0.437639" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2280447201019637"/>
<IV_DATA CI_END="1.604338094390449" CI_START="0.8340205227836948" EFFECT_SIZE="1.1567414993010838" ESTIMABLE="YES" ESTIMATE="0.145607" LOG_CI_END="0.20529589577824373" LOG_CI_START="-0.07882326252527021" LOG_EFFECT_SIZE="0.06323631662648682" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="119" SE="0.166893" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.444422872012385"/>
<IV_DATA CI_END="10.73350667778134" CI_START="0.4547459744472223" EFFECT_SIZE="2.2093028206706844" ESTIMABLE="YES" ESTIMATE="0.792677" LOG_CI_END="1.0307416308205164" LOG_CI_START="-0.3422311367572684" LOG_EFFECT_SIZE="0.3442552470316239" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="120" SE="0.806491" STUDY_ID="STD-USA-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.3616156067931072"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.8531553934524181" CI_END="1.103266363356844" CI_START="0.8905028625470027" DF="2" EFFECT_SIZE="0.9911921381453201" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.04268037750865371" LOG_CI_START="-0.0503646801464206" LOG_EFFECT_SIZE="-0.00384215131888341" MODIFIED="2010-03-22 11:34:17 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6527391665393112" P_Z="0.8714103188898781" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="78.73800259898516" Z="0.16186734465963137">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.1866211059121425" CI_START="0.8807848785634742" EFFECT_SIZE="1.0223296565549107" ESTIMABLE="YES" ESTIMATE="0.022084" LOG_CI_END="0.074312068676693" LOG_CI_START="-0.055130149999990156" LOG_EFFECT_SIZE="0.009590959338351369" MODIFIED="2010-03-22 11:33:41 +0000" MODIFIED_BY="[Empty name]" ORDER="124" SE="0.076035" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="40.6835756428931"/>
<IV_DATA CI_END="1.1734571539777872" CI_START="0.653682039205814" EFFECT_SIZE="0.8758241063894341" ESTIMABLE="YES" ESTIMATE="-0.13259" LOG_CI_END="0.06946723698469726" LOG_CI_START="-0.18463344769580153" LOG_EFFECT_SIZE="-0.05758310535555215" MODIFIED="2010-03-22 11:34:01 +0000" MODIFIED_BY="[Empty name]" ORDER="123" SE="0.14926" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.557457496607675"/>
<IV_DATA CI_END="1.1902593077267205" CI_START="0.8283071916132454" EFFECT_SIZE="0.9929251454538985" ESTIMABLE="YES" ESTIMATE="-0.0071" LOG_CI_END="0.07564158630579927" LOG_CI_START="-0.08180856794882545" LOG_EFFECT_SIZE="-0.0030834908215130693" MODIFIED="2010-03-22 11:34:17 +0000" MODIFIED_BY="[Empty name]" ORDER="125" SE="0.092487" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="27.496969459484372"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.6552686990463972" CI_END="1.0920291926281838" CI_START="0.8938098919078051" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.987960775852546" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.03823424828435144" LOG_CI_START="-0.04875484325677068" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0052602974862096035" MODIFIED="2010-06-08 14:33:31 +0100" MODIFIED_BY="Denise Atherton" NO="5" P_CHI2="0.6469240061400213" P_Q="0.663340790433542" P_Z="0.8126249298451383" Q="0.18949077074843673" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="0.23704106890376314">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.4373157137976353" CI_END="1.1111573744097267" CI_START="0.8416679302178837" DF="1" EFFECT_SIZE="0.9670705907356364" ESTIMABLE="YES" I2="30.425863267171277" ID="CMP-002.05.01" LOG_CI_END="0.04577557289000411" LOG_CI_START="-0.07485922028132772" LOG_EFFECT_SIZE="-0.014541823695661794" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2305744771065782" P_Z="0.6365524239033393" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="51.99773457944517" Z="0.4725245505672478">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.0899678249523774" CI_START="0.8157493197428064" EFFECT_SIZE="0.9429424753114307" ESTIMABLE="YES" ESTIMATE="-0.05875" LOG_CI_END="0.037413678076515064" LOG_CI_START="-0.0884432797001471" LOG_EFFECT_SIZE="-0.02551480081181603" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="128" SE="0.073929" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="47.77218783792919"/>
<IV_DATA CI_END="2.0946091388186043" CI_START="0.7905416248319427" EFFECT_SIZE="1.2868083431457444" ESTIMABLE="YES" ESTIMATE="0.252165" LOG_CI_END="0.32110299403685266" LOG_CI_START="-0.10207525797858576" LOG_EFFECT_SIZE="0.1095138680291335" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="126" SE="0.248577" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.225546741515984"/>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="127" SE="0.0" STUDY_ID="STD-USA-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.02846221450032475" CI_END="1.1683454310267096" CI_START="0.8750165933176071" DF="1" EFFECT_SIZE="1.011099223061309" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.06757126453103994" LOG_CI_START="-0.0579837111857509" LOG_EFFECT_SIZE="0.004793776672644498" MODIFIED="2010-03-22 11:36:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8660267625518239" P_Z="0.8810284592248753" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="48.002265420554814" Z="0.14966558791751614">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.168202670733382" CI_START="0.8715845615686326" EFFECT_SIZE="1.0090527303339802" ESTIMABLE="YES" ESTIMATE="0.009012" LOG_CI_END="0.06751819478455574" LOG_CI_START="-0.05969047104273155" LOG_EFFECT_SIZE="0.003913861870912074" MODIFIED="2010-03-22 11:35:50 +0000" MODIFIED_BY="[Empty name]" ORDER="129" SE="0.074723" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="46.76233569621695"/>
<IV_DATA CI_END="2.68276256930491" CI_START="0.4439918497906917" EFFECT_SIZE="1.0913866023068617" ESTIMABLE="YES" ESTIMATE="0.087449" LOG_CI_END="0.4285822383061066" LOG_CI_START="-0.3526250020101917" LOG_EFFECT_SIZE="0.037978618147957485" MODIFIED="2010-03-22 11:36:03 +0000" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.458885" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2399297243378657"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.1999838829762575" CI_END="1.384629315439709" CI_START="0.8809828551765522" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="1.1044612658111779" ESTIMABLE="YES" I2="0.0" I2_Q="17.59520157306166" ID="CMP-002.06" LOG_CI_END="0.14133352227680618" LOG_CI_START="-0.05503254331856338" LOG_DATA="YES" LOG_EFFECT_SIZE="0.04315048947912134" MODIFIED="2010-03-22 14:16:37 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8208383812833309" P_Q="0.27063587446469717" P_Z="0.38902596738482875" Q="1.213521565599871" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="0.8613851383937564">
<NAME>Antepartum haemorrhage</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Traditional/routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.4014061157228242" CI_END="1.331551402112225" CI_START="0.7707570923856771" DF="2" EFFECT_SIZE="1.0130659835638003" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="0.12435793624458827" LOG_CI_START="-0.11308247027347311" LOG_EFFECT_SIZE="0.005637732985557569" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8181554167401222" P_Z="0.9258448436344451" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="68.39488489803075" Z="0.09307391078195267">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.3298892582039405" CI_START="0.7038741702365227" EFFECT_SIZE="0.9675095338676324" ESTIMABLE="YES" ESTIMATE="-0.03303" LOG_CI_END="0.12381547814502535" LOG_CI_START="-0.15250497161955412" LOG_EFFECT_SIZE="-0.014344746737264385" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.162312" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="50.50179597884451"/>
<IV_DATA CI_END="3.5152748448132667" CI_START="0.2611611278158611" EFFECT_SIZE="0.9581508978517731" ESTIMABLE="YES" ESTIMATE="-0.04275" LOG_CI_END="0.5459592863741606" LOG_CI_START="-0.5830914645768887" LOG_EFFECT_SIZE="-0.01856608910136401" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="131" SE="0.66321" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.0248646698357677"/>
<IV_DATA CI_END="2.153095612445955" CI_START="0.6665096730033954" EFFECT_SIZE="1.1979395028950328" ESTIMABLE="YES" ESTIMATE="0.180603" LOG_CI_END="0.333063315952465" LOG_CI_START="-0.176193543322119" LOG_EFFECT_SIZE="0.07843488631517297" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.29914" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.868224249350472"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.5850562016535625" CI_END="1.990560664574786" CI_START="0.890602955976752" DF="2" EFFECT_SIZE="1.331465062223321" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="0.2989754177345383" LOG_CI_START="-0.050315867747057756" LOG_EFFECT_SIZE="0.12432977499374026" MODIFIED="2010-03-22 11:38:12 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7463742991785127" P_Z="0.16292743582406047" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="31.605115101969233" Z="1.3952932198564054">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="2.170422173621503" CI_START="0.910496067676011" EFFECT_SIZE="1.4057598850014175" ESTIMABLE="YES" ESTIMATE="0.340578" LOG_CI_END="0.33654421764640347" LOG_CI_START="-0.04072192553111207" LOG_EFFECT_SIZE="0.1479111460576457" MODIFIED="2010-03-22 11:37:45 +0000" MODIFIED_BY="[Empty name]" ORDER="135" SE="0.221608" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="27.09175957328139"/>
<IV_DATA CI_END="4.545017580504113" CI_START="0.2912539838561643" EFFECT_SIZE="1.1505452955091025" ESTIMABLE="YES" ESTIMATE="0.140236" LOG_CI_END="0.6575355674482302" LOG_CI_START="-0.5357281255198613" LOG_EFFECT_SIZE="0.06090372096418445" MODIFIED="2010-03-22 11:38:00 +0000" MODIFIED_BY="[Empty name]" ORDER="134" SE="0.700929" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.708070859452136"/>
<IV_DATA CI_END="3.9475842177643923" CI_START="0.13641087590522594" EFFECT_SIZE="0.7338211095729579" ESTIMABLE="YES" ESTIMATE="-0.30949" LOG_CI_END="0.5963314040179385" LOG_CI_START="-0.8651510024264133" LOG_EFFECT_SIZE="-0.13440979920423735" MODIFIED="2010-03-22 11:38:12 +0000" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.858482" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.8052846692357087"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.08535892567735703" CI_END="1.2112908432347527" CI_START="0.8148667628039266" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.9934991938802676" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.08324843418053171" LOG_CI_START="-0.08891339605684286" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0028324809381555256" MODIFIED="2015-03-30 14:56:39 +0100" MODIFIED_BY="Leanne V Jones" NO="7" P_CHI2="0.9935345598682469" P_Q="0.922782174839942" P_Z="0.9485781971416349" Q="0.009395378564959934" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="0.06449235138853565">
<NAME>Postpartum haemorrhage</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.06623067663369896" CI_END="1.2193003515929193" CI_START="0.8129189302857236" DF="1" EFFECT_SIZE="0.9955864289522647" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="0.08611069903288086" LOG_CI_START="-0.08995276299768641" LOG_EFFECT_SIZE="-0.001921031982402742" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7969061208023728" P_Z="0.9658845493472762" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="95.61703383205818" Z="0.042770413068502725">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.263897719316539" CI_START="0.8049055205817923" EFFECT_SIZE="1.0086219567948236" ESTIMABLE="YES" ESTIMATE="0.008585" LOG_CI_END="0.10171193016968791" LOG_CI_START="-0.09425509391540905" LOG_EFFECT_SIZE="0.003728418127139441" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SE="0.115112" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="77.1805282633778"/>
<IV_DATA CI_END="1.495915744574761" CI_START="0.5942242191697943" EFFECT_SIZE="0.9428199007571588" ESTIMABLE="YES" ESTIMATE="-0.05888" LOG_CI_END="0.1749071331696723" LOG_CI_START="-0.22604965135859925" LOG_EFFECT_SIZE="-0.02557125909446348" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.235524" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.436505568680396"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.00973287047869813" CI_END="2.445992019182954" CI_START="0.36822425483325566" DF="1" EFFECT_SIZE="0.949038244009025" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="0.38845503568045525" LOG_CI_START="-0.4338876080283445" LOG_EFFECT_SIZE="-0.022716286173944576" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9214119526777638" P_Z="0.9137707472220982" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.382966167941807" Z="0.10828358009657763">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="5.180463581814026" CI_START="0.14951260926091464" EFFECT_SIZE="0.8800821707648432" ESTIMABLE="YES" ESTIMATE="-0.12774" LOG_CI_END="0.714368624999145" LOG_CI_START="-0.8253221792357877" LOG_EFFECT_SIZE="-0.05547677711832139" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SE="0.904422" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2502783472386136"/>
<IV_DATA CI_END="2.997146597596992" CI_START="0.31916064873273575" EFFECT_SIZE="0.9780446065677002" ESTIMABLE="YES" ESTIMATE="-0.0222" LOG_CI_END="0.47670798584533364" LOG_CI_START="-0.49599066084183796" LOG_EFFECT_SIZE="-0.00964133749825221" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.571368" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.132687820703193"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.9313432915042492" CI_END="1.0866400989381255" CI_START="0.9009191472384077" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="0.989431590000236" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.03608572722654124" LOG_CI_START="-0.04531418292082987" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0046142278471443185" MODIFIED="2010-06-08 14:33:35 +0100" MODIFIED_BY="Denise Atherton" NO="8" P_CHI2="0.5867784817994177" P_Q="0.8912963229827242" P_Z="0.8241545530764474" Q="0.018677073118285294" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.22220467763395216">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.9126662183859637" CI_END="1.1223948463526683" CI_START="0.8608776357935396" DF="2" EFFECT_SIZE="0.9829774268796503" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="0.0501456638954493" LOG_CI_START="-0.06505857430273232" LOG_EFFECT_SIZE="-0.007456455203641507" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3842995638957216" P_Z="0.7997175960146561" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="49.9241797400381" Z="0.2537126043285497">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.0809485269613854" CI_START="0.7532493820190901" EFFECT_SIZE="0.9023435099384876" ESTIMABLE="YES" ESTIMATE="-0.10276" LOG_CI_END="0.033805014037611575" LOG_CI_START="-0.12306121595836787" LOG_EFFECT_SIZE="-0.04462810096037813" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="142" SE="0.092144" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="26.927059664905798"/>
<IV_DATA CI_END="1.8104348243780188" CI_START="0.7108647794440786" EFFECT_SIZE="1.1344489200177148" ESTIMABLE="YES" ESTIMATE="0.126147" LOG_CI_END="0.2577828948407012" LOG_CI_START="-0.1482130028234022" LOG_EFFECT_SIZE="0.054784946008649506" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="143" SE="0.238484" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.0198010597114555"/>
<IV_DATA CI_END="1.335151337623639" CI_START="0.8683098595785308" EFFECT_SIZE="1.076719587677344" ESTIMABLE="YES" ESTIMATE="0.073919" LOG_CI_END="0.125530495191069" LOG_CI_START="-0.06132526757545615" LOG_EFFECT_SIZE="0.0321026138078065" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SE="0.10976" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.977319015420843"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.1369313178408043" CI_START="0.8723777001561035" DF="0" EFFECT_SIZE="0.995908393524931" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="0.05573422969768125" LOG_CI_START="-0.05929544444928797" LOG_EFFECT_SIZE="-0.0017806073758033466" MODIFIED="2010-03-22 11:40:56 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.951615084513178" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="50.07582025996191" Z="0.060678713611271445">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.1369313178408043" CI_START="0.8723777001561035" EFFECT_SIZE="0.995908393524931" ESTIMABLE="YES" ESTIMATE="-0.0041" LOG_CI_END="0.05573422969768125" LOG_CI_START="-0.05929544444928797" LOG_EFFECT_SIZE="-0.0017806073758033466" MODIFIED="2010-03-22 11:40:56 +0000" MODIFIED_BY="[Empty name]" ORDER="144" SE="0.067569" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="50.07582025996191"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.1707337334474235" CI_END="1.089095422953939" CI_START="0.8631307505847227" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="0.969552345091599" ESTIMABLE="YES" I2="7.865254536597396" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.03706593287496556" LOG_CI_START="-0.06392341059269606" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.013428738858865275" MODIFIED="2010-03-22 14:18:22 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.3377780777720536" P_Q="0.8817290970176634" P_Z="0.6021995693691641" Q="0.02213478996684966" RANDOM="YES" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.001003444141284846" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999997" Z="0.5212400361746579">
<NAME>Induction of labour</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="2.1513500646762687" CI_END="1.1438530721334184" CI_START="0.829317531358607" DF="1" EFFECT_SIZE="0.9739699204896652" ESTIMABLE="YES" I2="53.51756013959178" ID="CMP-002.09.01" LOG_CI_END="0.05837024293627824" LOG_CI_START="-0.08127915375209692" LOG_EFFECT_SIZE="-0.011454455407909401" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14244465377792104" P_Z="0.7478132874131378" STUDIES="2" TAU2="0.0072174182514999985" TOTAL_1="0" TOTAL_2="0" WEIGHT="97.47814208950408" Z="0.3215240537289234">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.24868182140091" CI_START="0.9020147089492598" EFFECT_SIZE="1.0612866576477693" ESTIMABLE="YES" ESTIMATE="0.059482" LOG_CI_END="0.09645178920384653" LOG_CI_START="-0.04478638045870805" LOG_EFFECT_SIZE="0.025832704372569227" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="145" SE="0.082964" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="44.6214498250417"/>
<IV_DATA CI_END="1.0435511789636616" CI_START="0.7771440977513691" EFFECT_SIZE="0.9005496318543983" ESTIMABLE="YES" ESTIMATE="-0.10475" LOG_CI_END="0.018513753062675428" LOG_CI_START="-0.10949844702140668" LOG_EFFECT_SIZE="-0.04549234697936561" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="146" SE="0.075195" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="52.85669226446238"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.9087226997390572" CI_START="0.44370547788284" DF="0" EFFECT_SIZE="0.9202775220733922" ESTIMABLE="YES" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="0.2807428384403929" LOG_CI_START="-0.35290520955343724" LOG_EFFECT_SIZE="-0.03608118555652218" MODIFIED="2010-03-22 11:42:20 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8233732147107284" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.5218579104959025" Z="0.22320852856467352">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.9087226997390572" CI_START="0.44370547788284" EFFECT_SIZE="0.9202775220733922" ESTIMABLE="YES" ESTIMATE="-0.08308" LOG_CI_END="0.2807428384403929" LOG_CI_START="-0.35290520955343724" LOG_EFFECT_SIZE="-0.03608118555652218" MODIFIED="2010-03-22 11:42:20 +0000" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.372208" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.5218579104959025"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="1.0670046104250959" CI_START="0.7252961003474537" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.02816629597353505" LOG_CI_START="-0.13948465757497658" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2015-03-30 14:57:03 +0100" MODIFIED_BY="Leanne V Jones" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.1931235559114914" Q="0.0" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.3013942058713026">
<NAME>Severe postnatal anaemia</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.0670046104250959" CI_START="0.7252961003474537" DF="0" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" I2="0.0" ID="CMP-002.10.01" LOG_CI_END="0.02816629597353505" LOG_CI_START="-0.13948465757497658" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2010-03-22 11:43:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1931235559114914" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.3013942058713026">
<NAME>Cluster trial</NAME>
<IV_DATA CI_END="1.0670046104250959" CI_START="0.7252961003474537" EFFECT_SIZE="0.8797126138655034" ESTIMABLE="YES" ESTIMATE="-0.12816" LOG_CI_END="0.02816629597353505" LOG_CI_START="-0.13948465757497658" LOG_EFFECT_SIZE="-0.05565918080072073" MODIFIED="2010-03-22 11:43:34 +0000" MODIFIED_BY="[Empty name]" ORDER="148" SE="0.098479" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="1.0525111099512652" CI_START="0.6135958193348462" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.11" LOG_CI_END="0.0222266887975521" LOG_CI_START="-0.2121176080649299" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2010-03-22 14:18:46 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.11224714968510936" Q="0.0" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5881733318804259">
<NAME>Treated urinary tract infections</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard visits</GROUP_LABEL_2>
<GRAPH_LABEL_1>Reduced more treated UTI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Routine more treated UTI</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="1.0525111099512652" CI_START="0.6135958193348462" DF="0" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.01" LOG_CI_END="0.0222266887975521" LOG_CI_START="-0.2121176080649299" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2010-03-22 11:45:19 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.11224714968510936" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5881733318804259">
<NAME>Cluster trial</NAME>
<IV_DATA CI_END="1.0525111099512652" CI_START="0.6135958193348462" EFFECT_SIZE="0.8036270384137003" ESTIMABLE="YES" ESTIMATE="-0.21862" LOG_CI_END="0.0222266887975521" LOG_CI_START="-0.2121176080649299" LOG_EFFECT_SIZE="-0.0949454596336889" MODIFIED="2010-03-22 11:45:19 +0000" MODIFIED_BY="[Empty name]" ORDER="149" SE="0.137655" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="1.9028626759031375" CI_END="1.1384636165555946" CI_START="0.9549256519501437" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="1.0426639493436367" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="0.056319155828083514" LOG_CI_START="-0.02003044014895248" LOG_DATA="YES" LOG_EFFECT_SIZE="0.018144357839565573" MODIFIED="2015-03-30 14:57:26 +0100" MODIFIED_BY="Leanne V Jones" NO="12" P_CHI2="0.8624160065241852" P_Q="0.6649819154311827" P_Z="0.3515616301987121" Q="0.18752817464561644" RANDOM="NO" SCALE="10.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.9315645337233133">
<NAME>Low birthweight (&gt; 2500 g)</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.0203920664799315" CI_END="1.23563264387675" CI_START="0.8077126905950622" DF="2" EFFECT_SIZE="0.9990176011326227" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.01" LOG_CI_END="0.09188937330072147" LOG_CI_START="-0.09274309353056955" LOG_EFFECT_SIZE="-4.2686011492403707E-4" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6003779456981413" P_Z="0.9927691440784377" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.10004849242109" Z="0.009062658004263383">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.4309189740060044" CI_START="0.794737921607247" EFFECT_SIZE="1.0663984111906328" ESTIMABLE="YES" ESTIMATE="0.064287" LOG_CI_END="0.15561504246812063" LOG_CI_START="-0.0997760637518919" LOG_EFFECT_SIZE="0.027919489358114332" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="150" SE="0.150018" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.937209694426947"/>
<IV_DATA CI_END="3.26771609846792" CI_START="0.5284076123351577" EFFECT_SIZE="1.3140342694848528" ESTIMABLE="YES" ESTIMATE="0.273102" LOG_CI_END="0.5142443176814637" LOG_CI_START="-0.27703093448798" LOG_EFFECT_SIZE="0.11860669159674188" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="152" SE="0.464799" STUDY_ID="STD-USA-1995" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.931018520664126"/>
<IV_DATA CI_END="1.233598063050666" CI_START="0.6415968361268494" EFFECT_SIZE="0.8896474663064673" ESTIMABLE="YES" ESTIMATE="-0.11693" LOG_CI_END="0.09117367879453747" LOG_CI_START="-0.19273778633243197" LOG_EFFECT_SIZE="-0.05078205376894727" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="151" SE="0.166771" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.231820277330019"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.6949424347775894" CI_END="1.1585176819747887" CI_START="0.9550971359183261" DF="2" EFFECT_SIZE="1.0519015733255934" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.02" LOG_CI_END="0.0639026666330962" LOG_CI_START="-0.019952457266455326" LOG_EFFECT_SIZE="0.021975104683320427" MODIFIED="2010-03-22 11:47:15 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.706472437350853" P_Z="0.3042991169022454" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="82.89995150757892" Z="1.0272577687059115">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.2133474603640517" CI_START="0.9545712081139505" EFFECT_SIZE="1.0762093435302011" ESTIMABLE="YES" ESTIMATE="0.073445" LOG_CI_END="0.08398518545887422" LOG_CI_START="-0.020191669012105576" LOG_EFFECT_SIZE="0.03189675822338432" MODIFIED="2010-03-22 11:46:45 +0000" MODIFIED_BY="[Empty name]" ORDER="154" SE="0.061194" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="53.71196069965597"/>
<IV_DATA CI_END="1.2165431687792112" CI_START="0.7609151931472435" EFFECT_SIZE="0.9621258650735846" ESTIMABLE="YES" ESTIMATE="-0.03861" LOG_CI_END="0.08512752438887938" LOG_CI_START="-0.11866374428144856" LOG_EFFECT_SIZE="-0.016768109946284537" MODIFIED="2010-03-22 11:47:02 +0000" MODIFIED_BY="[Empty name]" ORDER="153" SE="0.119708" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.035967066802622"/>
<IV_DATA CI_END="1.320580285834762" CI_START="0.8406639770812104" EFFECT_SIZE="1.053643333934635" ESTIMABLE="YES" ESTIMATE="0.052254" LOG_CI_END="0.12076480965887212" LOG_CI_START="-0.07537756194412712" LOG_EFFECT_SIZE="0.022693623857372495" MODIFIED="2010-03-22 11:47:15 +0000" MODIFIED_BY="[Empty name]" ORDER="155" SE="0.115215" STUDY_ID="STD-Zimbabwe-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.152023741120331"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="3.028465824260992" CI_END="1.0543001259373375" CI_START="0.7800880226662638" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="0.9068885822080077" ESTIMABLE="YES" I2="0.0" I2_Q="35.80677501446112" ID="CMP-002.13" LOG_CI_END="0.02296425839496089" LOG_CI_START="-0.1078563901282248" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.04244606586663197" MODIFIED="2015-03-30 14:57:40 +0100" MODIFIED_BY="Leanne V Jones" NO="13" P_CHI2="0.5530731411028875" P_Q="0.21198814466336924" P_Z="0.20342297104380735" Q="1.557796792769447" RANDOM="NO" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.2718597763145794">
<NAME>Neonatal intensive care unit admission</NAME>
<GROUP_LABEL_1>Reduced visits</GROUP_LABEL_1>
<GROUP_LABEL_2>Routine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours reduced visits</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours routine</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.282898509850195" CI_END="1.4136104325054464" CI_START="0.7950504290116128" DF="2" EFFECT_SIZE="1.0601375292002198" ESTIMABLE="YES" I2="0.0" ID="CMP-002.13.01" LOG_CI_END="0.15032974162238413" LOG_CI_START="-0.09960532373739216" LOG_EFFECT_SIZE="0.02536220894249601" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5265288248722346" P_Z="0.6907957189148726" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="27.39669743728018" Z="0.3977754463873785">
<NAME>Individual randomisation</NAME>
<IV_DATA CI_END="1.6012804893730814" CI_START="0.7167862392146198" EFFECT_SIZE="1.071342998252883" ESTIMABLE="YES" ESTIMATE="0.068913" LOG_CI_END="0.204467412067605" LOG_CI_START="-0.1446103408048074" LOG_EFFECT_SIZE="0.02992853563139879" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="157" SE="0.20505" STUDY_ID="STD-England-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.044563702167896"/>
<IV_DATA CI_END="1.5232404223165457" CI_START="0.6576134893404973" EFFECT_SIZE="1.0008513622032378" ESTIMABLE="YES" ESTIMATE="8.51E-4" LOG_CI_END="0.18276845609035183" LOG_CI_START="-0.18202928688215253" LOG_EFFECT_SIZE="3.6958460409970364E-4" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="156" SE="0.214284" STUDY_ID="STD-USA-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.860217395675084"/>
<IV_DATA CI_END="30.268177103222424" CI_START="0.4128227726696686" EFFECT_SIZE="3.5348822887627898" ESTIMABLE="YES" ESTIMATE="1.26268" LOG_CI_END="1.480986266419066" LOG_CI_START="-0.3842363535998701" LOG_EFFECT_SIZE="0.548374956409598" MODIFIED="2010-03-22 11:23:01 +0000" MODIFIED_BY="[Empty name]" ORDER="158" SE="1.095641" STUDY_ID="STD-USA-1997" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.491916339437204"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.1877705216413499" CI_END="1.0203108123128828" CI_START="0.7164745542352077" DF="1" EFFECT_SIZE="0.85500101428784" ESTIMABLE="YES" I2="0.0" ID="CMP-002.13.02" LOG_CI_END="0.008732488929108103" LOG_CI_START="-0.14479922906492484" LOG_EFFECT_SIZE="-0.06803337006790841" MODIFIED="2010-03-22 11:48:33 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6647787140962595" P_Z="0.08238565791433375" STUDIES="2" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="72.60330256271982" Z="1.7370085715469974">
<NAME>Cluster randomisation</NAME>
<IV_DATA CI_END="1.0161107459134109" CI_START="0.7037427897163048" EFFECT_SIZE="0.8456243911984913" ESTIMABLE="YES" ESTIMATE="-0.16768" LOG_CI_END="0.006941044284497282" LOG_CI_START="-0.15258604173557178" LOG_EFFECT_SIZE="-0.07282249872553725" MODIFIED="2010-03-22 11:48:20 +0000" MODIFIED_BY="[Empty name]" ORDER="159" SE="0.093707" STUDY_ID="STD-WHO-2001" TOTAL_1="0" TOTAL_2="0" WEIGHT="67.24867485572369"/>
<IV_DATA CI_END="1.8827145402564178" CI_START="0.512202799391025" EFFECT_SIZE="0.9820038991641141" ESTIMABLE="YES" ESTIMATE="-0.01816" LOG_CI_END="0.2747844766871424" LOG_CI_START="-0.2905580522698684" LOG_EFFECT_SIZE="-0.007886787791363061" MODIFIED="2010-03-22 11:48:33 +0000" MODIFIED_BY="[Empty name]" ORDER="160" SE="0.332085" STUDY_ID="STD-Zimbabwe-1996" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.354627706996132"/>
</IV_SUBGROUP>
</IV_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-05-26 09:56:01 +0100" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-05-26 09:56:01 +0100" MODIFIED_BY="Heather Maxwell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-05-26 09:56:01 +0100" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUQAAAInCAIAAABvALf4AAAaGUlEQVR42u3dMY4cxxnF8QUMGA42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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2010-03-23 11:29:13 +0000" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2010-03-23 11:29:13 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Sikorski, Clement, Wilson, 1999</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2010-03-23 11:29:13 +0000" MODIFIED_BY="[Empty name]">
<P>Abstract:<BR/>The conclusion that women were satisfied with the reduced number of visits is not justified by the data in the review.</P>
<P>Analyses:<BR/>The first comparison labelled 'Goal oriented, reduced number of ANC visits versus standard ANC visits' is incorrect, as at least one study (Sikorski 1996) made no attempt to focus on specific goals. For the outcome 'Small for gestational age' the numerators are the wrong way round, the correct data are experimental 277/1393 and control 302/1355. For the outcome 'Patient satisfaction (mean) score 1-6', under 'Quality of prenatal care' the experimental score should be 3.6 (1.02), which will change the direction of the overall effect.</P>
<P>Background:<BR/>The reviewers imply that dissatisfaction is determined entirely by women's expectations. However, further analyses of Sikorski 1996 show that women reporting no prior expectation of the number of visits they would receive were still dissatisfied if they were in the reduced visits group.</P>
<P>Results:<BR/>In results, for the first comparison under 'Biological outcomes' in the penultimate sentence the word 'controls' should be replaced with 'checks'.</P>
<P>Under 'Satisfaction outcomes', the Chi-square is quoted as 54.64, but in the analyses it is 44.94. Also, the sentence '.. two trials demonstrating an increased proportion of women who were less satisfied with the reduced number of visits' is inaccurate and could be replaced with '.. all high quality trials that looked at satisfaction finding greater dissatisfaction with fewer visits'.</P>
<P>Implications for practice:<BR/>The recommendation that four antenatal visits should be the minimum is not justified by the review, as only one trial in one country (Zimbabwe) used this schedule.</P>
<P>General:<BR/>A policy of circulating draft reviews to the trialists may help improve their quality before publication.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY>
<P>The review has been revised to incorporate the above comments and criticisms.<BR/>(reply from Jose Villar, July 1999)</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Jim Sikorski, Sarah Clement and Jenny Wilson</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>